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Chronic hypersensitive pain states can become established following sustained, 
repeated or earlier noxious stimuli and are notably difficult to treat, especially in 
cases where nerve injury contributes to the trauma. A key underlying reason is that a 
variety of plastic changes occur in the central nervous system (CNS) at spinal and 
potentially also supraspinal levels to upregulate functional activity in pain processing 
pathways. A major component of these changes is the enhanced function of 
excitatory amino acid receptors and related signalling pathways.  
Here we utilised rodent models of neuropathic and inflammatory pain to investigate 
whether evidence could be found for lasting hypersensitivity following neonatal (or 
adult) noxious stimuli, in terms of programming hyper-responsiveness to subsequent 
noxious stimuli, and whether we could identify underlying biochemical mechanisms. 
We found that neonatal (postnatal day 8, P8) nerve injury induced either long lasting 
mechanical allodynia or shorter lasting allodynia that nonetheless was associated 
with hyper-responsiveness to a subsequent noxious formalin stimulus at P42 despite 
recovery of normal mechanical thresholds. By developing a new micro-scale method 
for preparation of postsynaptic densities (PSD) from appropriate spinal cord 
quadrants we were able to show increased formalin-induced trafficking of GluA1-
containing AMPA receptors into the PSD of animals that had received (and 
apparently recovered from) nerve injury at P8. This was associated with increased 
activation of ERK MAP kinase (a known mediator of GluA1 translocation) and 
increased expression of the ERK pathway regulator, Sos-1. Synaptic insertion of 
GluA1, as well as its interaction with a key partner protein 4.1N, was also seen in 
adults during a nerve injury-induced hypersensitive pain state.  
Further experiments were carried out to develop and optimise a new technological 
platform enabling fluorometric assessment of Ca
2+
 and membrane potential 
responses of acutely isolated CNS tissue; 30-100 m tissue segments, 
synaptoneurosomes (synaptic entities comprising sealed and apposed pre- and post-




conditions were found that produced viable preparations, which could consistently 
deliver dynamic functional responses. Responsiveness of these new preparations to 
metabotropic and ionotropic receptor stimuli as well as nociceptive afferent stimulant 
agents was characterised in frontal cortex and spinal cord.  
These studies have provided new opportunities for assessment of plasticity in pain 
processing (and other) pathways in the CNS at the interface of in vivo and in vitro 
techniques. They allow for the first time, valuable approaches such as microscale 
measurement of synaptic insertion of GluA1 AMPA receptor subunits and ex vivo 
assessment of dynamic receptor-mediated Ca
2+
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Chapter 1 Introduction 
1.1 Pain 
The International Association for the Study of Pain (IASP) has defined pain as “an 
unpleasant sensory and emotional experience associated with potential or actual 
tissue damage or described in terms of such damage” and added that “the inability to 
communicate in no way negates the possibility that an individual is experiencing 
pain and is in need of appropriate pain relieving treatment” (Merskey and Bogduk, 
1994).  
This definition indicates that pain is a complex experience of somatic mechanisms 
and psychological influences such as affect and cognition that may help humans or 
animals to best avoid further injury, but in some cases its maintenance as prolonged 
chronic pain states produces a continuous unpleasant sensory experience that causes 
suffering and distress. 
Pain can be classified as acute (physiological) pain and chronic (pathological) pain, 
such as inflammatory pain and neuropathic pain (arising from nerve injury). The 
former appropriately signals the need for evasive or protective actions to avoid 
further damage, whereas the latter can represent inappropriately prolonged painful 
hypersensitivity even after resolution or healing from an acute injury.  
1.2 Normal somatosensory processing 
The somatosensory system is the part of the nervous system that is involved in the 
processing of many kinds of sensory modalities such as touch, pressure, 
proprioception, temperature, and nociception (pain) (Barker and Barasi, 2008c). It 
comprises the sensory receptors themselves, usually located on nerve terminals in the 
peripheral nervous system (PNS) and processing regions in the central nervous 
system (CNS). The full spectrum of events involved in somatosensory processing is 




by specialised endings of peripheral nerves and translated into electrical impulses, i.e. 
action potentials, which are carried along the axon towards to the spinal cord. There, 
the information is often influenced by interneurons before being relayed via 
ascending sensory pathways to higher centres of the brain including the cortex for 
cognitive awareness of that sensory input. 
1.2.1 Sensory transmission in the PNS 
Somatosensory stimuli can be detected by peripheral afferent nerve endings, which 
are distributed throughout the body to receive a variety of sensory information. The 
cell bodies of these afferents are located in the dorsal root ganglia of the spinal 
nerves for nerves originating in the body or in the trigeminal ganglia for nerves 
transmitting somatosensory information from the head. The central endings of their 
axons mainly terminate in the dorsal horn of spinal cord to form the first series of 
synapses before these inputs are relayed to higher levels of the CNS.  
1.2.1.1 Peripheral afferent fibres 
A peripheral sensory nerve is composed of afferent fibres that receive various stimuli 
in the periphery and transmit information as nerve impulses to CNS. The afferent 
fibres have been classified according to size, structure, function, and conduction 
velocity.  
A-fibres are large thick myelinated fibres (between 5-12 m in diameter) that 
convey low-threshold stimuli, such as pressure, vibration and light touch, with 
conduction speeds of 30-70 metres/second. They normally do not contribute to pain 
sensation but are involved in the process of innocuous sensation. However a 
subpopulation of them that express the VGLUT1 subtype of vesicular glutamate 
transporter may have a role to play in injury-induced mechanical allodynia 
(Neumann et al., 2008) A-fibres are smaller, lightly myelinated fibres (1-5 m in 
diameter) conveying high-threshold noxious stimuli at slower speeds of 2.5-30 
metres/second and serving pain, temperature, and pressure sensation. C-fibres are 




stimuli, such as thermal stimuli in the noxious range with lower speeds of 0.6-2.0 
metres/second.  
Generally there is a predictable correlation between the type of cutaneous stimulus 
detected and the type of afferent fibre involved; for example, faster, thicker, 
myelinated neurons are likely to conduct generalised touch sensation whereas slow, 
thin, unmyelinated neurons are likely to conduct nociceptive events. 
1.2.1.2 Sensory receptors 
There are many different kinds of sensory receptors in the skin. They can be divided 
into several broad groups, such as thermoreceptors, mechanoreceptors and a range of 
nociceptors. 
Thermoreceptors 
Thermoreceptors are represented by free endings of afferent fibres and encode a full 
range of innocuous thermal information. They are located in various tissues 
including cornea, urinary bladder and the skin (Darian-Smith et al., 1979; Dhaka et 
al., 2008). Cold-sensitive thermoreceptors give rise to the sensations of cooling and 
cold. They can be activated by temperatures below 27°C (Darian-Smith et al., 1979; 
Duclaux et al., 1980). Warm-sensitive thermoreceptors respond to a slight warming 
of the skin in the innocuous range, 30-37°C (Darian-Smith et al., 1979; Moqrich et 
al., 2005). 
Mechanoreceptors 
Mechanoreceptors are specialised for touch sensation and are found in the skin at 
particularly high density in the fingertips, whereas those subserving a proprioceptive 
role are found not only in the skin but also in the muscle and joints. Such 
mechanoreceptors can be further characterised by structure, location, receptive fields 
and speed of adaptation. Meissner corpuscles with very small, sharply defined 
receptive fields are packed in high density at the fingertips, palm of the hand, plantar 




location of a stimulus, low-frequency flutter-vibration and dynamic touch stimuli 
(Fukuda et al., 1982). In contrast, Pacinian corpuscles are rapidly adapting receptors 
and responsive to high-frequency vibration with a very short recovery cycle as they 
are only transiently responsive to vibration and quickly stop firing in the presence of 
continuous sensory stimuli (Weerakkody et al., 2007). These receptors are distributed 
abundantly in the subcutaneous connective tissue of the hands and feet. Ruffini‟s 
corpuscles are found in the dermis of the skin and are widely located, especially in 
joint capsules. They are more slowly adapting receptors and associated with 
sensations of direction, magnitude, pressure, touch, and flexion and extension of 
joints (Grandis et al., 2007). The discharge of these receptors is temperature-
dependent, tending to increase with skin cooling and to decrease to skin warming. 
Nociceptors  
Nociceptors that detect potentially damaging levels of thermal, mechanical or 
chemical stimuli are specialised endings of peripheral afferents. They were 
discovered by Charles Scott Sherrington in 1906 and are found ubiquitously in the 
skin, cardiac muscles, visceral organs and associated blood vessels. Nociceptors 
encode the intensity, duration, location, and quality of the noxious stimulus and 
transduce this information into action potentials which are relayed to the CNS. 
Nociceptors are represented by two main types of peripheral afferents, which are thin 
myelinated A-fibres and unmyelinated C-fibres. The A- and C-fibres have been 
proposed to mediate rapid, sharp pain („first pain‟) and dull, diffuse pain („second 
pain‟) respectively (Wolf and Hardy, 1941). Several distinct types of nociceptors 
have been identified:  
Thermal nociceptors are activated by noxious heat or cold. There is increasing 
evidence that Transient Receptor Potential (TRP) ion channels, which are expressed 
in nociceptive afferent fibres, may play a key role. TRP channels are non-selectively 
permeable to cations, including sodium, calcium, magnesium, and potassium. The 
first to be discovered was the transient receptor potential vanilloid 1 (TRPV1) 
receptor (Caterina et al., 1997b), whose temperature activation threshold of around 




Other TRP channels such as TRPV2, TRPV3 and TRPV4 (Dhaka et al., 2006), 
expressed by some afferents, can respond selectively to distinct ranges of elevated 
temperatures (Numazaki and Tominaga, 2004; Brauchi et al., 2006). It is possible 
that monomers of these TRP channels may combine to form heteromeric (tetramer) 
complexes with potentially intermediate properties but there is little documentation 
of this at the present time. Moreover, the heat sensitivity primarily mediated by TRP 
channels may be modulated by heat-sensitive potassium channels like TREK-1 
(Alloui et al., 2006), whose activity could be reduced by increased heat. 
Cool stimuli are sensed by other TRP channels such as TRPM8. Although this 
channel appears to be activated by cool stimuli, it is seems improbable that it 
contributes to a major extent in the detection of noxious levels of cold since TRPM8 
knockout mice still respond to intense cold (Bautista et al., 2007; Dhaka et al., 2007). 
Other candidate channels such as transient receptor potential cation channel, 
subfamily A member 1, also known as TRPA1 may also contribute to the detection of 
intense cold (Bandell et al., 2004b). 
Chemical nociception can be mediated by individual TRP channels that respond to a 
wide variety of pungent plant-derived chemicals such as chili, garlic, mustard, and 
horseradish (Xu et al., 2006). Other chemical stimulants are environmental irritants 
like formalin, which is thought to exert its noxious effects by molecular modification 
and activation of the TRPA1 channel (McNamara et al., 2007). Moreover the TRPV1 
channel for example, not only detects noxious heat stimuli and chemicals such as 
capsaicin, but also protons (Jancso, 1967) and some spider toxins (Siemens et al., 
2006). Nociceptors further show amplified responsiveness to such stimuli in the 
presence of endogenous inflammation-associated ligands like ATP, interleukin IL-
1bradykinin, nerve growth factor (NGF) and certain fatty acid derivatives that 
arise from injury-induced changes in tissues (Geppetti, 2006).  
There are also mechanical nociceptors that respond to excess pressure or mechanical 
deformation and also to incisions that break the skin surface (Kwan et al., 2006). 
Many mechanical nociceptors have polymodal characteristics, whereby some forms 




Candidate molecular mediators of mechanical nociception, for example TRPA1 
(Kwan et al., 2006), can also respond to thermal and chemical stimuli. 
Although most nociceptors are polymodal, some are unimodal and respond only to 
thermal or mechanical stimuli, for example A-mechanonociceptors (Cooper and 
Bomalaski, 1994).  
1.2.2 Sensory transmission in the spinal cord 
As part of the CNS, the spinal cord is the gateway for information transfer between 
body and brain, as well as a centre for neuronal circuits that integrate and coordinate 
complex sensory, motor, and autonomic functions. The spinal dorsal horn is one of 
the sensory processing components and is the main target of investigation in this 
study. 
The central terminals of sensory afferents form synapses with neurons in the spinal 
dorsal horn and release neurotransmitters and neuropeptides into the synaptic cleft. 
These agents diffuse from the presynaptic active zone to the postsynaptic membrane 
and bind to their receptors on the postsynaptic membranes especially at the 
postsynaptic density (PSD). The activated receptors in turn either gate ion 
movements or trigger intracellular signalling pathways to transmit the nociceptive 
message. This processing of nociceptive information can be diversely modulated by 
different types of interneurons or by descending neuronal tracts before transmission 
to higher centres of the CNS. As well as informing the brain of incoming sensory 
information, the circuitry of the dorsal horn processes different kinds of reflex 
circuits, such as nociceptive withdrawal responses and crossed extensor reflexes. 
However, many reflexes can be heavily modulated by other influences supplied from 
the brain. Behavioural reflex assessments of „pain‟ sensitivity need careful design 
and handling because in many cases the animals can experience a learned component 
to responses with certain reflexes becoming extensively modulated across time with 
training. In addition, the regulation of some reflexes may not necessarily give a close 
reflection of influences over transmission processes to the brain, as it is possible that 




hypothetically be inhibitory processes that set a gate to limit activity in transmission 
neurons but do not impinge on local reflexes.  
1.2.2.1 Dorsal horn organisation  
Axons of peripheral sensory afferents arriving from the body tissues end in different 
regions of spinal dorsal horn (Light and Perl, 1977), which can be broadly divided 
into five layers known as laminae I-V extending from the superficial to the deep 
dorsal horn (Molander et al., 1984; Barker and Barasi, 2008) (Figure 1.1) according 
to the cytoarchitectonics, or cellular organisation, originally investigated in the cat 




Figure 1.1: Laminar organization of lumbar spinal cord in rats 
Source: Molander, Xu and Grant (1984) 
The diagram shows a schematic drawing of the cytoarchitectonic subdivisions of rat 
spinal L5 segment. This is a transverse view of a hemisected spinal cord. 
Abbreviations: 
Liss- Lissauer‟s tract 
Pyr- Pyramidal tract 
LSN- Lateral spinal nucleus 
IM- Intermedio-medial nucleus 
VM- Ventro-medial nucleus 



















Lamina I („marginal zone‟) is a thin layer extending in both rostrocaudal and 
mediolateral axes with loosely packed small and large cells. The marginal zone is 
functionally heterogeneous because many cells respond to a wide range of intense 
mechanical and thermal stimuli, receiving convergent inputs from A- and C-fibres. 
Therefore, lamina I is considered to relay information related to nociception (pain) 
and temperature sensation. Indeed, a recent study gives support to the theory that 
lamina I may comprise part of a specific pain transmission system (Honore et al., 
2002), signalling pain intensity rather than finely resolved location, to autonomic and 
affective centres in the brain (Bernard et al., 1996; Doyle and Hunt, 1999). Moreover, 
it has been reported that the cells in lamina I have two major axonal outputs, one 
projecting to different segments of the spinal cord via a propriospinal system (Sar et 
al., 1978) and another contributing importantly to the contralateral 
Spinomesencephalic and Spinothalamic tracts (Ding et al., 1995; Bester et al., 2000) 
(see section 1.2.2.4 below).  
Lamina II („substantia gelatinosa‟) cells are located radially and oriented just ventral 
to the marginal zone. C-fibre thermoreceptors and nociceptors terminate in the most 
superficial substantia gelatinosa, which is referred as outer zone (LIIo). The deeper 
portions of lamina II receive input from C-fibre mechanoreceptors, whereas A 
mechanoreceptors distribute to the deep substantia gelatinosa known as inner zone 
(LIIi) and lamina III immediately below this (Light and Perl, 1979; Sugiura et al., 
1986). Lamina II is the main termination site for unmyelinated C-fibres and is 
considered to be an important site for transmission of nociceptive information (Light 
and Perl, 1979; Sugiura et al., 1986; Todd, 2002; Todd and Koerber, 2005). Only 
~1% of LII neurons send projections to brainstem (Willis et al., 1979) and are mostly 
intrinsic interneurons with extensive local integration.  
Directly below these superficial layers are laminae III-V where cells are less tightly 
packed than in lamina II and are generally larger. They may be mainly concerned 
with exteroceptive and proprioceptive sensation, although cells in this layer are also 
responsive to noxious stimuli as well as non-noxious events. Many of the cells in 
laminae III-V contribute to the Spinocervical and Postsynaptic dorsal column tracts 




broadly identifies the superficial laminae as receiving predominantly noxious 
information from the periphery, whilst the deeper layers of the dorsal horn appear to 
be involved in both non-nociceptive and nociceptive processing. It may well be that 
the more superficial laminae contribute more to sensory noxious awareness in terms 
of their trajectories to predominantly the brainstem, whereas the deeper layers of 
dorsal horn neurons appear to access more direct routes to the cortex (Hunt and 
Mantyh, 2001). These distinct trajectories may correspond to partially separate 
processing of the affective and discriminative properties of pain respectively. There 
are many different influences within the spinal dorsal horn that affect processing and 
neurotransmission towards higher levels of the CNS. These influences are mediated 
by the actions of neurotransmitters, through receptors involving numerous second 
messenger pathways, and also ion channels, all of which may modulate synaptic 
activation, which is the subject of this thesis. 
1.2.2.2 Dorsal horn neuron types 
The spinal cord dorsal horn contains various cell types ranging across nociceptive- 
and proprioceptive-specific neurons, wide dynamic range neurons, inhibitory and 
excitatory interneurons and glial cells. As mentioned before, nociceptive-specific 
cells are mostly found in superficial laminae I and II and form primary synapses with 
A- and C-fibres only, being activated when a noxious stimulus is applied in the 
periphery (Cervero et al., 1976). Proprioceptive-specific and non-nociceptive cells 
appear to be more often present in the deeper dorsal horn, responding to joint 
movement, touch and pressure (Iggo and Ramsey, 1974). Wide dynamic range 
neurons (WDRs), which are commonly found in laminae III-V are responsive to a 
broad range of intensity of stimuli from peripheral nerves including both noxious and 
innocuous events (Mendell, 1966). These cells in particular may be involved in the 
phenomenon of „wind up‟, which is a kind of central sensitisation caused by repeated 
electrical activation of peripheral afferents at sufficient intensity to stimulate the C-
fibres (Dickenson and Sullivan, 1987). In addition, numerous interneurons are 
located in the spinal superficial dorsal horn to provide both glutamatergic excitatory 
and GABAergic or glycinergic inhibitory influences. Subsets of interneurons may 




influence the output from projection cells located in lamina I or those in laminae III-
V, which have dorsally directed dendrites in laminae I and II. Recently, the role of 
spinal glial cells such as astrocytes and microglia in nociceptive transmission 
especially in pathological conditions has been increasingly revealed (Meller et al., 
1994; Watkins et al., 1997; Coyle, 1998; Scholz and Woolf, 2007). 
1.2.2.3 Neurotransmitters and their receptors in dorsal horn 
Neurons in the dorsal horn communicate with other neurons or glial cells by 
releasing chemical neurotransmitters at their synapses. A vast number of 
neurotransmitters have been identified in the superficial spinal dorsal horn including 
excitatory amino acids (for example glutamate) inhibitory amino acids(such as -
aminobutyric acid (GABA) and glycine) as well as monoamines (such as serotonin, 
noradrenaline (NA) and dopamine) neuropeptides (such as substance P (SP) and 
neuropeptide Y (NPY)) purines, such as ATP and nitric oxide (NO) (von Bohlen und 
Halbach and Dermietzel, 2006).  
Excitatory transmission by glutamate and glutamate receptors 
Glutamate has long been established as an excitatory neurotransmitter at insect and 
crustacean neuromuscular junctions, and it has now become widely accepted that it is 
likely to represent the major excitatory neurotransmitter of the mammalian CNS 
(Wanaka et al., 1987; Battaglia and Rustioni, 1988; Westlund et al., 1989; Weinberg, 
1999). At synapses within the spinal dorsal horn, glutamate is believed to be stored in 
vesicles of the terminals of many primary afferents regardless of whether they are 
myelinated or unmyelinated (Wanaka et al., 1987). Nerve impulses are thought to 
trigger release of glutamate from the vesicles in the pre-synaptic active zone of these 
terminals (Curtis et al., 1960; Davies et al., 1979). It has been suggested that 
nociceptive inputs to the superficial laminae of spinal dorsal horn may release 
glutamate to transmit the nociceptive information and it was identified in early 
studies that glutamate receptor agonists both produce an increase in primary afferent-
induced nociceptive responses and directly excite dorsal horn neurons (Curtis et al., 




primary afferent fibres and dorsal horn neurons has provided evidence that glutamate 
is the principal fast excitatory transmitter, and synaptic responses are mediated by 
postsynaptic glutamate receptors, including -amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (Troca-Marin et al.) and N-methyl-D-aspartic acid (NMDA) 
receptors (Yoshimura and Jessell, 1990; Li and Zhuo, 1998). Both NMDA and 
AMPA receptors in the spinal cord appear to play a crucial role in the central 
sensitisation underlying chronic neuropathic pain (Garry et al., 2000; Shiokawa et al., 
2010; Wang et al., 2010).  
Glutamate binding to its receptors localised in the postsynaptic membrane of CNS 
neurons causes postsynaptic excitation and synaptic plasticity which is important for 
communication, memory formation, learning and states of hyper-responsiveness 
(Asztely and Gustafsson, 1996; Debanne et al., 2003; Perez-Otano and Ehlers, 2005). 
Glutamate receptors can either be ionotropic (which are ligand-gated ion channels) or 
metabotropic (involving second messenger production) (Palmada and Centelles, 
1998). The present study has concentrated on the ionotropic variety. Ionotropic 





 and also K
+
 in rapid response to glutamate binding. Several specific 
subtypes of ionotropic glutamate receptors with highly conserved structures have 
been identified. The main subtypes are designated by the pharmacological agonists 
capable of activating them; NMDA receptors, AMPA receptors and kainate receptors. 
The subunit monomers all have a common structure, with an extracellular N-
terminus, four transmembrane domains (of which the second transmembrane domain 
kinks back on itself within the membrane and returns to the intracellular side) and an 
intracellular C-terminus (Hollmann et al., 1994) (Figure 1.2). When the component 
monomers of the receptor come together, the second transmembrane domains form 




Figure 1.2: General structure of AMPA receptor subunits 
Source: modified diagram based on Song and Huganir, 2002 
The different subtypes of AMPA receptor subunits follow the same basic structural 
pattern with an extracellular N-terminus and large loop that together form the 
glutamate binding domain. The C-terminus is intracellular, subject to mRNA splicing, 
creating functionally distinct variant forms and furthermore represents the interaction 
site with intracellular proteins. 
Key: 
1- transmembrane domain I 
2- transmembrane domain II 
3- transmembrane domain III 


























The NMDA receptor is a tetramer with the GluN1 subunit (represented twice) 
comprising the core functional unit and generally the GluN2 subunit subtypes 
(ranging from A-D) or the GluN3 ones (A/B) determining the specific channel 
characteristics (Schuler et al., 2008). These subunits have been shown to be 
distributed throughout the spinal cord, particularly in the superficial dorsal horn, an 
area essential for the processing of nociceptive information in particular 
(Greenamyre et al., 1984; Furuyama et al., 1993; Wee et al., 2008). NMDA receptors 
are usually located in an electron-dense thickening in the excitatory postsynaptic 
membrane, known as the PSD, which additionally contains a variety of scaffolding 
and signalling proteins such as membrane-associated guanylate kinase (MAGUK) 
proteins (which are multivalent adapter proteins), signal transduction molecules and 
other receptors (Ehlers et al., 1996). In mammals, the MAGUK family includes 
PSD-95, synapse-associated protein-97, (SAP-97), PSD-93 and SAP-102. These 
proteins can interact with the intracellular terminal tails of GluN2A and GluN2B 
NMDA receptor subunits and are thought to play a role in the clustering and synaptic 
targeting of NMDA receptors (Scannevin and Huganir, 2000; Sheng and Sala, 2001). 
A unique property of the GluN2 subunit-containing NMDA receptor is voltage-
dependent activation corresponding to removal of ion channel block by extracellular 
Mg
2+
. Activation of NMDA receptors results in voltage-dependent nonselective 




 ions into the cell and K
+
 out of the cell (Dingledine et al., 
1999; Liu and Zhang, 2000; Cull-Candy et al., 2001; Paoletti and Neyton, 2007). In 
contrast, GluN1/3-containing NMDA receptors which are activated by glycine yet 
unaffected by glutamate or NMDA, are relatively impermeable to Ca
2+
, and show 
low affinity for Mg
2+
 (Chatterton et al., 2002), probably because the GluN3 subunit 
has a unique loop 1 structure which is different from that in all other glutamate ion 
channels (Yao et al., 2008). It has been suggested that GluN3 subunit-containing 
NMDA receptors may play a role in synapse formation and long-term potentiation 
when NMDA receptors are thought to be functionally silent in the absence of AMPA 
receptors (Chatterton et al., 2002). Little is still known of the potential functional 
roles of such receptors.  
AMPA receptors are tetramers homomerically or heteromerically made up of 




abundant), GluA3, and GluA4 (alternatively known as GluRA-D or GluR1-4) 
(Keinanen et al., 1990; Dingledine et al., 1999; Collingridge et al., 2009). All of the 
subunit proteins have an extracellular N-terminus, and four membrane-associated 
hydrophobic domains, an intracellular C-terminus, and generally including a PDZ 
domain-binding motif to associate with molecules such as MAGUK proteins. 
Different subunits are thought to bind with different members of the MAGUK 
protein family, for example GluA1 binds to SAP-97, while GluA2 binds to 
alternative partners, known as PICK1 (protein interacting with C-kinase-1) and 
GRIP/ABP (glutamate receptor-interacting protein)/AMPA receptor binding protein 
(Osten et al., 2000; Dev et al., 2004). The protein:protein interactions will be further 
addressed below (see section 1.3.2.4). However AMPA receptors are not thought to 
directly bind with high affinity to PSD-95 due to incompatible PDZ domains. A 
further link is provided by stargazin or other transmembrane AMPAR regulatory 
proteins (TARPs) that also co-assemble with AMPA receptors. They act as auxiliary 
subunits that are required for AMPA receptor maturation, trafficking, and channel 
function and also bind to PSD-95 (Chen et al., 2000; Rouach et al., 2005; Nicoll et 
al., 2006; Ziff, 2007). The GluA1 subunit has been identified consistently as the 
main subunit mediating activity-dependent synaptic insertion and synaptic 
strengthening (Hayashi et al., 2000). Immunohistochemical and in situ hybridization 
studies indicate that the four subunits of AMPA receptors are all expressed in spinal 
dorsal horn (Furuyama et al., 1993) and have also been described in dorsal root 
ganglion cells and afferent terminals (where it has been suggested that they may 
function to inhibit glutamate release acting as autoreceptors (Lee et al., 2002)) and 
also possibly in glia (Tachibana et al., 1994). The GluA1 subunit appears to be 
predominantly expressed in the superficial dorsal horn of adults, whereas the GluA4 
subunit is mainly expressed in younger animals, whilst the expression of GluA2 and 
GluA3 subunits shows little change during development (Brown et al., 2002). AMPA 
receptors open and close quickly within a millisecond time-range and are thought to 
be responsible for most fast excitatory synaptic transmission in the CNS (Platt, 2007). 
AMPA receptor permeability to calcium ions is governed by the GluA2 subunit, with 
the presence of GluA2 subunit rendering the channel impermeable to calcium ions 




channels are the subject of much debate still within the nervous system in adult 
animals and have as yet been little addressed in vivo in neonatal animals.  
Metabotropic glutamate receptors (mGluRs), which are G protein-coupled receptors 
(GPCRs), can indirectly modulate voltage-sensitive ion channels on the plasma 
membrane through signalling cascades over a longer time scale. They are members 
of the group C family of GPCRs containing seven transmembrane domains, an 
extracellular N-terminus and an intracellular C-terminus. Eight different types of 
mGluRs, named mGluR1 to mGluR8, are classified into groups I (mGluRs 1 and 5), 
II (mGluRs 2 and 3), and III (mGluRs 4, 6, 7 and 8) (Chu and Hablitz, 2000; Hinoi et 
al., 2001; Endoh, 2004). They are found at various levels of the nervous system 
(Anwyl, 1999; Chu and Hablitz, 2000; Hinoi et al., 2001). In dorsal root ganglia, 
mGluR1 and mGluR2/3 types are mainly expressed in small and medium diameter 
afferent neurons (Carlton and Hargett, 2007). Group I mGluRs are mainly expressed 
in postsynaptic membrane and coupled to Gq/11 proteins to facilitate nociceptive 
transmission (Conn and Pin, 1997). It is reported that group I mGluR expression is 
increased chronically in the dorsal horn following spinal cord injury (Gwak and 
Hulsebosch, 2005) and activation of group I mGluRs is necessary for activity-
dependent central sensitisation mediated by C-fibres (Young et al., 1997; Azkue et 
al., 2003). Groups II and III mGluRs are found both in afferents and in superficial 
dorsal horn neurons where they are coupled to inhibitory Gi/o proteins to exert 
antinociceptive effects (Pin and Duvoisin, 1995; Proudfoot et al., 2006; Zhang et al., 
2009a). mGluR2 and mGluR3 are strongly expressed in the inner part of lamina II, 
and are also detectable in lamina III-VI of spinal dorsal horn (Tang and Sim, 1999).  
mGluR 7 is reported to be localised in axon terminals of nociceptive afferents in 
laminae I and II of the spinal dorsal horn that are predominantly co-labelled with IB4 
(Li et al., 1997a). mGluR4 is expressed in lamina II of spinal dorsal horn and 
occasionally is reported as present in postsynaptic densities (Azkue et al., 2001).  
Activation of group II/III metabotropic glutamate receptors is consistently reported 
to exert antinociceptive influences in chronic neuropathic pain models (Fisher et al., 
2002; Simmons et al., 2002; Chen and Pan, 2005), although a contrary role for 




and III metabotropic glutamate receptors may modify the vulnerability of a neuron to 
excitotoxicity through their modulation of the outcome from NMDA receptor 
activation (Baskys and Blaabjerg, 2005). Consistently, agonists of group II and III 
mGluRs are reported to reduce NMDA receptor-induced activation and neurotoxicity 
(Ambrosini et al., 1995; Wang and Brownell, 2007).  
Inhibitory amino acids 
The inhibitory amino acids, GABA and glycine, are the chief inhibitory 
neurotransmitters in CNS and contribute to the modulation of sensory processing. 
They bind to specific transmembrane receptors in the presynaptic membrane of 
peripheral afferents or postsynaptic membrane of dorsal horn neurons to regulate 
neuronal excitability. For instance, when GABA binds to its ionotropic GABAA 
receptor, which is a chloride channel (as opposed to GABAB which is a metabotropic, 
second messenger-coupled receptor), the flow of chloride ions into the cell causes 
hyperpolarisation. Such actions generally result in frank inhibition although it may 
be possible that influences are modified or even reversed during a noxious event or 
in chronic pain states following some kinds of damage (Coull et al., 2003). GABA 
receptor activation may also be involved in descending modulatory pathways 
targeting the spinal cord (Pinto et al., 2008), which could potentially attenuate 
chronic pain, for example after spinal cord injury (Gwak et al., 2006). A complex 
profile of influence of GABAergic neurons may therefore be exerted in pain states. 
Glycine is another inhibitory neurotransmitter in the CNS, especially in the spinal 
cord and its receptor is a ligand-gated chloride channel (Cronin et al., 2004; Rajalu et 
al., 2009).  
Neuropeptides 
Diverse neuropeptides are also expressed in dorsal root ganglia and are released from 
the endings of peripheral afferent fibres in dorsal horn of the spinal cord. Here they 
may mediate or modulate neuronal communication by acting on cell surface 
receptors, generally metabotropic GPCRs, which means that cell signalling cascades 
are going to be instigated following activation. Neuropeptides including SP, 




galanin, somatostatin (SOM) and neuropeptide Y (NPY) have been found in afferents 
and/or dorsal horn (Buck et al., 1982; Merighi et al., 1992; Rowan et al., 1993; 
Wiesenfeld-Hallin and Xu, 2001). Many of these co-exist with conventional 
neurotransmitters such as glutamate in synaptic vesicles and their co-release is likely 
to result in complex conjoint actions on target cells (De Biasi and Rustioni, 1988).  
Studies using pharmacological and behavioural approaches showed that 
neuropeptides (including substance P) can potentially act as nnociceptive transmitters 
in the spinal dorsal horn (Levine, 1993; Cao, 1998; De Felipe, 1998). Substance P is 
synthesised in a subset of small DRG cells and is axonally transported to the 
superficial laminae I and II of the dorsal horn, where it preferentially activates 
neurokinin-1 (NK1) receptors during responses to C-fibre mediated nociceptive 
inputs (Honore et al., 2002; El-Nour et al., 2006). Evidence for a role of SP in 
synaptic plasticity following synaptic activation of superficial dorsal horn neurons by 
capsaicin (which selective acts on C-fibre afferents) has been reported (Urban and 
Dray, 1992). In addition, increased expression of NK1 receptors in the superficial 
dorsal horn in both inflammatory and neuropathic pain models indicated that NK1 
receptors may participate in nociceptive transmission (Abbadie et al., 1996). It is 
reported that release of SP due to activation of presynaptic NMDA receptors located 
on the central terminals of small-diameter fibres facilitates and prolongs the 
neurotransmission of nociceptive messages (Liu et al., 1997). Together, the co-
release of glutamate and SP from fine afferent fibres may allow sufficient membrane 
depolarisation to allow for some NMDA receptor activation following prolonged 
peripheral inputs (Afrah et al., 2001).  
Small unmyelinated sensory neurons are classified into two populations; peptidergic 
and nonpeptidergic. The peptidergic population terminate in lamina LIIo of dorsal 
horn and predominantly express SP, CGRP and TrkA (the NGF receptor) while the 
non-peptidergic dorsal root ganglion (DRG) neurons, which terminate in LIIi of 
dorsal horn postnatally switch their dependency from NGF to glial cell line-derived 
neurotrophic factor (GDNF) and are identified by positive staining for lectin B4 (IB4) 





Adenosine 5‟-triphosphate (ATP) is thought to be released from non-peptidergic 
small afferents (Hamilton and McMahon, 2000). P2X3 ion-channel receptors, which 
are predominantly expressed by non-peptidergic afferents within the superficial 
dorsal horn are activated by ATP and play a role in primary afferent transmission and 
nociception (Lewis et al., 1995; Bradbury et al., 1998; Dowd et al., 1998). 
Adenosine is a related neurotransmitter that is produced by metabolism of ATP and 
can exert a modulatory influence by coupling to metabotropic receptors that are 
widely distributed throughout the nervous system and generally exert inhibitory 
effects (Collo et al., 1996).  
Nitric oxide 
Nitric oxide (NO) was identified as a signalling molecule in the body in 1987 
(Palmer et al., 1987). NO is very stable in low, physiological concentrations (~50 nM) 
and freely diffusible across cell membranes, so can ONLY ONE SPACE NOT TWO 
HERE LITINGmediate transcellular signalling (Garthwaite, 2008). NO is 
synthesised by three well-characterised isoforms of NO synthase (NOS): neuronal 
NOS (nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS) in different cell 
types. In the nervous system the expression of nNOS is predominant and it plays a 
role in the development and maintenance of inflammatory and neuropathic pain (Chu 
et al., 2005; Guan et al., 2007). A recent study revealed that nNOS was present in 
27% of neurons in laminae I-III of spinal dorsal horn, which is a key site for 
nociceptive processing. Expression of nNOS in spinal cord and DRG can be 
increased in inflammatory pain evoked by peripheral formalin or CFA injection (Chu 
et al., 2005; Herdegen et al., 1994; Lam et al., 1996). However, following peripheral 
nerve injury, nNOS expression was increased only in DRG (Guan et al., 2007). 
NMDA receptors may be important in recruiting nNOS to synaptic sites through the 
direct interaction with the NMDA receptor-interacting protein, PSD-95 (Brenman et 
al., 1996a). The NO produced in pain states is thought to diffuse out from DRG 
neurons or interneurons in spinal cord to influence neighbouring DRG or dorsal horn 




GC)/cGMP signalling pathway. NO-GC is expressed in neurokinin 1 (NK1)-
receptor-positive projection neurons in lamina I, in inhibitory interneurons in laminae 
II and III of the spinal cord (Ding and Weinberg, 2006) and in satellite non-neuronal 
cells in DRG (Schmidtko et al., 2008). The NO-dependent production of cGMP in 
pain states may contribute to central sensitisation via activation of cGMP-dependent 
protein kinase (cGKI; more commonly known as PKG) in peripheral afferents to 
promote the release of glutamate and substance P or other factors that facilitate 
sensitisation in the spinal cord (Schmidtko et al., 2009).  
Interestingly, NO may also play a role in antinociception in spinal cord, depending 
on the concentration of NO (Luo and Cizkova, 2000; Sousa and Prado, 2001). The 
mechanical allodynia evoked by CCI could be reduced by low intrathecal doses of an 
NO donor but increased by high doses (Sousa and Prado, 2001). cGMP may be 
responsible for both effects of NO because intrathecal injection of the cell-permeable 
cGMP analogue, 8-Br-cGMP also elicits dose-dependent dual effects on nociceptive 
processing (Tegeder et al., 2002).  
1.2.2.4 Ascending sensory pathways 
Most of the sensory output from the dorsal horn to higher centres in the brain is 
carried by spinal projection neurons terminating in the thalamus along such tracts as 
the Spinothalamic (STT), Spinoreticular (SRT), and Spinomesencephalic (SMT) 
tracts. In addition, further ascending pathways may include the Postsynaptic dorsal 
column, Spinocervical, Spinotectal, and Spinohypothalamic tracts, as well as an 
intersegmental system to pass innocuous or in some cases, noxious stimuli to other 
segments of spinal cord (propriospinal system) and/or other brain areas such as 
medulla, mesencephalon, pons, and hypothalamus. These tracts serve different 
purposes, which may depend on both their laminae of origin in the dorsal horn and 
final destination (Dostrovsky and Craig, 2006). Many of these ascending pathways 






Spinothalamic tract (STT) 
The axons of spinal nociceptive-specific neurons (that have received synaptic inputs 
from primarily A-fibres in laminae I and V) traverse across the midline to the 
contralateral side of the spinal cord in the anterior white commissure to form the STT. 
Then, the nociceptive input is transmitted through the STT to the contralateral 
ventroposterior lateral nucleus of thalamus (Barker and Barasi, 2008), whereas a 
large proportion of STT cells with projections to the intralaminar nuclei of the medial 
thalamus originate from more ventral laminae of the spinal cord (laminae VI-VIII) in 
the rat (Matsuzaki et al., 1993). The STT also sends some collateral projections to 
the reticular formation when it ascends through the brainstem. An average of 15% of 
STT cells project to both the thalamus and the reticular formation of brainstem 
(Matsuzaki et al., 1993).  
Spinoreticular tract (SRT) 
C-fibres terminate on nociceptive-specific neurons in laminae II and III of dorsal 
horn. The axons of some neurons that synapse with these nociceptive-specific 
neurons in laminae V-VIII partially form the SRT (Willis, 1985; Zhang et al., 1999). 
SRT neurons are also located in the lateral part of dorsal horn, in or around the 
nucleus proprius, or sparsely in lamina I or III of lumbar dorsal horn (Menetrey et al., 
1980). Many of the axons ascend ipsilaterally, however a small portion of axons 
cross to the opposite side of the spinal cord in the anterior white commissure. 
Approximately 86% of SRT neurons in the rat have clear cutaneous sensitivity and 
generally large receptive fields: 40% respond to innocuous and noxious mechanical 
cutaneous stimuli and radiant heat, 26% are exclusively excited by light tactile 
stimuli and 20% require noxious cutaneous mechanical stimulation for activation, 
whereas the remaining 14% have more complex receptive fields associated with both 
excitatory and inhibitory inputs originating from a single peripheral area (Menetrey 
et al., 1980). The SRT conveys sensory information to the brainstem reticular 
formation, the region responsible for producing arousal and wakefulness, thus 
alerting the organism following an injury. Then the signals are relayed predominantly 




nuclei of the thalamus through reticulothalamic fibres (Menetrey et al., 1980; 
Kevetter et al., 1982).  
Spinomesencephalic tract (SMT) 
Spinomesencephalic tract cells are located throughout spinal gray matter including 
marginal zone, lateral neck of the dorsal horn, nucleus proprius, the region around 
the central canal, the lateral cervical and spinal nuclei, and the ventral horn 
(Yezierski and Mendez, 1991). Most SMT cells in lumbar cord project to the 
contralateral midbrain containing the parabrachial nucleus, the periaqueductal gray 
matter (Zhang et al., 1990) and the Raphe nuclei, whilst 5% of the cells have both 
ascending and descending projections (see descending modulatory pathways below). 
Of note, the projection cells originating in lamina I mainly terminate in the 
parabrachial nucleus of the midbrain to form the Spinoparabrachial tract, which 
relays nociceptive signals to the thalamus (Kitamura et al., 1993). About 80% of the 
projection neurons in lamina I express NK1 receptors (Ding et al., 1995; Todd et al., 
2000). This indicates that the Spinoparabrachial tract may well be an important tract 
for nociceptive transmission. It has been shown that NK1-positive lamina I neurons 
with projections to parabrachial area of the brainstem respond to a variety of types of 
noxious stimuli (Doyle and Hunt, 1999). 
Postsynaptic dorsal column tract (PSDC) 
The postsynaptic dorsal column tract represents a component of the Dorsal Column-
Medial Lemniscus (DCML) pathway, which is generally responsible for the 
transmission of innocuous touch, vibration and proprioceptive information to higher 
parts of the CNS. Most neurons of the DCML pathway are afferents that do not relay 
in the spinal cord but pass directly up the dorsal column to synapse in the gracile and 
cuneate nuclei of the medulla. From there, projections pass to the medial lemniscus. 
In a small proportion of cases the afferents synapse in the dorsal horn with neurons 
known as postsynaptic dorsal column cells that then contribute their ascending axons 




Postsynaptic dorsal column cells are concentrated in lamina III or IV of spinal cord 
and project ipsilaterally through the dorsal column (Bennett et al., 1983; Giesler et 
al., 1984). They contain two types of fibres, some of which are specifically 
responsive to gentle stimulation such as hair movement, pressure, pinching and 
cooling, while others are vigorously responsive to noxious cutaneous stimulation 
(Brown et al., 1983).  
Other pathways  
Many kinds of pathways transmit pain information to the brain. Spinocervical tract 
neurons are mainly located in laminae III, IV, and V and generally display a wide-
dynamic range (WDR) profile of responsiveness.  Many respond to low threshold 
tactile stimuli, although some are activated by intense cutaneous pressure, pinch and 
thermal nociceptive stimulation. Spinotectal fibres are predominantly large diameter 
fibres in the spinal cord (Antonetty and Webster, 1975) that end in the deep layers of 
the superior colliculus and have the reflex function of turning the upper body, head 
and eyes in the direction of a painful stimulus (Antonetty and Webster, 1975; 
Rhoades, 1981). Spinohypothalamic neurons are mainly found within the deep dorsal 
horn, while some are also found within the lateral spinal nucleus, the superficial 
lamina I of the dorsal horn, in the gray matter surrounding the central canal, and in 
ventral horn (Burstein et al., 1990). Their fibres ascend to the hypothalamus where 
they synapse with neurons that give rise to the Hypothalamospinal tract. 
Spinohypothalamic neurons are also NK1-positive and responsive to SP (Li et al., 
1997b). Moreover this tract is also associated with autonomic nociception (Zhang et 
al., 1999). The intersegmental propriospinal system consists of axons that arise from 
dorsal horn neurons and the dorsolateral fasciculus proprius. Neurons of both 
laminae I and II contribute axons that ascend or descend for up to five to six 
segments before terminating in the spinal grey matter (Christensen and Perl, 1970; 
George and Austin, 1983).  
Overall, about 15% of nociceptive-specific neurons from the spinal cord carrying 
nociceptive information terminate directly in the thalamus, while approximately 85% 




relayed to eventually reach the thalamus via what must be multiple additional 
synaptic relays (Patestas and Gartner, 2006). The brainstem reticular formation sends 
fibres not only to the thalamus but also to the hypothalamus and the limbic system, 
which may each contribute to the affective and autonomic events surrounding 
nociception. From the thalamus, nociceptive information is transmitted to cortical 
regions including primary and secondary somatosensory, insular, anterior cingulate, 
and prefrontal cortices, which have been proposed to function together in what  has 
been described as a „pain matrix‟(Tracey and Mantyh, 2007).  
1.2.2.5 Spinal and supraspinal modulation of sensory 
processing 
Presynaptic inhibition in the spinal dorsal horn 
It was proposed some years ago that nociceptive signals from the periphery are 
filtered by modulation in the lamina II of the dorsal horn by a process of presynaptic 
inhibition known as „Gate Control‟ (Woolf and Wall, 1982). In this theory it was 
proposed that cutaneous stimulation of large A-fibres selectively inhibits C-fibre- 
and noxious stimulation-evoked excitation of dorsal horn neurons. Although there is 
some evidence to support this concept, the precise operation of any gating process 
may be much more complex than originally configured. The basis has never been 
fully resolved experimentally, but it does still provide a target for endeavour with 
modern approaches to address how balanced regulation of sensory processing within 
the dorsal horn may occur. 
Descending modulatory pathways 
The spinal cord is thought not only to be a processing area before transmission to the 
brain but it also importantly receives feedback from the brainstem in particular, via 
descending modulatory pathways. The descending pathways from the brainstem may 
in turn specifically target spinal dorsal horn cells, thus forming a spino-bulbo-spinal 
loop. In addition, a variety of brain regions including the frontal lobe, anterior 
cingulate cortex (ACC), insular cortex and amygdala are involved in contributing to 




brainstem structures including the periaqueductal gray (PAG), nucleus cuneiformis 
(NCF), and rostral ventromedial medulla (RVM). The PAG plays a pivotal role in the 
regulation of nociceptive processing by direct links to serotonergic or a few 
GABAergic and enkephalin-containing neurons in the RVM and to noradrenergic 
neurons in the locus coeruleus (LC) of the medulla (Bajic et al., 2001; Odeh and 
Antal, 2001; Lu et al., 2010). Generally, the descending fibres arising from the 
brainstem may contain serotonin or noradrenaline and many appear to terminate in 
superficial lamina II of the dorsal horn, in broad terms to facilitate or inhibit 
nociceptive transmission to the brain, respectively. 
The descending pathway from the RVM is generally facilitatory and has been 
reported to play a role in maintaining chronic neuropathic pain (Burgess et al., 2002). 
A growing body of evidence indicates that these descending influences may have 
important facilitatory gating influences and recent evidence indicates that they may 
act via 5-hydroxytryptamine (5-HT) receptors such as 5-HT3 within the dorsal horn. 
These 5-HT3 receptors are mainly expressed on nerve terminals of thinly myelinated 
afferents A- and C-fibre afferents (Zeitz et al., 2002) and exert pro-nociceptive 
effects at the spinal level (Green et al., 2000). An active role of descending 
serotonergic facilitation in maintaining neuropathic pain was suggested by its 
attenuation following pharmacological inhibition of spinal 5-HT3 receptors (Suzuki 
et al., 2004). In addition, inhibition may be achieved by serotonin acting on other 
receptor types such as 5-HT1B which exerts a direct inhibitory influence (El-Yassir et 
al., 1988; Sommer, 2004). The descending serotonergic input could also suppress 
incoming nociceptive impulses by the excitation of inhibitory interneurons in the 
superficial laminae I-II of the dorsal horn, which may release the opioids, enkephalin 
or dynorphin. Enkephalinergic neurons in the spinal dorsal horn are closely 
associated with small diameter nociceptive afferents and may modulate the 
excitability of fine nociceptive fibres through pre- and postsynaptic mechanisms 
(Glazer and Basbaum, 1983).  
Descending noradrenergic fibres originating from the LC in the brainstem release 
noradrenaline  in the spinal cord, where it appears to act predominantly at 2-




terminals and suppress activity of projection neurons in the dorsal horn (Fleetwood-
Walker and Coote, 1981; Millan, 2002). It is reported that application of 2-
adrenoceptor antagonists to the spinal cord promotes responses of dorsal horn 
neurons to peripheral inflammation (Green et al., 1998) and further that an 2-
adrenoceptor agonist can inhibit capsaicin-induced glutamate release into the spinal 
cord (Li and Eisenach, 2001). The descending pathways are important to ensure that 
a balanced profile of somatosensory messages reaches the brain and so that the 
resultant pain experienced is appropriate for any particular circumstance. It has been 
suggested that in chronic pain states however, the modulatory effects of descending 
pathways may serve a maladaptive role, causing exacerbation of the pain state (see 
reviews (Zambreanu et al., 2005; Bingel and Tracey, 2008; Mello and Dickenson, 
2008)) and thereby represent a potential target for therapeutic intervention. 
1.3 Chronic pain states 
Chronic pain states can develop when injuries bring about a sensitisation of 
nociceptive processing pathways, which then inappropriately register noxious stimuli 
as intensely noxious (hyperalgesia) and normally innocuous stimuli as noxious 
(allodynia). These changes can long outlast the acute injury and are therefore seen as 
functionally maladaptive. In the clinical setting, chronic pain states represent an 
added level of difficulty for treatment. Various types of injury can induce chronic 
pain states but the focus of the current work, because of its special characteristics, is 
that brought about by nerve injury, i.e. neuropathic pain.   
1.3.1 Neuropathic pain 
Neuropathic pain is a major clinical problem. It arises from traumatic or degenerative 
damage to the nervous system and manifests as a chronic state of hypersensitivity to 
somatosensory stimuli. Neuropathic pain may result from disorders of the peripheral 
or central nervous system. Peripheral neuropathic pain is common in cancer as a 
direct result of the physical or chemical impact of the cancer on peripheral nerves or 
as a side effect of chemotherapy, radiation injury or surgery. Apart from cancer, it has 




HIV infection, genetic and immune-mediated disorders. Central neuropathic pain is 
found in spinal cord injury, multiple sclerosis, and some strokes (Schestatsky and 
Nascimento, 2009). 
The common symptoms of neuropathic pain are weakness, numbness, paraesthesias 
(abnormal sensations such as tickling, pricking) and pain manifesting as increased 
response to a stimulus which is normally painful (hyperalgesia), painful responses to 
normally innocuous stimuli (allodynia) and spontaneous pain. The core mechanisms 
underlying neuropathic pain remain to be fully elucidated.  
1.3.2 Animal models of neuropathic pain  
The first developed animal model of peripheral neuropathic pain was chronic 
constriction injury (Bennett and Xie, 1988) in which the application of loose 
ligatures soaked in chromic salts around the sciatic nerve in rats brought about 
protective behaviour and lowered thresholds for reflex withdrawal responses to heat, 
cooling, and mechanical stimuli. The chromic salts are thought to enhance local 
neuroinflammation. Similar behaviours were also found in the model of partial 
sciatic nerve ligation (PSL), involving tightly ligating around 33%-50% of the sciatic 
nerve (Seltzer et al., 1990). Another widely used neuropathic pain model is spinal 
nerve ligation (SNL), which involves tightly ligating one (L5) or two (L5 and L6) 
segmental spinal nerves in the rat resulting in long-lasting behavioural signs of 
mechanical allodynia, thermal hyperalgesia and spontaneous pain (Kim and Chung, 
1992). In these three animal models of neuropathic pain, only a portion of afferents 
from the hind paw are injured. Aside from the trauma models, Ahlgren and Levine 
developed a metabolic model of neuropathic pain mimicking diabetic neuropathy in 
human by injection of streptozotocin in the rat, inducing decreased nociceptive 
thresholds (Ahlgren and Levine, 1993). The model used in this study was the Bennett 




1.3.3 Alterations in somatosensory processing in 
chronic pain: peripheral mechanisms 
A number of nociceptive small diameter afferents can be activated by (or their 
activation thresholds lowered by) a variety of endogenous chemical mediators for 




, ATP and 
enzymes, especially in conditions of tissue inflammation (Kidd and Urban, 2001). 
These chemical mediators can be released from damaged cells, peripheral sensory 
neurons themselves and inflammatory cells to interact with and sensitise high-
threshold nociceptors (i.e. peripheral sensitisation) and thereby promote primary 
hyperalgesia. Peripheral sensitisation accounts for the heat hyperalgesia that 
develops in the area of primary hyperalgesia within the injured skin area (Meyer and 
Campbell, 1981; LaMotte et al., 1983). Alterations in the properties of voltage-gated 
sodium and potassium channels expressed in nociceptive neurons make them more 
electrically excitable. Inflammatory mediators, including NGF, regulate functional 
expression of the sodium Nav1.8 channel, which is one of the tetrodotoxin-resistant 
subtypes of sodium channel that is predominantly expressed in small sensory 
afferents, especially nociceptors. Both antisense and knockout studies support a key 
role for the channel in contributing to mechanical, cold and inflammatory pain but 
not noxious heat or nerve injury-induced pain (Khasar et al., 1998; Akopian et al., 
1999). For example, phosphorylation of Nav1.8 residues S551 and S556 by p38 
mitogen-activated protein kinase (MAPK) increases current density in dorsal root 
ganglion neurons, implying altered insertion or retention of channels at the plasma 
membrane (Hudmon et al., 2008). In addition, tyrosine phosphorylation of potassium 
channel Kir3.1 in superficial layers of spinal dorsal horn in inflammatory or 
neuropathic pain states results in reduction of potassium channel activity that may 
elevate neuronal excitability to contribute to the hyper-responsiveness to noxious 
stimuli, possibly through a role of glial Kir3.1 in potassium buffering following 
intense pain-induced activity (Ippolito et al., 2005). A variety of primary transducer 
molecules, such as the heat sensor TRPV1, are further regulated by inflammatory 
mediators to alter the gain of the sensory system, for example through 




Furthermore, there is evidence for increased ATP receptor P2X3 immunoreactivity in 
both ipsilateral L4-5 dorsal root ganglia and the associated level of spinal dorsal horn 
following CCI injury in rat (Novakovic et al., 1999). 
In overall terms, following nerve injury there are a number of distinct peripheral 
processes that could contribute peripherally to sensitisation of nociceptive processing; 
(1) direct injury to afferents could lead to spontaneous activity in A-fibres (Boucher 
et al., 2000; Liu et al., 2000) and ectopic sensitivity due to the accumulation and 
clustering of sodium channels around the damaged axons (Lyu et al., 2000; Roza et 
al., 2003), (2) intact A-fibres or adjacent C-fibres that share the same innervation 
territory of the injured fibres could develop spontaneous activity. For instance, A-
fibres of the L5 spinal nerve and approximately half of C-fibres in the L4 spinal 
nerve developed spontaneous activity after ligation and transaction of the L5 spinal 
nerve using single nerve fibre recording (Wu et al., 2001). Spontaneous activity in 
intact L4 C-fibres in both neuropathic and inflammatory pain states may result from 
peripheral inflammation (Djouhri et al., 2006). Unmyelinated mechanoreceptors may 
display hypersensitivity by cross-activation with A-fibres after peripheral injury 
(Neumann et al., 2008; Seal et al., 2009), (Gillinov et al.) inflammation around the 
distal part of the injured nerve may expose the surviving nerve fibres from uninjured 
portions of the nerve to cytokines and growth factors (Scholz and Woolf, 2007) to 
sensitise nociceptors and activate silent nociceptors, (those acting through synapses 
with low basal AMPA receptor content or subject to high levels of tonic inhibition), 
(4) changes in gene expression (including genes for various peptides and receptors). 
The expression of NGF in dorsal root ganglion neurons of both the injured nerve and 
adjacent intact nerve is up- or down-regulated, reflecting the loss of trophic support 
from the periphery (Griffin, 2006), (5) then cross-excitation of afferents via ephaptic 
(non-synaptic, electric field-induced) transmission might occur in dorsal root 
ganglion where spontaneous activity has been observed in uninjured, myelinated 
afferents (Boucher et al., 2000), (6) sympathetic activity may contribute to activation 
of nociceptor afferents; potentially by the sprouting of sympathetic efferents into 
more superficial areas of skin to activate sensory afferents which are induced to 




1.3.4 Alterations in somatosensory processing in 
chronic pain: central mechanisms 
The persistent nociceptive inputs from the peripheral nerves that are generated by 
injury and noxious stimuli are thought to induce functional reorganisation and central 
sensitisation in spinal cord, triggering an increased excitability of nociceptive 
neurons in the dorsal horn of the spinal cord (Woolf and Mannion, 1999; Ji and 
Woolf, 2001). Some degree of structural organisation may occur (Woolf et al., 1995). 
However this hypothesis is now questioned by more recent data (Bao et al., 2002; 
Hughes et al., 2003).  An understanding of the molecular and cellular mechanisms 
underlying pain transmission and modulation is essential to the development of 
clinical strategies aimed at alleviating chronic pain. Studies have shown that the 
activation of NMDA and AMPA receptors is crucial to the generation of spinal hyper-
excitability and pain-related behaviours as a result of nerve injury. In the present 
study, I aim to specifically address the involvement of the GluA1 subunit of AMPA 
receptors and associated proteins in dorsal horn in the development of neuropathic 
pain in rats, since the GluA1 subunit appears to be the main AMPA receptor subunit 
that is recruited to synapses in circumstances of potentiated  responsiveness in other 
parts of the brain (Shi et al., 2001; Malinow, 2003). 
1.3.4.1 Spinal dorsal horn re-organisation 
Large myelinated A-fibres normally terminate in the deep laminae III-IV of dorsal 
horn. However, there is a hypothesis that structural changes occur following 
repetitive discharge from nociceptive afferents. It is reported that A-fibres may 
sprout into the superficial laminae I and II after peripheral axotomy (Woolf et al., 
1992; Shortland and Woolf, 1993; Koerber et al., 1994). The consequence would be 
that the dorsal horn neurons which normally synapse with high-threshold nociceptive 
afferents begin to receive physical connections from innocuous inputs from low-
threshold mechanoreceptors, providing an explanation for the emergence of allodynia 
after peripheral nerve injury. Recently, the tracing methods used by Woolf et al. 




This hypothesis remains largely conjectural because it is not fully supported by 
recent studies which showed that A-fibres sprouted only to the lamina IIi and not 
further dorsally further into the superficial laminae I and IIo following peripheral 
axotomy (Bao et al., 2002; Hughes et al., 2003).  
Other functional re-organisation of the dorsal horn was reported in peripheral 
neuropathy. Coull and colleagues demonstrated that a depolarising shift in chloride 
ion reversal potential occurred in GABA interneurons in the superficial lamina I of 
dorsal horn that was due to a reduction in KCC2 expression in these cells following 
chronic nerve constriction injury (Coull et al., 2003). This could result in GABAA 
receptor-mediated responses becoming excitatory rather than their normal inhibitory 
influence.  
1.3.4.2 Mechanisms potentially responsible for spinal hyper-
excitability 
Modification of neuronal excitability is one of the main ways with which 
neurotransmission can be regulated at spinal and supraspinal levels such as the 
brainstem. The spinal dorsal horn is a prime site contributing to mechanisms of 
chronic pain. Neurons in the spinal dorsal horn and related areas are sensitised by 
noxious stimuli carried by nociceptive fibres (A-fibres and C-fibres) and convey up-
regulated signals to supraspinal structures (Zhuo, 2000). This central sensitisation 
has been experimentally characterised as an increased excitability in response to 
sensory inputs, a prolonged neuronal afterdischarge to repeated stimulation, and 
expansion of peripheral receptive fields (Treede et al., 1992; Yaksh et al., 1999). 
Elsewhere in the CNS, repetitive activity of synapses can induce maintained 
alterations in synaptic strength observed as either long-term potentiation (LTP) or 
long-term depression (LTD) in hippocampus, for example, that may be reflective of 
changes in dendritic spine structure and glutamate receptor clustering at synapses 
(Hayashi et al., 2000; Makino and Malinow, 2009). Some of the mechanisms 
involved in central sensitisation in spinal cord may be comparable. Central 
sensitisation can be brought about by multiple mediators from nociceptive inputs and 




been described in dorsal horn (Liu and Sandkuhler, 1995) and is likely to play some 
part in spinal excitability changes in chronic pain (Ji et al., 2003). In both cases, 
long-lasting changes occur in the processing of neuronal inputs, altering the 
organism‟s perception of future sensory stimuli (Woolf and Salter, 2000b; Zhuo, 
2000). Recent electrophysiological and pharmacological studies demonstrate that 
stimulus- or injury-induced release of glutamate contributes to spinal sensitisation 
(McAdoo et al., 2005; Nguyen et al., 2009).  
The NMDA receptor is thought to act as a synaptic enhancer by reinforcing 
postsynaptic responses to glutamate. NMDA receptors are voltage- and ligand-
dependent (Brown et al., 1988; Daw et al., 1993; Newpher and Ehlers, 2008). At 
resting membrane potentials, NMDA receptors are inactive because of pore blockade 
by extracellular Mg
2+
, even in the presence of glutamate. Thus, to activate NMDA 
receptors at synapses, two events need to happen simultaneously. First, glutamate 
and its obligatory co-agonist, glycine need to be released and then bind to the GluN2 
subunit and GluN1 subunit respectively; second, the postsynaptic membrane needs to 
be depolarised so that the extracellular Mg
2+
 blockage can be removed. Activation of 
NMDA receptors appears to be important for initiating long-lasting changes in 
synapses, such as „wind-up‟ (the increased responsiveness of dorsal horn neurons) 
seen after repeated stimulation of afferents at high intensity), but does not play an 
extensive role in normal non-nociceptive or nociceptive transmission (Davies et al., 
1979; Dickenson and Sullivan, 1987). In various chronic or subacute pain states 
evoked by Complete Freund‟s Adjuvant (CFA), formalin, surgery, varicella zoster 
virus (VZV), diabetic neuropathy or mustard oil, nociceptive inputs are sensitive to 
NMDA receptor antagonists (Yaksh et al., 1995). There is some evidence that 
GluN2B subunit levels are increased in the superficial dorsal horn following nerve 
injury (Boyce et al., 1999), suggesting a possible role for this subunit in nociceptive 
processing.  Moreover, the synaptic expression of the GluN1 subunit in spinal dorsal 
horn is elevated after injection of CFA (Yang et al., 2009). Activation of NMDA 
receptors results in Ca
2+ 
influx, elevating intracellular Ca
2+
 levels, which can have 
many cellular effects, such as the activation of Ca
2+
/calmodulin-dependent kinase II 
(CaMKII). This was highlighted in a recent study where the NMDA receptor (and the 




a neuropathic injury (Garry et al., 2003a) (Figure 1.3a). Furthermore, the 
sensitisation was inhibited by a selective CaMKII inhibitor and was not apparent in 
PSD-95 mutant mice lacking the GluN2-binding region. This provides a clear 
demonstration that receptor-associated protein complexes may play a key role in the 
sensitisation of dorsal horn neurons in neuropathic pain states. In addition, a point 
mutation of the SH3 domain of PSD-95 disrupts recruitment of (and functional 
signalling through) phosphatidylinositol 3-kinase C2 (PI 3-K C2) to the 
NMDAR:PSD-95 complex in inflammatory pain models (Arbuckle et al., 2010) 
(Figure 1.3b). Moreover, NMDA receptors may play a structural role in controlling 
spine and synaptic stability mediated by C-terminal interactions with anchoring 
proteins such as PSD-95 (Alvarez et al., 2007). 
An increased involvement of AMPA receptors has also been shown in established 
neuropathic and inflammatory pain (Morales-Alcelay et al., 2003; Garry et al., 2003b; 
Galan et al., 2004; Vikman et al., 2008; Park et al., 2009). A number of studies have 
tested the hypothesis that silent synapses that contain Mg
2+
-blocked NMDA 
receptors and lack AMPA receptors can become active in chronic sensitised states 
such as LTP because AMPA receptors are rapidly delivered to synapses (Petralia and 
Wenthold, 1992; Molnar et al., 1993; Baude et al., 1995; Petralia et al., 1999). These 
studies indicated the existence of pools of non-synaptic AMPA receptors on both the 
plasma membrane and intracellular regions of dendrites and soma. The trafficking of 
AMPA receptors into synapses may contribute to exciting the cells and may 
contribute importantly to long-lasting changes in synaptic strength (Shi et al., 1999). 
The subunit composition of the AMPA receptor may be crucially important. 
Potentiation of synaptic transmission may occur as a result of delivery of GluA1 
subunit-containing AMPA receptors to synapses, from reserve pools. In addition, 
maintenance of potentiated synaptic transmission may require that GluA2 subunit-
containing AMPA receptors be constitutively exchanged with existing synaptic 





Figure 1.3: Roles of specific domains of PSD-95 in recruiting signalling enzymes 
to NMDA receptor complexes during pain states.    
The MAGUK protein, PSD-95 is an abundant protein in postsynaptic densities of 
excitatory synapses where it serves as an adapter protein to recruit a variety of 
signalling and structural proteins to NR2 subunits of the NMDA receptor. PSD-95 
has a modulator domain structure consisting of 3 PDZ domains, an SH3 domain and 
a GK domain. PDZ domains 1 and 2 mediate interaction with the NMDA receptor.  
Diagrams a) and b) summarise data from PSD-95 mutant mice showing (a) that 
PDZ1/2 domain deletion disrupts neuropathic pain-induced recruitment of CaM 
kinase II to the NMDA receptor (NR2A/B immunoprecipitates probed for CaM 
kinase II) and (b) that W470L mutation in the SH3 domain disrupts inflammatory 
pain-induced recruitment of PI 3-K C2 to PSD-95 (PSD-95 immunoprecipitates 
probed for PI 3-K C2). In each case the hypersensitivity of reflex pain behaviour 
responses was attenuated in the mutant mice compared to wild type litter mates. 
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1.3.4.3 GluA1 subunit-containing AMPA receptor trafficking 
The current consensus view of the insertion of GluA1 subunit-containing AMPA 
receptors into excitatory synapses to strengthen synaptic plasticity during LTP is 
considered to have two main steps which are: extra-synaptic exocytosis to the 
dendritic spine surface and their lateral diffusion into synapses (Makino and Malinow, 
2009). Extra-synaptic insertion is thought to replenish the plasma membrane GluA1 
pools near synapses for subsequent bouts of activity-induced plasticity, while lateral 
diffusion may actually increase the number of GluA1 subunit-containing AMPA 
receptors within synapses. Thus the evoked multisteps AMPA receptor clustering at 
the postsynaptic density may represent a key determinant of long-term changes in 
synaptic excitability.  
GluA1 mRNA and protein are strongly expressed in laminae I and II of the spinal 
dorsal horn in adult rats (Jakowec et al., 1995b; Garry et al., 2004; Polgar et al., 
2008) and this may be increased following nerve injury, but possibly not 
inflammation (Harris et al., 1996). The intracellular carboxy-terminal tail of GluA1 
(containing 82 amino acids from I808 to L889) is thought to be important in 
determining GluA1 trafficking by protein-protein interactions and phosphorylation 
events (Ruberti and Dotti, 2000). The extracellular N-terminus may also contribute to 
the trafficking (Anand, 2000). The GluA1 carboxy-terminal tail can bind to 
intracellular proteins through its PDZ target motif and membrane proximal region to 
facilitate trafficking (Ruberti and Dotti, 2000; Shen, 2000; Hirbec et al., 2002; 
Douyard et al., 2007). For example, the PDZ target motif at the carboxy-terminus of 
GluA1 binds SAP-97 (Leonard et al., 1998), another MAGUK family member, 
whilst protein 4.1 and the p85 subunit of phosphatidylinositol 3-kinase (PI 3-K) have 
been reported as binding to GluA1 at proximal regions of the carboxy-terminal tail 




Figure 1.4: Sequence of the rat GluA1 intracellular C-terminus 
The diagram represents the residues (808-889) of the C-terminal tail of the GluA1 
subunit where binding sites for potential partner proteins (4.1N, p85 PI 3-kinase, AP-















































































































































































































SAP-97 not only binds to the GluA1 carboxy-terminal tail but also interacts with the 
actin-associated protein 4.1N and A-kinase anchoring protein (AKAP) 79/150 (Lue 
et al., 1994; Colledge et al., 2000). 4.1N interaction with SAP-97 may be important 
for synaptic insertion of GluA1 (Rumbaugh et al., 2003), but synaptic clustering of 
GluA1 appears not to be prevented in SAP-97 knockout mice (Klocker et al., 2002). 
GluA1 and PDZ domain interactions however, are required to drive AMPA receptors 
into synapses by LTP or CaMKII in hippocampal neurons (Hayashi et al., 2000). It is 
possible that other PDZ domain proteins may be involved in addition to SAP-97 
(Hirbec et al., 2003; Dev et al., 2004).  
Protein 4.1N can also bind directly to GluA1 in a proximal domain of the C-terminal 
tail between amino acids 812 and 823 (Shen et al., 2000). 4.1N and 4.1G are 
homologs of the erythrocyte membrane cytoskeletal protein 4.1R, which comprises a 
30 kDa N-terminal domain that interacts with glycophorin C, calmodulin, and p55 
(Han et al., 2000), a 16 kDa domain critical for membrane association, a 10 kDa 
domain containing the binding site for spectrin and actin complexes (Correas et al., 
1986) and a 22-24 kDa C-terminal domain (CTD) whose function is for the most part 
unknown. 4.1N is enriched in neurons and shows homology to the other 4.1 family 
members at the 10, 16, and 22-24 kDa domains, but is distinct at its N-terminal 
domain (Walensky et al., 1999). More recently, these proteins have also been shown 
to interact with the GluA4 subunit in a similar manner, but not with GluA2 and 
GluA3 subunits (Coleman et al., 2003). In unpublished work, S. Fleetwood-Walker, 
E. Garry and I have recently found that following nerve injury, the thermal 
hyperalgesia and mechanical allodynia were attenuated after injection of a 
myristoylated peptide, which was designed as a decoy blocker of the proposed 
binding region for 4.1N on the carboxy-terminal tail of GluA1. The amount of 4.1N 
bound to GluA1 in the spinal cord was correspondingly decreased after treatment 
with this agent. In addition, there may well be an increased association between 4.1N 




interactions, 4.1N could potentially link GluA1 to actin in the vicinity of the synapse. 
Recent evidence has further demonstrated that 4.1N is required for activity-
dependent extra-synaptic insertion of GluA1 subunit, thereby supporting the idea of 
the importance of lateral diffusion in supplying AMPA receptors to synapses from 
extra-synaptic pools (Lin et al., 2009).  
An additional GluA1 binding protein is the p85 subunit of Class 1A PI 3-K; one of a 
number of lipid kinases that can phosphorylate PtdIns(4, 5)P2 to PtdIns(3, 4, 5)P3  
(PIP3), which is an important signalling molecule involved in many membrane 
trafficking and recruitment processes (James and Piper, 1994; Carpenter and Cantley, 
1996; De Camilli et al., 1996; Rapoport et al., 1997; Cheever et al., 2001). Moreover, 
PI 3-K is required for selective AMPA receptor insertion into activated synapses 
during LTP in the hippocampus through a process that may involve the p85/GluRA1 
interaction (Man et al., 2003). A recent study illustrated that postsynaptic PIP3 was 
necessary for LTP and required for cycling and synaptic retention of AMPA receptors, 
perhaps through accumulation of PSD-95 at dendritic spines (Arendt et al., 2010).  
PI 3-K, together with its downstream kinase, protein kinase B (PKB/Akt), has been 
implicated in a number of chronic pain states (Pezet et al., 2008) and PI 3-K can be 
activated by a complex of Ca
2+
 and calmodulin through direct interaction with the 
SH2 domain of the PI 3-K p85 subunit during inflammatory hyperalgesia (Joyal et 
al., 1997). A recent report indicated that activation of a PI 3-K, extracellular-
regulated kinase (ERK), PKB signalling pathway was required to drive GluA1 into 
synapses in alerted animals (Qin et al., 2005). Overlapping binding sites in GluA1 
have been reported for 4.1N, PI 3-K and adapter protein-2 (AP-2), which may play a 
role in the regulated exocytosis of GluA1 (Lin et al., 2000), but it is not yet clear 
whether these interactions are mutually exclusive. Stabilisation of AMPA receptor 
localisation at synaptic sites requires the interaction between stargazin-like TARPs 




synaptic GluA1 levels in rat hippocampal neurons (Kessels et al., 2009). Thus the 
acknowledged consensus view is that AMPA receptor trafficking into synaptic 
entities is regulated by a number of different protein-protein interactions.  
Apart from protein-protein interactions, phosphorylation of GluA1 is also important 
for its clustering at excitatory synapses. The GluA1 carboxy-terminal tail can be 
directly phosphorylated on at least 5 distinct sites including serine 816 (S816), S818, 
S831and S845 as well as threonine 840 (T840) (Fang et al., 2003a; Lee et al., 2007; 
Lin et al., 2009). Protein kinase C (PKC) phosphorylation of the S816 residue 
increased GluA1 binding with protein 4.1N and facilitated GluA1 trafficking to 
extra-synaptic plasma membrane of the soma and dendritic shaft, but not on spines 
(Lin et al., 2009). Phosphorylation of the two major sites S831 and S845 on GluA1 
in spinal dorsal horn contributes to central sensitisation and the increased in the 
number of AMPA receptors in excitatory synapses. After capsaicin injection, which 
activates TRPV1 channels in nociceptors, a significant up-regulation of GluA1 
phosphorylation at both S831 and S845 was detected on the ipsilateral side of the 
spinal dorsal horn (Fang et al., 2003a). Pain state-induced phosphorylation of GluA1 
at Ser831 can be achieved by CaMKII and PKC (Fang et al., 2002). Cyclic AMP-
dependent protein kinase A (PKA) bound to GluA1-associated SAP-97 and AKAP 
79/150 can phosphorylate GluA1 at S845 and control the synaptic trafficking 
underlying plasticity (Colledge et al., 2000). The state of phosphorylation at the 
GluA1 PKA site can also affect channel open-time (Banke et al., 2000) and has been 
correlated with changes in synaptic strength (Lee et al., 2000). The PKA signalling 
pathway can be triggered by Ca
2+
  entry through NMDA receptors causing the 
activation of Ca
2+
–dependent adenylate cyclase isoforms (Chetkovich and Sweatt, 
1993; Roberson and Sweatt, 1996). In addition, GluA1 recycling between the plasma 
membrane and endosomal compartments is controlled by PKA phosphorylation 
(Ehlers, 2000). However, the role of phosphorylation of GluA1 may differ between 




with inflammatory but not SNL-induced neuropathic pain (Lu et al., 2008). 
Interestingly, GluA4 contains a corresponding PKA site at S842, at which 
phosphorylation is necessary and sufficient to drive receptors into synapses in early 
postnatal animals (Roche et al., 1996; Carvalho et al., 1999).  In more mature 
animals, other factors such as CaMKII play a greater role, with CaMKII being 
required for LTP only after approximately P14-20 (Yasuda et al., 2003).  
1.3.4.4 The role of GluA2 subunit-containing AMPA receptors  
GluA2 is also a critical subunit in determining mammalian AMPA receptor function. 
The great majority of AMPA receptors include GluA2 subunits. Although during 
early postnatal development expression of GluA2 is low compared with that of 
GluA1, it increases rapidly during the first postnatal week (Monyer et al., 1991; 
Wisden and Seeburg, 1993). AMPA receptors containing GluA2 subunits have a 
linear current-voltage relationship (Boulter et al., 1990), are impermeable to Ca
2+
, 
and exhibit a relatively low single-channel conductance, while those lacking GluA2 
are Ca
2+
-permeable, and of higher conductance. There is also evidence that even in 
neurons expressing high levels of GluA2, a functionally relevant population of 
GluA2-lacking AMPA receptors can be expressed on the surface under certain 
conditions (Ju et al., 2004; Clem and Barth, 2006). This may reflect GluA1 
homomers, produced by local dendritic synthesis of this subunit (Ju et al., 2004; 
Sutton et al., 2006), potentially suggesting a differential assembly and trafficking for 
local dendritically synthesized AMPA receptors.  
The best functionally characterised GluA2 interactions are at the intracellular tails, 
which contain a proximal NSF/AP-2 site and a distal PDZ binding site. The 
interaction of NSF with GluA2 may contribute to stabilising excitatory currents in 
hippocampal neurons (Song et al., 1998), to the movement of AMPA receptors to the 




containing proteins that can dock to GluA2 include GRIP/ABP and PICK1. GRIP 
and ABP are structurally very similar and contain multiple PDZ domains, so they are 
capable of interacting with many individual postsynaptic proteins. GRIP and ABP 
anchor AMPA receptors at the synapses in a phosphorylation-dependent manner 
(Hirbec et al., 2002). PICK1 contains a single PDZ domain, but can dimerise via a 
separate Bin/amphiphysin/Rvs BAR domain and PICK1 also interacts with PKC 
through its PDZ domain (Perez et al., 2001). It has been proposed that PICK1 may 
translocate GluA2/3 together with PKC and contribute to synaptic clustering (Xia et 
al., 1999). In addition, the BAR domain of PICK1 forms a curved structure on 
dimerisation that can deform membranes or stabilise already curved membranes, 
suggesting that PICK1 may participate in AMPA receptor endocytosis (Perez et al., 
2001; Madsen et al., 2008). A possible role for NSF, GRIP and PICK1 in neuropathic 
sensitisation was suggested in experiments with cell-permeable blocking peptides 
acting as decoys for interaction motifs on GluA2. Differential changes in expression 
of these proteins were also demonstrated following peripheral nerve injury (Garry et 
al., 2003b). Association of NSF/GRIP or PICK1 with GluA2 may act to determine 
recruitment to the PSD (Hanley, 2008). PKC regulation of these interactions may be 
important in the plasma membrane turnover of GluA2 during the maintenance of 
inflammatory pain (Tao et al., 2003; Park et al., 2009).  
1.3.4.5 Involvement of intracellular kinases in nociceptive 
sensitisation 
During nociceptive transmission, a variety of intracellular kinases become activated 
following stimulation of excitatory synapses containing NMDA receptors, AMPA 
receptors and possibly also group I mGluRs. The elevation of intracellular Ca
2+
 
concentration as a result of influx through ionotropic glutamate receptors and 
voltage-sensitive Ca
2+ 
channels as well as release from endoplasmic reticulum is a 
key determinant of central sensitisation. A number of Ca
2+




kinases are responsible for critical regulatory phosphorylation events, both those 
discussed above and other key events in sensitisation. 
CaMKII is a multifunctional, widely distributed kinase. It can be activated following 
NMDA receptor stimulation and is thought to be a critical mediator of neuronal 
plasticity. For example, activation of the CaMKII cascade may evoke alterations in 
gene expression in dorsal horn neurons, thereby producing long-lasting changes in 
function (Ji and Woolf, 2001). Nerve injury increases the assembly of CaMKII in a 
postsynaptic complex with GluN1/2 subunits in a manner dependent on domain-
specific interactions with PSD-95 and furthermore, local administration of an 
inhibitor of CaMKII significantly attenuates nerve injury-induced sensitisation 
(Garry et al., 2003a). 
PKA and PKC are two major intracellular kinases that contribute to activity-
dependent central sensitisation. PKA not only phosphorylates S845 within the 
intracellular terminus of the GluA1 subunit of AMPA receptors to drive them into 
synapses, but also phosphorylates the GluN1 subunit of NMDA receptors at S879 to 
enhance their response to glutamate (Raman et al., 1996; Zou et al., 2002). PKC also 
plays several different roles in hyper-excitability of nociceptive neurons. In addition 
to its effects on AMPA receptors such as phosphorylation of S816, S818, S831 and 
T840 in the GluA1 subunit, PKC phosphorylates GluA1 at S890 and S896 and 
enhances NMDA receptor activation (Lan et al., 2001) as well as decreases inhibition 
arising from spinal GABA and glycine interneurons or from descending pathways 
originating from PAG (Lin et al., 1996b).  
A further kinase of major importance in synaptic plasticity is ERK MAP kinase. ERK 
increases AMPA receptor and NMDA receptor currents by contributing to the 
recruitment of AMPA receptors to the membrane, the phosphorylation of GluN1 
subunit of the NMDA receptor, and reduces outward currents by phosphorylation of 




as cAMP-response element binding protein (CREB) to regulate expression of several 
genes including c-Fos, NK1 and COX-2, which may help to bring about a long-
lasting synaptic strengthening (in the case of COX-2, indirectly by way of increased 
prostaglandin synthesis) (Ji et al., 2009). The role of ERK is a focus of interest in the 
current work.  
1.3.4.6 Regulation of the ERK MAP kinase pathway in the 
nervous system by the small G protein Ras 
The Ras subfamily of small GTP-binding proteins is importantly involved in cell 
growth, differentiation and survival through regulation of gene transcription and 
other signalling events (Young et al., 2009). Activation of the Ras pathway is 
mediated by various Ras-specific guanine nucleotide exchange factors (GEFs) which 
include the highly homologous guanyl nucleotide-releasing factors (GRF) 1/2 (Shou 
et al., 1992), the closely related Son of Sevenless (Sos) 1/2 (Bowtell et al., 1992), 
and guanyl nucleotide-releasing protein (GRP) (Ebinu et al., 1998). In neurons, the 
three types of Ras-specific GEFs can be activated by diverse receptor systems 
including receptor tyrosine kinases (RTKs) for growth factors, GPCRs for 
neurotransmitters, and intracellular Ca
2+
 released from endoplasmic reticulum or 
Ca
2+
 influx through voltage-gated or ligand-gated Ca
2+
 channels (for example, 
NMDA receptors). Activated Ras can enhance AMPA receptor-mediated synaptic 
transmission in LTP by driving more AMPA receptors into synapses (Zhu et al., 
2002). 
Ras-GRF1 and Ras-GRF2 are present predominantly in the adult, where they are 
highly expressed in neuronal cells but not in glial cells (Zippel et al., 1997). Both of 
them can be activated by Ca
2+
 via direct interaction with Ca
2+
/calmodulin in 
combination (Farnsworth et al., 1995). It has been reported that Ras-GRF1 binds 




pathway (Krapivinsky et al., 2003). In addition, experiments with Ras-GRF knock-
out mice indicate that Ras-GRF2 contributes to the induction of NMDA receptor-
dependent LTP in the hippocampus (Li et al., 2006). Furthermore, Ras-GRF proteins 
appear to play an age-dependent role in synaptic recruitment of AMPA receptors. 
Their function is largely limited  to mature neurons because their level of expression 
at least in cortical neurons is very low in normal neonatal animals, where 
interestingly, NMDA receptors signal through Son of Sevenless (Sos) (Tian et al., 
2004). Sos is ubiquitously present in tissues (Guerrero et al., 1996) and highly 
expressed in young animals (Tian et al., 2004). Sos-1 is stable and participates in 
short- and long-term signalling events, whereas Sos-2 appears to be degraded by a 
ubiquitin-dependent process and is predominantly involved in short-term signalling 
events (Qian et al., 2000). Sos plays a crucial role in the coupling of RTKs to Ras-
dependent signalling via binding through the adapter protein Grb2 (Chardin et al., 
1993). Similarly, it contributes to the Ras activation that occurs following GPCR 
transactivation of RTKs (Marinissen and Gutkind, 2001).  
The ERK MAP kinase pathway is the best understood downstream cascade initiated 
by Ras activation. Ras is attached to plasma membrane because of its lipid 
modification by prenyl moieties and when activated leads to sequential activation of 
Raf (MAPK kinase kinase), MEK 1/2 (MAPK kinase) and MAPK/ERK1/2. ERK1 
and 2 act as critical transducers of growth factor signalling to the nucleus where they 
act as important regulators of gene transcription. Among the major substrates of 
MAPKs are the ribosomal S6 kinases (RSKs) which directly phosphorylate the 
cAMP response element (CRE)-binding factor CREB, inducing expression of many 
immediate-early genes (IEGs) such as Fos (De Cesare et al., 1998; Frodin and 
Gammeltoft, 1999). In addition, MAPKs can directly phosphorylate and activate 
serum response element (SRE)-binding proteins, such as p90RSK and Elk1, thus 




have effects on cytosolic proteins by phosphorylation of a wide range of substrates 
(see section 1.3.2).  
1.4 Aims and objectives of this study 
The overall aim of this work was to assess the biochemical events that may underlie 
the changes in synaptic function occurring in chronic pain states brought about 
following nerve injury both in adult animals and in neonates, where particularly 
long-lasting sensitisation may ensue. 
The study should help to identify new molecular targets for potential intervention in 
otherwise largely intractable chronic neuropathic pain in adults and neonates. The 
outcomes may be valuable for future therapeutic developments in both clinical and 
veterinary medicine. 
The experiments necessitated the development of new or greatly enhanced 
experimental procedures, a key aspect of this thesis. 
Specifically, I asked: 
1) In neonatally nerve-injured animals (where lasting facilitation of nociceptive 
responsiveness is observed), can I identify changes in expression, activation or 
synaptic insertion of key signalling/transduction proteins that may explain the lasting 
upregulation of sensitivity? These studies involved the unprecedented development 
of techniques for micropreparation of postsynaptic densities and subsequent 
quantitative Western blotting from injured/uninjured spinal dorsal horn. 
2) In adult animals, in the first instance, can I develop a new technological platform 
that enables assessment of dynamic receptor-mediated responses in ex vivo tissue in a 
variety of formats (30-100 m tissue segments, synaptoneurosomes and 150 × 150 
m microslices)? These studies, utilising novel no-wash Ca
2+




potential- fluorophores in both cortex and spinal cord, establish for the first time the 
ability to measure dynamic responses to both metabotropic and ionotropic receptor 
activation. This will potentially enable deployment of the approach for assessing 
alterations in responsiveness in chronic pain and other states of hypersensitivity at 




Chapter 2: Materials and methods 
2.1 Material information 
Company Product 
Ascent Scientific Ltd.  
Unit 3 Avon Riverside Estate, 
Victoria Road, Avonmouth, Bristol 
BS11 9DB, UK 
Substance P (SP) 
  
Astra-Zeneca Ltd. 
Hurdsfield Industrial Estate, 






Becton Dickinson (BD) Biosciences 
The Danby Building, Edmund 
Halley Road, Oxford Science Park, 
Oxford , OX4 4DQ, UK 
Mouse anti-protein 4.1N monoclonal IgG 
 
  
Cell Signalling Technology, Inc. 
3 Trask Lane, Danvers, MA 01923, 
USA 
 
Goat anti-rabbit horseradish peroxidase 
(HRP)-linked IgG, 
Rabbit anti-ERK polyclonal IgG, 
Rabbit anti-phospho-ERK (Thr202/Tyr204) 
polyclonal IgG  
  
Emmanuel Merck, Darmstadt 
(EMD) Biosciences Inc. 
10394 Pacific Center Court 
San Diego, CA 92121, USA 
3-[(3-Cholamidopropyl)dimethylammonium]-
1–propanesulphonate (CHAPS), 
Protease Inhibitor Cocktail Set III 
  
GE Healthcare Ltd. 
Pollards Wood, Nightingales Lane, 
Little Chalfont, Buckinghamshhire, 












Genus Xpress (Ethicon) 
10  Castings Court, Falkirk, KK2 
9HJ, UK 




5791 Van Allen Way 
P.O. Box 6482, Carlsbad,  
CA 92008, USA 
4-12% Bis-Tris Nu-PAGE gels, 
Hanks‟ Balanced Salt Solution (HBSS), 
2-(N-morpholino)ethanesulfonic acid (MES) 
running buffer, 
3-Morpholinopropane-1-sulfonic acid (MOPS) 
running buffer, 
Sodium pyruvate,  
Blot transfer buffer, 
Tris-acetate running buffer 
  
Santa Cruz Biotechnology, Inc. 
2145 Delaware Avenue, Santa Cruz, 
CA 95060, USA 
 
Mouse anti-GluA1 (E-6) monoclonal IgG,  
Mouse anti-GluA1 (G-12) monoclonal IgG,  
Rabbit anti-Sos1 (H-122) polyclonal IgG, 



















ethanesulfonic acid (HEPES),  
2,5-dimethoxy-4-iodoamphetamine (DOI), 
Acetylcholine chloride, 
Allyl isothiocyanate  (AITC), 




DL-homocysteic acid (DLH), 
Glutathione, 
Isoleucine, 
Krebs-Henseleit buffer,  
Kynurenic acid,  







N-methyl-D-aspartic acid (NMDA), 
1-Noradrenaline hydrochloride, 
Phosphocreatine disodium salt, 
Prazosin, 
1-Propranolol, 
Protein-G Sepharose beads 
  
Thermo Scientific  
3747N, Meridian Road, Rockford, 
IL 61101, USA 
Pierce 3-Colour Protein Molecular Weight 
Marker mix  
 
  
Tocris Cookson Ltd. 
Churchill Building, Langford 
House, Langford, Bristol, BS18 
7DY, UK 
 
1-Aminocyclopropane carboxylic acid 
(ACPC), 
-Amino-3-hydroxyl-5-methyl-4-isoxazole-
propionate hydrobromide (AMPA), 
Capsaicin 
  
UC Davis/NIH NeuroMab Facility 
Department of Neurobiology, 
Physiology and Behavior, UC 
Davis, Davis CA 95616, USA 




Whatman GMBH, Hahnestraβe 3 
D-37586, Dassel, Germany. 












Sprague-Dawley rats were used throughout this study and were given access to food 
and water ad libitum. Animals were housed in accordance with Home Office 
guidelines. The temperature and humidity of the animal house were controlled at 
21°C and 50% respectively. Animals were kept in 12h:12h scheduled lighting with 
lights on from 7am to 7pm.  The experiments described were all carried out on 
female animals as they are reported to show greater long term consequences of early 
life inflammatory pain than males (LaPrairie and Murphy, 2007) and also exhibit 
greater nocifensive responses following formalin injection (S. Fleetwood-Walker, 
unpublished observations; T.L Yaksh, personal communication). Animals were used 
at various ages from postnatal day 8 (P8), the earliest time at which surgery to 
produce nerve-injury was feasible, then P9, P18, P28, P42 and P68 (spanning 
postnatal development into early adulthood) as well as adult animals of at least 180g 
in weight. Pain model surgery on all the neonates and adults was carried out by 
Andrew Allchorne, the experienced technical officer of the group, to ensure the 
greatest possible consistency between animals. Animal behavioural tests were carried 
out by Andrew Allchorne and Hayley Gooding with my technical and analytical 
assistance. I contributed to the design and planning of these experiments, provided a 
technical support role for the combined behavioural and tissue harvest procedures, 
helping with preparation of the apparatus, tubes and solutions, participated in tissue 
removal, homogenization and subsequent processing and carried out data analysis 
enabling interpretation of the behavioural and biochemical findings. In further 
experiments to obtain spinal cord tissue for ex vivo Ca
2+
 fluorescence measurements 
or Western blotting I carried out surgery on animals terminally anaesthetised with 
2.5-3.5% isoflurane in oxygen under the supervision of Sue Fleeetwood-Walker, 




segments. In these studies I carried out all experimental design, biochemical and 
fluorescence procedures, data analysis and interpretation. All animal experiments 
were carried out in accordance with the UK Animal (Scientific Procedures) Act 1986 
by staff with Home Office Personal Licences under the range of procedures covered 
by S.Fleetwood-Walker‟s Project Licence and approved by the University of 
Edinburgh Ethical Committee. 
2.2.2 Neuropathic pain model 
P8 litters or adult animals were divided into experimental and control groups. 
Chronic constriction injury (CCI) of the sciatic nerve was performed on experimental 
groups of P8 and adult rats as a neuropathic pain model. The procedure is well 
characterised and has previously been described in detail (Bennett and Xie, 1988). 
Briefly, rats were anaesthetised by inhalation of an isoflurane/O2 mixture (Astra-
Zeneca, Cheshire, UK), 4-5% for induction and 1.5-3% for maintenance. Animals 
were carefully monitored during surgery until recovery from anaesthesia and for a 
short time afterwards and were all marked using permanent marker pens (whilst 
anaesthetised) for identification. Following hair removal and sterilisation of the area 
with 10% Hibitane (Astra-Zeneca, UK), a small incision was made below the pelvis 
and the right biceps femoris and the gluteus superficialis were carefully separated to 
expose the sciatic nerve. Upon isolation of the nerve, two loose ligatures were tied 
around it proximal to the trifurcation using 4-0 chromic catgut in adults (SMI AG, 
Hunningen, Belgium) (or 5-0 grade in the neonates – Medgut, South Africa) with a 1 
mm separation between ligatures (Figure 2.1). This is a modification of the classic 
CCI model for adults, which usually consists of four ligatures. Two were used 
instead here in both adult and neonates to standardise the injury, as four ligatures are 
difficult to place around the sciatic nerve of P8 animals. Earlier pilot experiments in 
the laboratory had shown no discernible difference in sensitised pain behaviours of 




the extent of nerve constriction under a microscope, ensuring that the ligatures were 
just tight enough to prevent sliding along the nerve. The nerve was then carefully 
placed back into position and the wound was closed. Vetbond (Vetbond, 3M, 
Loughborough, UK) was used to close the wound in P8 animals. Control animals did 







Figure 2.1: Schematic outline of procedure for Chronic Constriction Injury 
(CCI) applied to the sciatic nerve 
The diagram shows an outline of the spinal cord at the lumbar level with dorsal roots 
arising from lumbar (L) segments 4, 5 and 6 on the left side. Each root passes 
through a dorsal root ganglion (DRG) before merging to form the sciatic nerve, 
which innervates the hind limb. The location of two loose ligatures, approximately 1 































2.2.3 Subsequent acute noxious stimulus from 
intraplantar formalin 
At P42 (34 days after surgery and a time at which to mechanical stimulation with von 
Frey filaments within the sciatic receptive field had fully returned to normal), an 
injection of formalin (40 l of 4% formalin in 0.9% saline) was given under 
isoflurane anaesthesia into the hind paw ipsilateral to the original injury at P8 (Figure 
2.2). Adult animals were also subjected to this formalin injection after behavioural 
recovery from previous nerve-injury. The two control groups for the neonates and 
adults received an equal volume of 0.9% saline. Rats were then placed in clear 
observation boxes to recover from the anaesthesia before recording. Each animal was 
observed for 60 seconds within a 5 minute window and nocifensive behaviours 
including flinching, flicking, licking or biting of the injected paw were recorded 
during this time using a stopwatch. The cumulative time in seconds was recorded 
every 5 minutes over 60 minutes or until the termination of nocifensive responses to 
formalin. At the end of the test, animals were euthanized by carbon dioxide 
asphyxiation. Tissue was collected immediately after death (within 5-6 minutes, see 
section 2.2.5).  
2.2.4 Pain-related behavioural tests 
Animals were weighed on every day of behavioural testing to ensure that pups were 
all gaining weight and therefore not in a distressed state which may be accompanied 
by weight loss. Behavioural tests were carried out to assess the development and 
progression of the neuropathic pain sensitivity characteristic of the CCI model, in 
both P8 and adult rats. Measurements of reflex responses to graded sensory stimuli 
were recorded in conscious animals prior to injury (not possible for P8 injured 
animals) and regularly post injury to establish a time-course of sensitivity. The 
assessment generally used to measure hypersensitivity was the presence of 
mechanical allodynia in response to testing with von Frey filaments although thermal 




Spontaneous pain as indicated by spontaneous nocifensive behaviours was also 
observed following noxious challenge induced by formalin injection to hind paws 
ipsilateral to CCI in both P8 and adult rats.  
2.2.4.1. Thermal hyperalgesia 
Animals were monitored using the Hargreaves‟ thermal stimulator which consists of 
an infrared beam, directed to the underside of the hind paw to cause local increasing 
level of warming (Figure 2.2a). Animals were placed on the plate of the Hargreaves‟ 
stimulator and covered with a clear plastic box to contain the animal. They were 
given 5-10 minutes in their new test environment to allow them to become habituated 
before testing. To measure the paw withdrawal latency (PWL), the infrared beam was 
put under the middle of the hind paw until the withdrawal occurred, at which point 
the beam was automatically terminated and the timer stopped.  The latency for 
withdrawal was recorded for the ipsilateral and the contralateral hind paws. 
Responses were recorded at 5 minute intervals and mean values taken (using a set cut 
off point to avoid excessive heating).  
2.2.4.2. Mechanical allodynia 
Mechanical allodynia was measured as the withdrawal threshold to calibrated 
Semmes-Weinstein von Frey filaments (Stoelting, Illinois, US). It is only possible to 
begin testing the neonate on the plantar surface by around P14; before this time pups 
are too small for the mesh table used and are not able to produce the necessary 
response as testing depends on a fully developed foot withdrawal reflex and maturity 
of the motor system, as noted by other groups (Lee and Chung, 1996; Fitzgerald, 
2005) 
Animals were placed on a raised mesh grid and covered with a clear plastic box to 
contain the animal. Von Frey filaments were used to determine the threshold force for 
withdrawal of the ipsilateral paw compared to the contralateral paw. Filaments were 
applied to the middle of the plantar surface of each paw from below, (Figure 2.2b) 
until the filament bent; this was done 6-8 times per filament, in order of increasing 




applications was recorded. Data were expressed as the threshold indentation pressure 






Figure 2.2: Illustrations of the apparatus used for a) the Hargreaves’ (noxious 
heat) test and b) the Von Frey filament (mechanical threshold) test 
a) Thermal test 
The latency for paw withdrawal from a noxious heat source was recorded using 
Hargreaves‟ apparatus. Animals were placed within plastic boxes on a glass plate and 
the plantar surface of a hind paw was heated to a set noxious level by the infra-red 
unit which cuts out upon paw withdrawal, automatically recording the latency.  
b) Mechanical test 
The threshold for paw withdrawal from a punctate mechanical stimulus was recorded 
using Von Frey filaments. Animals were placed within plastic boxes on a raised metal 
grid and the plantar surface of a hind paw was probed with filaments of increasing 
(defined) bending pressures to determine the filament causing paw withdrawal in 















2.2.5 Tissue collection 
The rats were euthanized by carbon dioxide asphyxiation (Schedule 1) or by terminal 
anaesthesia and the lumbar 4-6 (L4-6) spinal cord segments were removed quickly 
and hemisected into half cords containing ipsilateral and contralateral sides or quarter 
cords containing ipsilateral and contralateral dorsal horns.  
Half cords were homogenised in ice-cold Laemmli buffer (Table 2.1) using 1 ml 
homogenisers kept on ice. The homogenates were boiled in sealed tubes at 100°C for 
5 minutes to denature proteins and centrifuged at 12,000 g, 4°C for 10 minutes. The 
supernatant from this whole tissue lysate was stored at -20°C and used for Western 
blot studies or controls in co-immunoprecipitation experiments.  
Quarter cords were collected and stored in sucrose storage/homogenising buffer at -














Table 2.1: Laemmli buffer 
 Component  Concentration   
SDS 2% 
Mercaptoethanol 5% 




Table 2.2: Sucrose-containing storage/homogenising buffer for synaptic fraction 
preparation 
Component Concentration   
Sucrose  0.32 M 
NaHCO3 1 mM 
MgCl2 1 mM 
CaCl2 0.5 mM 
Sodium orthovanadate (phosphatase inhibitor) 1 mM 
NaF (phosphatase inhibitor) 1 mM 
Protease inhibitors (Type III, Calbiochem, EMD) 0.1% 
















2.2.6 Preparation of subcellular fractions 
A modified subcellular fractionation technique for CNS tissue (Phillips et al., 2001; 
Feligioni et al., 2006) was used to allow simultaneous analysis of GluA1 AMPA 
receptor subunit translocation into the postsynaptic density (PSD) and the levels of 
signalling proteins in non-synaptic synaptosomal protein (NSSP) fractions under 
normal and CCI pain states (Figure 2.3). NSSP fractions include all the synaptosomal 
proteins excluding the PSD-associated proteins and the closely apposed presynaptic 
specialisation (Feligioni et al., 2006). To obtain sufficient fractions for reliable and 
consistent results, 8 spinal cord quadrants from spinal segments L4-L6 were pooled 
together as one set. I collected 4 complete sets of tissues for the analysis of GluA1 
subunit translocation. This is the first time that such a technique has ever been used 
to assess pain model-induced responses in the dorsal horn of spinal cord. 
Before the procedure, sucrose/Percoll gradients were prepared and kept on ice. 
Homogenisers, buffers and centrifuges were cooled down to 4°C. Only ipsilateral 
and contralateral dorsal spinal cord quadrants were collected, so ventral spinal cord 
tissues were not assessed in the current study. Tissue samples had been collected in 
homogenising buffer and stored at -20°C. They were thawed, superficially dried with 
filter paper and weighed before being homogenised in 10 volumes of homogenising 
buffer for 10 further strokes after tissue disruption with a motorised teflon-glass 
homogeniser. The homogenate was centrifuged at 1000 g for 12 minutes at 4°C to 
remove nuclei and debris. The supernatant, which contains crude synaptosomes was 
gently loaded onto the surface of prepared sucrose/Percoll density gradients (Table 
2.3) and centrifuged at 32,500 g, at 4°C, for exactly 6 minutes. The white bands, 
which include purified synaptosomes, present between the 3% and 23% Percoll 
layers were removed to clean tubes and washed twice with 10ml HEPES washing 
buffer (Table 2.4), by centrifugation at 40,000 g, for 22 minutes, at 4°C. The pellets 
were suspended in 2.5 ml 0.032 M sucrose containing 0.01 mM CaCl2 and incubated 
with 2.5 ml 40 mM Tris, pH 7.40 containing 1% Triton X-100 for 30 minutes at 4°C. 
The suspension was centrifuged at 40,000 g, for 30 minutes, at 4°C. The supernatant, 
representing the NSSP fraction, was stored at -20°C and was precipitated later. The 




Laemmli buffer and boiled for 5 minutes. The PSD fractions were kept at -20°C. The 
supernatant containing NSSP was subsequently precipitated using 5 volumes of -
20°C acetone for 1 hour at -20°C and centrifuged at 18,000 g, for 30 minutes, at -





Figure 2.3: Scheme for micropreparation of postsynaptic densities (PSD) from 
spinal cord quadrants 
Ipsilateral and contralateral dorsal lumbar spinal cord quadrants were collected and 
homogenised in ice-cold buffer, before centrifugation to remove nuclei and debris.  
Synaptosomes were isolated from the supernatent by a rapid discontinuous Percoll 
gradient method before incubation with Triton X-100 to obtain the insoluble PSD 
fraction and the soluble NSSP (non-synaptic synaptosomal protein) fraction.  These 




ID: ipsilateral dorsal spinal cord       CD: contralateral dorsal spinal cord   
IV: ipsilateral ventral spinal cord      CV: contralateral ventral spinal cord 





















































































































































































































Table 2.3: Sucrose/Percoll gradients 
Component Concentration   
3% Sucrose/Percoll solution Sucrose 0.32 M 
NaHCO3 1 mM 
Percoll 3% 
In: UHP water, pH adjusted to 7.40  
23% Sucrose/Percoll solution Sucrose 0.32 M 
NaHCO3 1 mM 
Percoll 23% 














Table 2.4: HEPES washing buffer 
Component Concentration   
NaCl 137.9 mM 
KCl 5.3 mM 
MgCl2 1 mM 
CaCl2 1 mM 
Na2HPO4 0.3 mM 
KH2PO4 0.4 mM 
NaHCO3 4.2 mM 
D-Glucose 5.6 mM 
HEPES 10 mM 














2.2.7 SDS-PAGE and Western blots 
SDS-PAGE and Western blots were used to examine the expression of GluA subunits 
and potential signalling proteins in the spinal cord of neonatal and adult nerve-
injured rats. NuPage 4-12% Bis-tris 10- or 12-well gels and MOPS running buffer 
from Invitrogen were used throughout the experiments. Proteins were loaded evenly 
into the NuPage gels and then separated by SDS-PAGE for 50 minutes at 200 V. The 
proteins were then transferred from gels to PVDF membranes for 120 minutes at 30 
V or to nitrocellulose membranes (for phosphorylated proteins) for 90 minutes at 30 
V. The uniformity and overall effectiveness of transfer of proteins from gels to PVDF 
membranes was checked by staining the membranes with Coomassie Blue. The 
membranes were blocked with 5% non-fat dried milk or 5% BSA in PBS or TBS 
with 0.05% Tween-20 for 90 minutes at room temperature with shaking. Blots were 
probed with primary antibodies to 4.1N, GluA1, phospho-ERK, ERK, PSD-95 or 
synaptophysin at 4°C overnight with rotation. After three washes of 10 minutes with 
PBS-0.1%Tween (PBST), blots were incubated in appropriate HRP-linked secondary 
antibodies (Table 2.5) at room temperature for 50 minutes with mixing by rotation. 
After a further three washes with PBST, the immunoreactive bands were detected by 
enhanced chemiluminescence and visualised by exposure to Amersham Hyperfilm. 
The ubiquitous housekeeping enzyme GAPDH or actin was used as control, for 
protein level normalisation. 
Following high resolution scanning of films, the density of immunoblot bands was 
quantified by Image J 7.0 software. Background grey values were obtained from 
appropriately matched regions of the film and subtracted from the total value. The 
data were analysed by comparing to GAPDH or actin levels on the same blot. 
2.2.8 Co-immunoprecipitation  
In addition, the interaction between GluA1 and its binding partners such as 4.1N in 
spinal cord of adult CCI rats was examined in comparison to that in naïve animals. 
The co-immunoprecipitation procedure used briefly involves: i) homogenising tissue 




clearing supernatant fractions from the homogenates with protein-G Sepharose beads 
to deplete non-specific binding of tissue proteins; iii) incubation of the cleared 
extracts with specific anti-rat GluA1 subunit antibody (or control); iv) precipitation 
of the antibody-protein complex using protein-G Sepharose beads (if there are any 
protein molecules that bind to the GluA1, they will also be precipitated); v) 
identification of co-precipitated proteins by Western blot analysis.  
Spinal cord segments L4-6 were collected rapidly, hemisected and homogenised 
gently in 10 volumes cold immunoprecipitation (IP) buffer (Table 2.6). They were 
kept at 4°C for 1.5 hours on a roller to allow mixing and solubilisation of membrane-
bound protein complexes and then centrifuged at 12,000 g for 15 minutes at 4°C. The 
supernatant was removed and added to Eppendorf tubes. Protein G-coupled 
Sepharose beads were washed in cold IP buffer and left with an equal volume of 
buffer after the final wash. The samples were pre-cleared with the beads (20 l of 
50 % suspension per ml of supernatant) for 1 hour at 4°C to remove non-specifically 
binding endogenous proteins. The supernatant was removed to new tubes after 
centrifugation of the samples at 12,000 g for 10 minutes at 4°C and incubated with 
GluA1 antibody (Santa Cruz, sc-13152, 1:50) and protein G-Sepharose beads (40 l 
of 50% suspension per ml of supernatant) overnight at 4°C on a roller. An aliquot of 
supernatant was incubated with non-immune IgG of the same species as the antibody, 
instead of the GluA1 antibody, as a control. On the second day, samples were 
centrifuged at 12,000 g for 15 minutes at 4°C and the beads were washed once with 1 
ml IP buffer and twice with PBS. After the final PBS wash, all remaining liquid was 
removed with thin strips of filter paper. An equal volume of Laemmli buffer 
containing sodium dodecyl sulphate and mercaptoethanol to solubilise and denature 
the proteins was added to beads and the mixture was boiled for 5 minutes in a sealed 
tube, briefly centrifuged at 12,000 g and stored at -20°C. Western blots were carried 
out to probe for GluA1 binding proteins and the levels of GluA1 itself collected in 




Table 2.5: Antibodies used for Western blots and co-immunoprecipitation 
Primary antibody Catalog 
number 





















IgG (Santa Cruz) 
sc-13152 1:100  
IP: 4 g/ml 
Mouse anti-GluR1 
(G-12) monoclonal 
















IgG (Santa Cruz) 
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Table 2.6: Immunoprecipitation (IP) buffer 
Component Concentration   
CHAPS 16.3 mM 
Deoxycholate  11.6 mM 
Sodium molybdate (phosphatase inhibitor) 5 mM 
Sodium orthovanadate (phosphatase inhibitor)  1 mM 
NaF (phosphatase inhibitor) 1 mM 
Protease inhibitor mix (Type III, Calbiochem, EMD) 1% 
Glycerol 10% 
















2.3 Methods specific to Chapter 4 
2.3.1 Preparation of freshly isolated neural tissue 
segments, synaptoneurosomes and microslices 
A number of reports in the literature describe the preparation from gently 
homogenised CNS tissue of subcellular fractions enriched in entities referred to as 
synaptoneurosomes (Hollingsworth et al., 1985; Moring et al., 1990; Johnson et al., 
1997; Villasana et al., 2006; Troca-Marin et al., 2010). These represent resealed 
presynaptic and apposed postsynaptic elements, presenting at the electron 
microscopy level as classic „snowman-shaped profiles‟ (Hollingsworth et al., 1985) 
with reportedly a greater inclusion of postsynaptic material than conventional 
synaptosomes. As part of the preparative procedure for synaptoneurosomes involves 
filtration through net and matrix filters of decreasing pore size, I took the opportunity 
to investigate for the first time, responsiveness in 30-100 m diameter tissue 
segments as well as the sub-5 m synaptoneurosome fraction. In addition, I explored 
whether it was possible to record dynamic cellular responses in tissue microslices, a 
preparation used successfully in the past for neurotransmitter release studies 
(Mitchell and Martin, 1978).     
Näive adult Sprague-Dawley rats were euthanised and brains were removed swiftly, 
normally within 60 seconds, dissected and homogenised gently in ice-cold, well 
oxygenated homogenising buffer (8 ml per frontal cortex) using a large clearance 
glass/glass homogeniser by hand for 15 seconds. For experiments on spinal cord, 
lumbar segments were removed following laminectomy from rats under terminal 
isoflurane anaesthesia. To prepare microslices, frontal cerebral cortex or lumbar 
spinal cord was rapidly removed from adult Sprague-Dawley rats and immersed in 
ice-cold, oxygenated homogenisation medium (as above). Perpendicular microslices 
(150 × 150 m) were prepared as quickly as possible using a McIlwain tissue slicer 
(Mitchell and Martin, 1978) and washed twice in fresh homogenising buffer before 




Krebs-Henseleit buffer (Krebs and Henseleit, 1932) (Table 2.7) was modified to 
make the homogenising buffer. The modifications included the addition of HEPES 
(10 mM, to ensure secure pH buffering), glutathione (5 M, as a sulphydryl group 
protectant), protease inhibitors (0.1% Calbiochem cocktail III, to minimise 
proteolysis), sodium pyruvate (0.5 mM, as a glycolytic intermediate), and creatine 





 channels and NMDA receptors) and 0.3 mM 
kynurenic acid (a broad spectrum blocker of glutamate receptors and the 7-nicotinic 
acetylcholine receptor); (Rozsa et al., 2008) were added into the basic solution. 
Finally, the pH value of the homogenising buffer was adjusted to 7.40 and the 
solution on ice was bubbled for at least 1 hour with 95% O2, 5% CO2.  
For the preparation of neural tissue segments and synaptoneurosomes, homogenate 
was loaded into 5 ml syringes and passed successively under modest manual pressure 
through 100 m and 30 m nylon net filters and then a 5 m pore size cellulose fibre 
matrix filter (Millipore) (Hollingsworth et al., 1985). A synaptoneurosome-enriched 
pellet was obtained by centrifugation of the sub - 5 m filtrate (1500 g, 4°C, 8 
minutes). The tissue segments captured on the 30 m nylon net filters (i.e. 30-100 
m range) were eluted by gentle washing. The medium used for resuspension of 
tissue segments, synaptoneurosome and microslices was the same modified Krebs-
Henseleit with the omission of MgCl2 and kynurenic acid but the addition of 2 mM 
CaCl2 and was similarly kept oxygenated on ice. Aliquots of the tissue segment, 
synaptoneurosomes or microslice suspensions were loaded into wells of 24-well cell 




Table 2.7: Buffers for experiments with acutely prepared neural tissue samples 
Basic buffer: 
Component Concentration   
D-glucose 11.1 mM 
MgSO4 1.2 mM 
KH2PO4 1.2 mM 
KCl 4.7 mM 
NaCl 118.5 mM 
NaHCO3 25 mM 
HEPES 10 mM 
Sodium pyruvate 0.5 mM 
Glutathione  5 M 
Phosphocreatine disodium 2 mM 
Protease inhibitors (Type III, Calbiochem) 0.1% 
In: UHP water, pH adjusted to7.40  
Additions to make homogenising buffer: 
MgCl2 5 mM 
kynurenic acid (KA) (as sodium salt) 0.3 mM 
Additions to make assay buffer: 






Figure 2.4 Preparation of freshly isolated neural tissue segments, 
synaptoneurosomes and microslices 
Rats were euthanised and brains were removed rapidly, dissected and homogenised 
gently in ice-cold, well-oxygenated buffer containing MgCl2 and kynurenic acid but 
lacking CaCl2, using a large clearance glass/glass homogeniser. For experiments on 
spinal cord, lumbar segments were removed following laminectomy from rats under 
terminal isoflurane anaesthesia.  
For the preparation of neural tissue segments and synaptoneurosomes, homogenate 
was syringe-filtered through 100 m and 30 m nylon net filters and then a 5 m 
pore size cellulose fibre matrix. A synaptoneurosome-enriched pellet was obtained by 
centrifugation of the sub - 5 m filtrate and the tissue segments captured on the 30 
m nylon net filters (i.e. 30-100 m range) were eluted by gentle washing. Each was 
resuspended in buffer containing CaCl2 but lacking MgCl2 and kynurenic acid, for 
assay. To prepare microslices, frontal cerebral cortex or lumbar spinal cord was 
rapidly immersed in ice-cold, oxygenated homogenisation medium. Perpendicular 
microslices (150 × 150 m) were prepared as quickly as possible using a McIlwain 

































































































































































































































































































































































































































2.3.2 Fluorometric measurements on 30-100 m 
neural tissue segments, synaptoneurosomes and 
tissue microslices 
The general strategy adopted was to try and achieve quantitative fluorometric 
measurements from the ex vivo preparations that would reflect dynamic responses to 
receptor stimuli and then ultimately might be able to reveal long term changes in 
responsiveness brought about by earlier in vivo events (such as the central 
sensitisation in chronic pain models). It was considered that the better approach (if it 
proved possible) would be to use a plate-reader format, where several aliquots of the 
same preparation could be subjected to different drug treatments and measured in 
parallel. The alternative would be to assess samples in suspension in a cuvette 
fluorometer but this would have meant samples could only be assessed one at a time 
and that the preparations would require constant mixing, which might cause 
deterioration of the tissue. An important consideration with the fluorometric plate 
reader is that the most robust readings are generally obtained in bottom reading mode 
from cells coating the bottom of the well rather than from above where the light is 
dispersed by passage through buffer. It therefore seemed that allowing samples time 
to settle to the bottom of wells would most likely be essential as would avoiding 
movements that would create turbulence, especially as the preparations were not 
anchored in any way to the well surface. Indeed it was found that automatic injection 
of drug solutions into the wells (a facility available in real-time recording mode) 
caused so much turbulence that fluorescence readings became too variable to be 
useful. A disadvantage of this was that any drugs (or vehicle controls) had to be very 
carefully added by hand to parallel wells before reading could be commenced. 
As a large proportion of cellular stimuli lead either directly or indirectly to elevation 
of intracellular Ca
2+
 concentrations and a wide range of Ca
2+
 indicator fluorophores 
with excellent spectral and signal-to-noise properties are available, the primary 
approach taken was to assess Ca
2+
 fluorescence of the tissue preparations. Some 
experiments were carried out in addition using a membrane potential-sensitive 




preparations, after loading the dyes in ester form, (normally needed to remove any 
extracellular dye which could contribute to a high basal fluorescence) would be a 
disadvantage as it could damage the preparations and would certainly disrupt the 
settled layer of tissue fragments. Fortunately several appropriate fluorophores are 
available in „no-wash‟ formulations where such procedures are completely 
unnecessary because they contain proprietary impermeant quenching agents, which 
suppress any unwanted basal fluorescence from extracellular dye. The use of these 
agents was considered to be an important factor in gaining usable quantitative data.     
For Ca
2+
 fluorometric studies the preparations were loaded with an intracellular Ca
2+
 
fluorometric dye (Calcium 4, Molecular Devices) according to the manufacturer‟s 
instructions by addition of 100 l of ice-cold 4 × concentrated solution in assay 
buffer to the wells. Importantly, Calcium 4 is a no-wash dye, meaning that samples 
do not have to be washed to avoid non-specific fluorescence from dye outside the 
cells responding to extracellular Ca
2+
.  The dye functions in principle like most Ca
2+
 
fluorophores such as Fluo-4 (Gee et al., 2000), being loaded as an inert 
acetoxymethoxy (AM) ester which is cleaved by intracellular esterases to the active 
form, but additionally contains a proprietary extracellular quenching agent that 
suppresses extracellular fluorescence. Calcium 4 otherwise displays very similar 
spectral properties and Ca
2+
 affinity to Fluo-4. After dye addition, the 24-well plate 
was then incubated at 37°C in a humidified 95% O2, 5% CO2 atmosphere for 45 
minutes, before careful transfer to a Varioskan Flash fluorometric plate reader 
(Thermo Scientific). The plate was then left undisturbed in the thermostatically 
controlled (28
o
C) carrier stage of the fluorometer to allow for settlement of the tissue 
preparations after the transfer. Drugs or vehicle as appropriate (Table 2.8) were then 
added very carefully (in 10% of the well volume; i.e. 40 l) from stock solutions that 
contained 10 × the final required concentration. The programme controlling the well 
reading cycle was then initiated as soon as possible and ran for up to 15 minutes. 
Readings were taken from each well on a 30 seconds-repeating cycle with excitation 
and emission wavelengths set at 488 and 519 nm respectively (bottom reading mode). 
Readings were collected through the complete time-period of the programme but 




seemed to best reflect the stable plateau values of fluorescence that were reached. 
The data collection period for synaptoneurosomes and microslices was routinely 
begun at 3 minutes into the fluorescence reading cycle and that for 30-100 m tissue 
segments was begun at 6 minutes because of an impression that they were more 
mobile in the wells and more easily disturbed. Retrospective analysis of time-course 
data however (Chapter 4), indicated that this distinction did not make any clear 
difference to the results and so was not really necessary.    
Pilot experiments were also carried out to assess changes in membrane potential 
using a no-wash voltage-sensitive fluorescent dye (R8042, MP Blue, Molecular 
Devices). The experimental protocol was identical to that for the above Ca
2+
 
fluorometric studies, apart from the excitation and emission wavelengths, which 




Table 2.8: Compounds used for calcium fluorometry 




An activator of the glycine site of the 
NMDA receptor 
10-200 M 
1-Noradrenaline Mediator released upon sympathetic 
activation that can act on Gq-coupled -



















Acetylcholine Acetylcholine receptor agonist 30 M 
Cyclothiazide Inhibitor of desensitisation at activated 
AMPA receptors. 
30 M 
Ionomycin Calcium ionophore  5 M 
N-methyl-D-aspartic 
acid (NMDA) 
Agonist at NMDA-type glutmate 
receptors 
10-200 M 







2.3.3 Morphological examination of ex vivo tissue 
preparations by light microscopy and electron 
microscopy  
For assessment by light microscopy, 30-100 m tissue segments or 
synaptoneurosomes were loaded with Calcium 4 in chambers based with collagen-
coated coverslips and incubated as normal for 45 minutes at 37
o
C in a 
95%O2:5%CO2 atmosphere. Samples were transferred, without washing, to a Zeiss 
Axiovert LSM510 microscope for imaging using a × 10 objective lens for 30-100 m 
segments and a × 40 lens for synaptoneurosomes. The basal levels of tissue Ca
2+
 
fluorescence at 488 nm excitation/519 nm emission were used to identify the 
morphology of the preparations.  It was not possible to add stimuli to the coverslips 
under these conditions without causing unacceptable disruption of the field of view.  
For electron microscope assessment, aliquots of synaptoneurosome suspension were 
pelleted by centrifugation (12,000 g, 15 minutes, 4°C) and resuspended in HEPES-
buffered 0.32 M sucrose with protease inhibitors before fixing in 2.5 % 
glutaraldehyde in 0.1 M cacodylate/0.1 M phosphate buffer (pH 7.40) for 30 minutes 
on ice. Samples were washed 3 times for 3 minutes with 0.1 M cacodylate buffer 
containing 2 mM CaCl2, fixed for 30 minutes in 1% OsO4 in 0.1 M cacodylate buffer 
and washed twice for 5 minutes with 0.1 M cacodylate buffer containing 2 mM 
CaCl2. Samples were gradually dehydrated with two 3 minute washes of 25% and 
50% ethanol and then stained en bloc with filtered 2% ethanolic uranyl acetate for 30 
minutes. The samples were dehydrated further in a series of 70, 95, and 100% 
ethanol washes. Durcupan ACM Epoxy Resin was used to embed the samples and 
cured at 55°C for 2–3 days. Eighty nanometre thin sections were cut using a 
MT6000-XL ultramicrotome and then stained in uranyl acetate and lead citrate. 
Samples were processed with the kind help of Heather Anderson and Steven Mitchell 
from the stage of post-fixing. Ultrathin sections (10 nm) were examined using a 
Phillips Biotwin electron microscope (School of Biology, University of Edinburgh) 




2.4 Statistical analysis 
2.4.1 Analysis of behavioural data 
In experiments investigating drug effects on behavioural responses to a noxious 
thermal stimulus, differences from pre-drug baseline were analysed by One-way 
Repeat-Measures ANOVA followed by Dunnett‟s post-hoc test and 
ipsilateral:contralateral differences at each time point were assessed by Student‟s t-
test. For mechanical von Frey responses, differences from pre-drug baseline were 
analysed by Friedman test followed by Dunn‟s post-hoc test and 
ipsilateral:contralateral differences at each time point were assessed by Wilcoxon 
test. Ipsilateral:contralateral differences in von Frey paw withdrawal threshold 
following nerve injury at P8 or in adults were analysed by Mann-Whitney U-test. 
Non-parametric tests were used for the Von Frey data because the data from discrete 
filaments are at non-linear intervals.  Comparisons at different time points of 
formalin-induced nocifensive behaviours between P8 nerve-injured animals assessed 
at P42 and adult nerve-injured animals, assessed correspondingly 34 days later, were 
made by Student‟s t-test. In all cases p values less than 0.05 were considered 
significant.  
2.4.2 Analysis of immunoblots 
After high resolution scanning of films at submaximal development times, the grey 
scale density of immunoblot bands was quantified by Image J 7.0 software. 
Background grey values were obtained from appropriately matched regions of the 
film and subtracted from the total value. In each experiment, specific image density 
for the protein of interest was normalised to that for a protein that is generally 
considered to be unchanged by pain or activity-related stimulation, either actin (in 
the case of synaptic preparations) or GAPDH (for whole tissue analysis), from the 
same lane of the same gel. Statistical significance of ipsilateral:contralateral 
differences in the ratios of GluA1 or phospho-ERK normalised to actin was assessed 




values of two measures might be predicted to provide a more appropriate assessment 
than a comparison of absolute values (Motulsky, 2003). Here this is indicated when 
comparing relative GluA1:actin (or phospho-ERK:actin) ratios for individual 
datasets which were run on a single gel, as such relative values will represent a more 
appropriate comparison than absolute grey scale values, which will vary from gel to 
gel. Comparisons of individual ipsilateral:contralateral ratios for GluA1 (or phospho-
ERK) normalised to actin between two treatment groups (formalin-injection either 
following or not following previous nerve-injury) were made by Student‟s unpaired 
t-test. In all cases p values of less than 0.05 were considered significant.  
2.4.3 Analysis of fluorometric data 
All relative fluorescence values were saved both within the fluorometer driver 
software and exported as Excel spreadsheets. The specific drug-induced increases in 
fluorescence values were obtained by subtraction of corresponding basal values from 
parallel control wells.  Increases in fluorescence values specifically induced by 





fluorescence or membrane potential fluorescence experiments, respectively) were 
similarly obtained by subtraction of corresponding basal values.  In many parts of the 
study, the specific drug-induced increase was then divided by the specific positive 
control-induced increase to normalise the data and enable easy and rigorous 
comparisons between experiments. Statistical analysis of differences between groups 
was generally carried out by Student‟s t-test for comparisons between two groups or 
One-way ANOVA (with an appropriate post-test such as Tukey‟s test) for 
comparisons between 3 or more groups. Comparisons of time-course curves were 
made by Repeated-Measures One-way ANOVA with Tukey‟s post-test. Individual 
comparisons between matched groups with or without addition of a further drug were 





Chapter 3: Translocation of GluA1 
AMPA receptor subunits to spinal 
postsynaptic densities in pain states 
3.1 Introduction 
As mentioned in the general introduction, AMPA receptors mediate fast excitatory 
transmission in the dorsal horn and are thought to be required in spinal sensory 
processing of both acute and chronic nociceptive inputs. There is some evidence to 
suggest that AMPA receptors may play a greater role in sensitised pain states, as 
nociceptive withdrawal responses in sensitised pain states are more readily reversed 
by AMPA receptor antagonists than responses in naïve animals (Garry et al., 2003b; 
Larsson and Broman, 2008)(Figure 3.1). AMPA receptors are tetrameric structures 
made up from four subunits, GluA1-4. The GluA1 subunit of AMPA receptors has 
received particular attention due to evidence that NMDA receptor-dependent GluA1 
incorporation to synapses contributes to the enhanced synaptic transmission in LTP 
in hippocampal neurons (Shi et al., 1999). Such signal-directed trafficking to 
synapses is most clearly established for AMPA receptors containing GluA1 subunits 
rather than other subtypes (Shi et al., 1999). As many AMPA receptors contain 
GluA1 subunits and they are strongly expressed in superficial dorsal horn, I 
hypothesised here that GluA1 trafficking to synapses may be important in bringing 




Figure 3.1: Intrathecal administration of the selective AMPA receptor 
antagonist NBQX inhibits sensitised reflex responses ipsilateral to CCI nerve 
injury in adult rats.  
Thermal and mechanical reflex withdrawal responses were measured in adult 
animals with established CCI-induced sensitisation. Paw withdrawal latency (PWL, 
seconds) to a noxious thermal stimulus a) or paw withdrawal threshold (PWT, 
mN/mm
2
) to mechanical von Frey stimulation b) are shown prior to and following 
the intrathecal injection (at arrow) of 5 nmol NBQX (50 l of 100 M solution of 
NBQX, sodium salt, in 0.9% saline). For thermal sensitivity, significant differences 
between ipsilateral () and contralateral () responses are indicated by * (p<0.05, 
Student‟s t-test) and differences from pre-drug baseline are indicated by † (p<0.05 
One-way Repeated Measures ANOVA followed by Dunnett‟s post-hoc test). For 
mechanical sensitivity, significant differences between ipsilateral () and 
contralateral () responses are indicated (*, p<0.05, Wilcoxon rank test). Significant 
differences from pre-drug baseline are indicated (†, p<0.05, Friedman test followed 
by Dunn‟s post-hoc test). Data are shown as mean ± SEM (n=9), in each case. 
NBQX had no discernible effect on contralateral responses in CCI animals at a dose 
of 5 nmol or on responses of control animals at doses up to 10 nmol (data not shown), 
suggesting a greater involvement of AMPA receptors in the sensitised pain state. 
These experiments were carried out by Emer Garry as part of our joint research 
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3.1.1 GluA1 subunits in spinal dorsal horn 
The expression and localisation of the GluA1 subunit of AMPA receptors in spinal 
cord are age-dependent. Differential changes in expression of GluA1 mRNA in 
spinal cord occur over postnatal development; it is widely expressed across the 
whole spinal cord for the first few days after birth and then diminishes gradually to 
leave limited expression in the superficial dorsal horn in adult (Jakowec et al., 
1995b). A quantitative immunostaining study indicated that almost 65% of spinal 
GluA1 locates in laminae I–II and 34% in lamina III of adult rat dorsal horn (Polgar 
et al., 2008), which are known as the main nociceptive processing sites in the spinal 
cord. There are several lines of evidence to suggest that this subunit plays a role in 
synaptic plasticity in the dorsal horn in pain states. For example, a study of 
inflammatory pain showed a rapid up-regulation of GluA1 mRNA in the lumbar 
dorsal horn following injection of Complete Freund's Adjuvant (CFA) into the 
hindpaw of rats (Zhou et al., 2001). Another report describes phosphorylation of the 
GluA1 subunit at both S831 and S845 sites in spinal cord tissue after intradermal 
capsaicin injection, as shown by Western blot (Fang et al., 2003a). More specifically, 
S845 phosphorylation of GluA1 at synapses in laminae I–II of the ipsilateral dorsal 
horn has also been demonstrated after capsaicin injection (Nagy et al., 2004). In 
addition, it has been reported that GluA1-containing receptors can be recruited to a 
membrane fraction in lumbar spinal cord following a noxious visceral stimulus 
(Galan et al., 2004). Synaptic plasticity involving GluA1 could therefore potentially 
occur in nociceptive processing neurons in the superficial dorsal horn. 
3.1.2 GluA1 subunit mobility and synaptic activity 
AMPA receptors containing GluA1 subunits are most probably assembled in the 
rough endoplasmic reticulum, sorted in the Golgi and then transported by vesicles to 
dendrites, where they are inserted and concentrated into synapses (Makino and 
Malinow, 2009). However, local protein synthesis may occur, since the mRNAs 
coding for AMPA receptor subunits are found in dendrites (Grooms et al., 2006) and 
transfected tagged GluA1 subunit can be synthesised in a dendritic compartment 




The full range of molecular mechanisms that underlies the synaptic targeting is not 
clear. A growing body of studies focuses on the relationship between the GluA1 
subunit mobility and synaptic activity, which may be helpful in understanding the 
role of GluA1-containing AMPA receptors in neuropathic pain mechanisms. 
There is increasing understanding of the dynamic process that controls AMPA 
receptor trafficking to and from the synapses. Using a single-cell genetic approach, it 
was found that approximately 80% of AMPA receptors contain the GluA1 subunit at 
CA1 hippocampal synapses under conditions of basal synaptic transmission (Lu et 
al., 2009). In contrast, almost all (95% of) AMPA receptors contained GluA1 
subunits in the extrasynaptic compartment (Lu et al., 2009). Moreover, it has been 
well established that AMPA receptors are highly mobile on the surface of neurons 
and that there is a dynamic exchange between synaptic and extrasynaptic receptors 
(Borgdorff and Choquet, 2002). Indeed, GluA1-containing AMPA receptors actively 
shuttle between synaptic and extrasynaptic sites (Ehlers et al., 2007).  
Synaptic activity may regulate the postsynaptic accumulation of AMPA receptors 
through diverse mechanisms such as control of cytoskeletal organisation, the affinity 
of interactions with PSD scaffold proteins or other intracellular proteins such as 4.1N, 
and spine morphology (Garry and Fleetwood-Walker, 2004; Ashby et al., 2006; 
Kopec et al., 2006). Indeed, it has been shown using single-molecule tracking and 
fluorescence photobleaching that postsynaptic accumulation of GluA1 is induced by 
local synaptic activity through stabilisation of GluA1 at active synapses and 
reduction of diffusional exchange of GluA1 between synaptic and extrasynaptic 
domains (Ehlers et al., 2007). The study illustrated that the mobility of GluA1 
subunits is reduced within active synapses, resulting in postsynaptic accumulation of 
GluA1 (Ehlers et al., 2007). Changes in mobility of GluA1 subunit-containing 
AMPA receptors are important for long-term forms of synaptic plasticity. As 
described in Chapter 1, synaptic insertion of GluA1 subunits is known to play an 
important role in mediating the enhancement in synaptic strength during LTP or 
central sensitisation through interactions with intracellular partner proteins and/or 
phosphorylation of a large number of molecules and kinases. 4.1N is one of the best-




containing AMPA receptors by association with the cytoskeletal protein actin (Shen 
et al., 2000) and is proposed to play a role in delivering more GluA1 subunits to 
synapses through 4.1N-actin-actin-CaMKII-NMDA receptor protein:protein 
interactions (Lisman and Zhabotinsky, 2001). In addition, the synaptic incorporation 
of GluA1 is also required to stabilise the increase in spine size and its C-terminal 
domain has been shown to play a key role in spine enlargement in hippocampal 
neurons (Kopec et al., 2007).  
Overall, GluA1 subunit translocation to synapses is widely considered to be crucial 
for long-term synaptic plasticity. It may be also critical for central sensitisation in 
spinal cord and contribute to the mechanisms underlying chronic pain states. 
3.1.3 Alterations in nociceptive circuitry in neonatal 
pain states 
The neonatal period is considered to be a time of continuing development for 
structural and functional organisation of spinal sensory systems (Fitzgerald and 
Beggs, 2001), and for expression of molecules, receptors, and channels associated 
with pain transmission (Alvares and Fitzgerald, 1999). The study of neonatal pain is 
not only beneficial for understanding the development of the nervous system but also 
helpful for investigating the mechanisms involved in the generation of chronic 
sensitised pain states. As the synaptic development of spinal sensory pathways is 
activity-dependent, inflammation related to pain or nerve injury in early life may 
affect normal synaptic development and lead to alterations in nociceptive circuits in 
later life (Ruda et al., 2000; Beggs et al., 2002). An important implication of such 
plasticity is that pain related to surgery or repeated procedural interventions in human 
neonates or neonatal husbandry procedures in farm animals or companion animals, 
such as tail-docking in pigs or dogs respectively, may have long-term consequences.  
Nociceptive primary afferents are changed in adult rats exposed to peripheral 
inflammation in neonatal life. Using wheat germ agglutinin–horseradish peroxidase 
(WGA-HRP) labelling, the density of nociceptive afferents including fine-myelinated 




compared to the contralateral side following CFA injection into the hind paw on 
postnatal day 1 (Ruda et al., 2000). Pain-related behaviours were also changed 
ipsilaterally in adult rats that had previously experienced neonatal inflammation 
caused by injection of CFA or formalin into the paw. The rats with neonatal 
inflammation showed corresponding increased spontaneous sensitivity or decreased 
mechanical threshold in later life. Consistent with these findings, another study on 
the effects of neonatal inflammation on the development of nociceptive processing 
showed that the expansion of afferent terminals in lamina II of dorsal horn following 
neonatal CFA inflammation was maintained into adulthood in a dose-dependent 
manner (Walker et al., 2003). Nevertheless, there are conflicting reports of what 
long-term effects are exerted upon adult pain responses when different inflammatory 
agents and injection volumes are used or the insult is applied at different 
developmental stages (Buck and Burks, 1986; Alvares and Fitzgerald, 1999; Ruda et 
al., 2000; Bhutta et al., 2001; Lidow et al., 2001). Thus long-term changes in sensory 
and pain processing may critically depend upon the degree, duration and timing of 
the neonatal inflammatory insult.  
The ability of early life injury to produce long-term changes in somatosensory 
structure and function depends upon the nature of the injury. Neonatal nerve damage 
is associated with accentuated nociceptive behavioural responsiveness, peripheral 
afferent rearrangement and alterations of their central termini as well as changes in 
the interneurons within the spinal dorsal horn. In animal pain models, infant rats 
show different and more lasting behaviours evoked by peripheral nerve injury 
compared to adults (Lee and Chung, 1996). The duration of behaviours elicited by 
nociceptive stimulation is age-dependent and may vary in different neuropathic pain 
models. Mechanical allodynia induced by partial ligation of L4-6 spinal nerves does 
not last longer than 4-5 weeks if the nerves are injured at an age of 2 weeks or 
younger and this finding points out that several factors may be important for 
maintenance of neuropathic pain behaviours, which may involve the development of 
altered C-fibre terminal distribution, changes in descending inhibition or sympathetic 
innervation and ectopic discharge in nociceptive afferents (Lee and Chung, 1996). A 
recent study further indicated that mechanical allodynia is not detectable at 4 weeks 




injury) at ages younger than 3 weeks (Howard et al., 2005). Surprisingly, postnatal 
day 10 rats that are subjected to chronic constriction injury (CCI), which evokes a 
significant mechanical allodynia in adult rats, are reported to show no change in 
nociceptive sensitivity compared to the sham group (Howard et al., 2005). A 
histochemical study has found that following neonatal peripheral nerve injury 
adjacent intact myelinated and unmyelinated primary afferents sprout into the central 
denervated terminal area in the dorsal horn of adult animals (Shortland and 
Fitzgerald, 1994). Neonatal changes in nociceptive circuitry may occur following 
peripheral nerve injury although this area is largely unexplored. Enhanced 
responsiveness of dorsal horn neurons that can be observed following early life 
injury may translate into a long-lasting facilitated response to noxious stimulation. 
 The level of expression of excitatory glutamate receptors in the superficial laminae 
of spinal dorsal horn may be important in determining the alterations in behaviours 
induced by early life injury. There is some evidence for expression of AMPA and 
NMDA receptor subunits in spinal dorsal horn changing through postnatal 
development on a long-term basis. The expression of GluA1-4 mRNA  in lamina II 
of the dorsal horn in rats is significantly reduced to varying degrees during postnatal 
development as assessed by immunoblotting and immunohistochemistry (Jakowec et 
al., 1995b). With regard to NMDA receptor subunits, diminished expression of 
GluN1 and GluN2B and slightly increased GluN2A mRNA expression in spinal 
dorsal horn of rats was detected by in situ hybridisation during postnatal 
development (Stegenga and Kalb, 2001). However, it is largely unknown whether the 
normal expression of the glutamate receptor subunits is disturbed by early life injury 
or not.  
3.1.4 Activation of the Ras/MAPK pathway in pain 
states  
If lasting changes in nociceptive responsiveness following early life injury were to 
involve the trafficking and synaptic insertion of AMPA receptors, in particular those 
containing GluA1 subunits (Hayashi et al., 2000; Shi et al., 2001; Makino and 




reported in events of neuronal plasticity in other parts of the CNS. In hippocampal 
neurons, NMDA receptors and CaMKII are important in driving synaptic delivery of 
AMPA receptors during LTP (Hayashi et al., 2000) and the contributions of both are 
dependent on the small G protein, Ras (Zhu et al., 2002; Kim et al., 2005). Ras is 
localised in the inner face of the plasma membrane and controls a variety of 
intracellular signalling cascades, which regulate cellular proliferation, differentiation, 
growth, and survival. Ras is highly expressed in the developing and adult nervous 
system where it acts as a master regulator of growth factor signalling to downstream 
ERK MAP kinase cascades (Nakafuku et al., 1992; Seger and Krebs, 1995). 
Moreover, it can also be activated by membrane depolarisation and voltage-
dependent Ca
2+
 influx such as that due to NMDA receptor activation (Rosen et al., 
1994; Zhu et al., 2002; Kim et al., 2005) and plays a key role in the regulation of 
neuronal plasticity and memory formation (Martinez and Derrick, 1996). Thus the 
Ras/ERK pathway may play a role in modulation of nociceptive transmission in 
spinal neurons during chronic pain states or following early life injury.  
The activation status of Ras is controlled by GTP-exchange factors (GEFs), notably 
those of the Sos and Ras-GRF families, both of which can be activated through Ca
2+
-
dependent processes (Farnsworth et al., 1995; Takai et al., 2001). Prior to cytosolic 
Ca
2+
 elevation or growth factor stimulation, Ras binds GDP in its inactive 
conformation. In addition to Ca
2+
 activation of the Ras-GEFs, Ca
2+
 influx through 
NMDA receptors or L-type voltage-dependent channels induces a rapid tyrosine 
phosphorylation of epidermal growth factor receptors (EGFRs) and increases the 
association of the EGFR with Grb2, an adapter protein, that binds and enables 
activation of Sos (Rosen and Greenberg, 1996). The Ca
2+
-dependent kinase that 
mediates EGFR phosphorylation and activates the Ras/ERK cascade is unknown, but 
could be tyrosine kinases Pyk2 ONLY ONE SPACE HERE LITING NOT TWOor 
Src (Lev et al., 1995; Rusanescu et al., 1995). Sos is thought be the major Ras-GEF 
for Ras activation in neonatal animals and differential changes in Sos and Ras-GRF 
expression occur through early life development (Tian et al., 2004), so the respective 
roles of these Ras-GEFs in ERK activation in hypersensitive pain responses may 




MAPKs such as ERK are important for intracellular signal transduction and play 
critical roles in regulating neural plasticity and inflammatory responses. The MAPK 
family consists of three major and distinct subgroups: ERK, p38 and c-Jun N-
terminal kinase (JNK). Activation of MAPKs under different persistent pain 
conditions results in the induction and maintenance of pain hypersensitivity via 
transcriptional and post-translational regulation. ERK itself is a major regulator of 
gene transcription with important additional post-translational roles in neuronal 
plasticity and development (Seger and Krebs, 1995; Impey et al., 1999; Widmann et 
al., 1999; Sweatt, 2001). In particular, pain-induced ERK activation in spinal cord 
dorsal horn neurons (via multiple neurotransmitter receptors, and using different 
second messenger pathways) plays a critical role in central sensitisation by regulating 
the activity of glutamate receptors and potassium channels and inducing gene 
transcription (Ji et al., 1999; Ji et al., 2002; Kawasaki et al., 2004). ERK was shown 
to be activated (phosphorylated by the upstream kinase MEK) in response to noxious 
chemical, thermal or electrical stimuli and the spinal administration of MEK 
inhibitors attenuated nociceptive behavioural responses. Interestingly, in the 
sensitised state following nerve injury even low threshold electrical stimulation 
elicits ERK activation in dorsal horn neurons (Wang et al., 2004). The magnitude of 
ERK activation in response to a set stimulus may therefore provide a measure of the 
degree of central sensitisation that is present.  
3.2 Results 
3.2.1 Behavioural tests after CCI in neonatal animals 
CCI surgery was performed in the right hind limbs of postnatal day 8 (P8) rats in a 
series of experiments carried out jointly with Hayley Gooding and Andrew Allchorne. 
The procedure was modified from that used for adult animals (Garry et al., 2003b; 
Proudfoot et al., 2006) as outlined in Chapter 2. Pain-related responses reflecting 
mechanical allodynia were assessed using von Frey filaments. The paw withdrawal 
threshold (PWT, mN/mm
2
) of both ipsilateral and contralateral sides was recorded 




PWT were seen on the contralateral side whereas consistent reductions developed in 
ipsilateral PWT values, so the data were presented as the difference between 
contralateral and ipsilateral value. The sensitisation of mechanical reflex withdrawal 
responses caused by CCI is similar between males and females (previous 
unpublished observations within the laboratory). Here, the difference between 
contralateral and ipsilateral PWT is shown in females, which were the animals 




Figure 3.2: Mechanical sensitisation in rats following CCI at postnatal 8 day (P8) 
Time-courses of mechanical sensitisation (PWT, mN/mm
2
) to calibrated von Frey 
filament testing were assessed following CCI surgery at P8. Data are plotted as mean
± SEM difference (Contralateral-Ipsilateral) in PWT from calibrated von Frey 
filaments. In each case, the statistical significance of differences between ipsilateral 
and corresponding contralateral responses is indicated as *: p<0.05 (Mann-Whitney 
Rank Sum Test on raw data). The white columns show results from the subgroup of 
animals (approximately half of the cohort) that showed rapid recovery from 
ipsilateral sensitisation, which displayed statistically significant ipsilateral: 
contralateral differences between days 10-20 following surgery (n=11). The grey 
columns show results from the subgroup of animals that displayed longer lasting 
sensitisation (n=9), which was statistically significant and continued to increase from 
beyond day 20 following surgery up to day 60 when the experiment was terminated. 
This subdivision of the cohort could be identified not only by the duration of 
sensitisation but also by an abnormal postural presentation of the affected hind paw 
in the long-lasting sensitised animals. An unusual flexed posture of the paw was 
observed, which correlated with the appearance of long-lasting hypersensitivity. It 
was considered that the most likely explanation for this was that the severity of the 
nerve injury had been greater in these cases (but the underlying basis was not further 
investigated here). The reflex response measurements were made by Hayley Gooding 











































































Interestingly, two different profiles of behavioural reflex sensitisation were observed 
in the P8 CCI animals. Approximately half of them showed short-lasting mechanical 
sensitisation (significant ipsilateral-contralateral differences in PWT) through post-
operative days 10-20 and then recovered by day 30, beyond which there were no 
longer significant differences in PWT.  The other half of the animals showed long-
lasting mechanical sensitisation that appeared to develop more slowly and reach a 
greater magnitude. Statistically significant ipsilateral:contralateral differences were 
seen between post-operative days 28-60 that appeared to be continuing to increase 
even as the experiment was terminated at 60 days. The long-lasting group, in every 
case, also displayed postural abnormality in the relevant paw that was not seen in the 
short-lasting group. This presented as abnormal flexion of the paw and was 
interpreted as most likely being due to greater severity of injury in these animals. The 
underlying basis was not further investigated here. Nevertheless, these findings 
suggested that different molecular events evoked by peripheral nerve injury may 
occur in the rapidly recovering and slowly recovering series of P8 CCI rats. In the 
present study, I only focus on the recovered CCI rats in order to address the 
hypothesis that there may be an enduring hypersensitivity to subsequent challenges 
even after apparent resolution of the neonatal injury-induced pain state.  
3.2.2 Behavioural assessment of formalin responses 
in animals that received neonatal CCI and had 
subsequently recovered  
To assess the responsiveness of rats that had recovered from early life nerve injury to 
a noxious challenge in later life, female animals of age P42 that had either received 
early postnatal (CCI) nerve injury at P8 or controls were given a unilateral hindpaw 
intraplantar injection of formalin or saline under brief isoflurane anaesthesia. CCI 
induced mechanical allodynia around the time of injury in early life but in the cohort 
of animals tested here, von Frey paw withdrawal thresholds had fully recovered to 
the normal range before formalin testing at P42. Formalin-induced nocifensive 
behaviours exemplified by paw shaking, flicking and lifting were observed for 60 




1 minute was recorded using a stop-watch by the same observer who was blinded to 
the treatment history of the animals.   
Interestingly, formalin-induced inflammation in the hind paw triggered a greater 
nocifensive behavioural response in the early life injury rats even though, in terms of 
von Frey PWT scores, they had apparently fully recovered from a hypersensitive 
state. The number of nocifensive behaviours in both pre-treated (n=8) and näive 
(n=15) rats showed a similar profile following formalin injection with a slow 
increase, a peak for few minutes, and a decrease back to normal levels. Notably, in 
the peak stage of response to formalin (25-35 minutes following injection) the 
number of nocicfensive behaviours in the rats that had received early life nerve 
injury was significantly greater than that in age-matched controls (Figure 3.3). This 
result indicated that when the nerve-injured neonates grew to adulthood, they were 
more sensitive to noxious stimuli such as formalin challenge. This implies that the 
neonatally nerve-injured rats that had apparently recovered at the level of acute 
behavioural reflexes may still have long-lasting or permanent alterations in the 
sensitivity of nociceptive processing. In the latter stages of the formalin response of 
neonatally injured animals there was a trend to lower nocifensive scores compared to 
age-matched controls but this did not reach statistical significance. It is possible that 
a more extensive study would expose a significant effect, which might reflect greater 
induction of endogenous analgesic processes in addition to the hypersensitivity seen 
in peak formalin responses. The animals available for this study were females, which 
provided an advantage in that their formalin nocifensive scores are consistently 
greater than in males, allowing easier discrimination of changes in sensitivity. The 
underlying basis for the difference is not known but it is consistently observed in this 
and other labs (Fleetwood-Walker, unpublished observations; Yaksh, T.L, personal 
communication). Animals that were uninjected or injected with saline displayed 
minimal nocifensive behaviour.  
When adult rats were subjected to CCI and then tested with formalin 34 days later 
(equivalent to the P8/P42 time interval) they showed a broadly similar profile of 
nocifensive responses, with a peak around 25-35 minutes after injection. This profile 




under brief anaesthesia and displays only the slowly developing peak of nocifensive 
behaviours without an initial acute pain response. The nocifensive response profile in 
previously CCI-injured adults (that had recovered normal von Frey PWT values) 
showed no discernible difference in nocifensive behaviour scores at any stage of the 
response, when compared to uninjured age-matched controls. Thus the lasting 
hypersensitivity to a subsequent noxious challenge was seen only in animals that 




Figure 3.3: Formalin-induced nocifensive behaviours are increased in recovered 
neonatally-injured animals compared to controls but not in recovered adult-
injured animals  
Time-courses of differences in duration of nocifensive (spontaneous paw-shaking, 
flicking and lifting) behaviours (seconds per minute) between CCI-injured animals 
and age-matched controls following intraplantar injection of formalin under brief 
isoflurane anaesthesia. Animals were tested at 34 days following injury, or equivalent 
for controls, at which time the sensitisation of von Frey PWT values had recovered to 
normal. Female animals were used for these experiments because of their availability 
and consistently greater nocifensive responses to formalin, which facilitated 
discrimination of any changes in responsiveness. In all cases nocifensive behaviours 
increased to a peak around 25-35 minutes following formalin injection and then 
declined. Uninjected or saline-injected animals displayed minimal nocifensive 
behaviour. White columns display the differences in time-course of nocifensive 
behaviour between P8-injured animals (n=8) and age-matched controls (n=15) when 
formalin-injected at P42. Grey columns display the differences in time-course of 
nocifensive behavior between adult-injured animals (n=8) and age-matched controls 
(n=8) when formalin-injected 34 days later. Data showing the difference in 
nocifensive scores between injured and control groups are plotted as mean ±SEM. 
The statistical significance of differences between nerve-injured animals and 
corresponding controls was assessed by Student‟s unpaired t-test on the raw 
nocifensive score data (* indicates p<0.05). The reflex response measurements were 
made by Hayley Gooding and Andrew Allchorne with my assistance as described in 
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3.2.3 Assessment of GluA1 expression in 
postsynaptic density of dorsal horn in animals that 
received early life nerve injury at P8 and a 
subsequent acute noxious challenge at P42   
In order to optimise the procedure for preparation of postsynaptic density (PSD) and 
non-synaptic synaptosomal proteins (NSSP), a number of pilot experiments were 
carried out using forebrain and näive adult spinal cord tissue. Several minor 
procedural changes were made to the published methods for rapid Percoll/sucrose 
gradient separation of synaptosomes and for subsequent ultrafractionation of PSD 
and NSSP. This was essential before attempting to apply this kind of approach to the 
very small tissue samples of microdissected ipsilateral and contralateral dorsal horn 
following various pain-related interventions – a strategy that to my knowledge has 
not been attempted previously. This approach was especially challenging in young 
animals where the amounts of tissue are considerably smaller than in adults. A 
number of variants of the final protocol were explored, including for example 
attempts to separate pre- and post-synaptic components of the NSSP fraction using 
different pH buffers (Feligioni et al., 2006) but were rejected because of inconsistent 
recovery of marker proteins with the very small tissue samples involved here. The 
final selected protocol was validated using näive adult spinal cord by probing the 
PSD and NSSP fractions for the marker proteins PSD-95 and synaptophysin, 
respectively, using immunoblot.  
The PSD marker protein PSD-95 was very selectively recovered from the PSD 
fraction and not the NSSP fraction, whereas the synaptophysin overwhelmingly 
presented in the NSSP fraction of both frontal cortex and spinal cord of näive adults 
(Figure 3.4). This indicated that the two subcellular fractions of dorsal horn were 
successfully isolated by the final optimised protocol. GluA1 and a key GluA1-
interacting protein, 4.1N, were highly concentrated in PSD rather than NSSP 




Figure 3.4: Validation of the protocol for preparation of postsynaptic density 
(PSD) and non-synaptic synaptosomal protein (NSSP) fractions and 
identification of GluA1 and 4.1N expression in the PSD fraction.   
Marker proteins for subcellular fractions were probed in both the PSD fraction and 
the NSSP fraction prepared from CNS regions of naïve adult rats.  Following SDS-
PAGE electrophoresis, proteins were blotted to PVDF membrane and probed with 
specific anti-PSD-95 and anti-synaptophysin antibodies and HRP-conjugated 
secondaries before visualisation by enhanced chemiluminescence and X-ray film. 
PSD-95 is a postsynaptic marker, whereas synaptophysin is a marker for non-
synaptic synaptosomal proteins and is localised to presynaptic terminals. Highly 
selective recovery of PSD-95 and synaptophysin in their predicted subcellular 
fractions from a) frontal cortex and b) spinal cord, served to validate the final 
optimised protocol before its use with microdissected tissues from animals with pain 
state interventions. c) Shows the relative distribution of GluA1 and a key GluA1-
interacting protein, 4.1N, between PSD and NSSP fractions of spinal cord from naïve 
adult rats. Both GluA1 and 4.1N would be predicted to localise predominantly in the 
postsynaptic fraction and may be largely associated with the PSD. These data 
indicate that both GluA1 and 4.1N are highly concentrated in PSD compared to 
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Following my successful validation of the subcellular preparation protocol, the PSD 
fractions were isolated from ipsilateral and contralateral dorsal quadrants of L4-L6 
spinal cord in näive P42 rats (N), näive P42 rats with formalin challenge (N + F), P8 
nerve-injured rats recovered at P42 and injected with saline (CCI) and P8 nerve-
injured rats with formalin challenge at P42 (CCI + F) following the behavioural 
experiments as appropriate. The isolated PSD fractions were probed by immunoblot 
for content of GluA1 and actin (control protein for normalisation) (Figure 3.5). 
Female rats were used for these experiments because of their more robust 
nocifensive response profile. All animals that received early life nerve injury 
displayed initial mechanical sensitisation to von Frey filaments but had recovered to 
normal range PWT values before P42.   
PSD fractions from dorsal horn ipsilateral to formalin injection in animals that had 
received early life nerve injury (CCI + F) showed a significantly greater GluA1:actin 
ratio than those from contralateral dorsal horn, as did those from formalin-treated 
animals that had not received early life injury (N + F) (p<0.05, Ratio t-test, n=4; 
Figure 3.5a). Animals that had received early life nerve injury but saline instead of 
formalin (CCI) did not show a significant side difference in GluA1:actin ratio. The 
group means for ipsilateral and contralateral values of GluA1:actin ratio are shown in 
Figure 3.5a, below typical example blots. The Ratio t-test is recommended where 
comparing the relative values of two measures (here the GluA1 and actin image 
density ratios for ipsilateral:contralateral sides from the same blots) might be 
predicted to provide a more appropriate assessment than a comparison of absolute 
values (Motulsky, 2003). This test further avoids any requirement for normal 
distribution of data sets. When individual ipsilateral:contralateral ratio values for 
GluA1 normalised to actin were compared (Figure 3.5b), those for the CCI + F group 
were significantly greater than those for the N + F group (p<0.05, Student‟s unpaired 
t-test, n=4). This finding demonstrates that formalin induced significantly greater 
incorporation of GluA1 subunits into the PSD of dorsal horn in animals that had 
received nerve injury in early life but had apparently recovered. Thus a long-lasting 
susceptibility to increased biochemical changes that could explain hypersensitivity in 




Figure 3.5: Early life nerve injury facilitates formalin-induced increases in 
GluA1 content in the PSD fraction in ipsilateral dorsal horn.  
Immunoblots for GluA1 and actin (for normalisation of protein loading) in PSD 
fractions were prepared from ipsilateral (I) and contralateral (C) spinal dorsal horn of 
rats following various treatments: N: Näive at P42; N+F: Näive with formalin 
injection at P42; CCI: P8 CCI with saline injection at P42; CCI+F: P8 CCI with 
formalin injection at P42. Quantitative densitometry analysis of the results from 4 
separate experiments was carried out using Image-J software.   
a) Shows representative blots for GluA1 and actin from a typical example gel 
together with quantitative analysis of GluA1:actin ratios in each case. Data are 
shown as mean ± SEM (n=4). Statistical significance of differences in 
ipsilateral:contralateral ratios for GluA1 normalised to actin was assessed using the 
Ratio t-test, Section 2.4.2  (* p<0.05). Both N + F and CCI + F groups showed 
statistically significant increases in relative GluA1:actin content of PSD ipsilateral to 
formalin injection compared to the contralateral side. 
b) Shows a comparison of ipsilateral:contralateral ratios for GluA1 normalised to 
actin from each individual data set for the N + F and CCI + F groups. Data are shown 
as means ± SEM (n=4). Statistical analysis by Student‟s unpaired t-test indicated that 
the values for ipsilateral:contralateral ratio of GluA1 normalised to actin were 
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3.2.4 Assessment of phospho-ERK and Sos-1 
expression in subcellular fractions of dorsal horn in 
animals that received early life nerve injury at P8 and 
a subsequent acute noxious challenge at P42  
In order to further examine the intracellular signalling events that may be changed by 
early life nerve injury and potentially contribute to enabling both enhanced GluA1 
translocation to PSD and also amplified nocifensive responses to later life noxious 
stimuli, phosphorylated (activated) ERK in the NSSP fraction and Sos-1 in the PSD 
fraction were assessed using immunoblot.  
Animals of age P42 that had received either early life (P8) CCI nerve injury or age-
matched controls were given a unilateral intraplantar injection of formalin. Full 
recovery from early life injury was achieved as assessed by von Frey paw withdrawal 
thresholds before formalin testing at P42. Following formalin injection (or saline 
control) both PSD and non-synaptic synaptosomal protein (NSSP) fractions were 
prepared from ipsilateral and contralateral dorsal quadrants of L4-L6 spinal cord and 
then probed by immunoblot for phospho-ERK (activated state), Sos-1 and actin 
(normalisation control protein). 
NSSP fractions from dorsal horn ipsilateral to formalin injection in animals that had 
received early life nerve injury (CCI + F) showed a significantly greater phospho-
ERK:actin ratio than those from contralateral dorsal horn (p<0.05, Ratio t-test, n=3; 
Figure 3.6a). Animals that received formalin but not early life nerve injury (N + F) or 
those that received a saline injection following early life nerve injury (CCI) did not 
show statistically significant differences in phospho-ERK:actin ratios between 
ipsilateral and contralateral sides. The group means for values of phospho-ERK:actin 
ratio are shown in Figure 3.6a below typical example blots. Similar but less clear-cut 
results were observed in the PSD fraction. When individual ipsilateral:contralateral 
ratio values for phospho-ERK normalised to actin were compared (Figure 3.6a), 
those for the CCI + F group were greater than those for the N + F group but the 




The addition of further replicate observations may achieve a statistically significant 
result. In pilot experiments, evidence was provided for increased expression of the 
Ras-GEF, Sos-1 (a key regulator of ERK pathway activation) in the PSD following 
early life nerve injury (in both CCI and CCI + F groups; Figure 3.6c). Sos-1 
expression relative to actin appeared to be increased on both ipsilateral and 
contralateral sides following earlier unilateral nerve injury and may have been further 
increased ipsilateral to formalin in the CCI + F group.  This provides preliminary 
evidence to suggest that a key regulator of the ERK pathway shows increased 
expression in dorsal horn lasting over a prolonged period following early life nerve 
injury despite the recovery of von Frey thresholds to the normal range, but further 




Figure 3.6: Early life nerve injury facilitates formalin-induced increases in 
phospho-ERK content of the NSSP fraction in ipsilateral dorsal horn and elicits 
apparently enduring increases in expression of Sos-1 in the PSD fraction. 
Immunoblots for phospho-ERK and actin (for normalisation of protein loading) in 
NSSP and PSD fractions were prepared from ipsilateral (I) and contralateral (C) 
spinal dorsal horn of rats following various treatments: N:  Näive at P42; N+F: 
Näive with formalin injection at P42; CCI:  P8 CCI with saline injection at P42; 
CCI+F: P8 CCI with formalin injection at P42. Quantitative densitometry analysis of 
the results from 3 separate experiments was carried out using Image-J software. 
a) Shows representative blots for phospho-ERK and actin from a typical example gel 
together with quantitative analysis of phospho-ERK:actin ratios in each case. Data 
are shown as mean ± SEM (n=3). Statistical significance of differences in 
ipsilateral:contralateral ratios for phospho-ERK normalised to actin was assessed 
using the Ratio t-test, Section 2.4.2 (* p<0.05). The CCI + F group alone showed a 
statistically significant increase in relative phospho-ERK: actin content of NSSP 
ipsilateral to formalin injection compared to the contralateral side. 
b) Shows a comparison of ipsilateral:contralateral ratios for phospho-ERK 
normalised to actin from each individual data set for the N + F and CCI + F groups. 
Data are shown as means ± SEM (n=3). Statistical analysis by Student‟s unpaired t-
test indicated that the values for ipsilateral:contralateral ratio of phospho-ERK 
normalised to actin were not significantly greater in the CCI + F group than in the N 
+ F group, given the current number of replicate observations. 
c) Shows representative blots for Sos-1 and actin in the PSD fraction from pilot 
experiments. These suggested that a long-lasting increase in Sos-1 expression was 
caused on both ipsilateral and contralateral sides of spinal dorsal horn following 
early life nerve injury and that this may have been further increased ipsilateral to 
formalin injection in the CCI + F group. Further experiments would be required to 
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3.2.5 Assessment of behavioural reflex 
hypersensitivity and associated biochemical changes 
after CCI in adult rats 
In order to investigate whether equivalent events contribute to neuropathic pain 
mechanisms in adult animals, CCI surgery was performed in right hindlimbs of adult 
rats. These animals were assessed initially by testing for mechanical allodynia using 
von Frey filaments. The paw withdrawal threshold (PWT, mN/mm
2
) of both 
ipsilateral and contralateral sides was recorded for 60 days (Figure 3.7). As there 
were no marked changes in PWT on the contralateral side, the data were plotted as 
the difference between contralateral and ipsilateral values. In a cohort of 6 adult CCI 
rats, assessed in joint experiments with Hayley Gooding and Andrew Allchorne, 
significant differences between contralateral and ipsilateral PWT values were 
observed at post-operative days 10-14 (p<0.05, Mann-Whitney Rank Sum Test). The 
lowered ipsilateral mechanical threshold had recovered to normal levels from post-
operative days 28-60. The data show that CCI injury can reduce the paw withdrawal 
threshold and cause mechanical allodynia in adult rats. However, in contrast to the 
two subgroups of response in P8-injured rats (either short or long-lasting; Figure 3.2), 
all adult CCI animals showed rapid recovery from the hypersensitive state. This 
might suggest that there is the possibility of accessing some different molecular 




Figure 3.7: Sensitisation of mechanical reflex withdrawal responses in adult rats 
following CCI 
The time-course of mechanical sensitisation (Paw Withdrawal Threshold; PWT, 
mN/mm
2
) to von Frey filament testing was assessed following CCI surgery in adults. 
Data are plotted as mean±SEM difference (Contralateral-Ipsilateral) in PWT from 
calibrated von Frey filaments (*p<0.05, Mann-Whitney Rank Sum Test in the period 
10-14 days following CCI, n=6). The reflex response measurements were made by 



































































3.2.6 Measurement of nerve injury-induced changes 
in GluA1 content of postsynaptic density from dorsal 
horn of adult CCI rats 
The PSD fractions were isolated from ipsilateral and contralateral dorsal quadrants of 
L4-L6 spinal cord from nerve-injured rats at post-operative day 10; the time point at 
which the greatest behavioural responses were detected. The dorsal horns of näive 
rats (bilaterally combined) were used to prepare PSD fractions for controls. All 
animals were within the weight range 180-250 g and their normal rate of weight gain 
was not discernibly affected by nerve injury. Proteins within the PSD fractions from 
these animals were separated by SDS-PAGE and then probed by immunoblot for 
content of GluA1 and actin (control protein for normalisation). 
Figure 3.8 shows that PSD fractions from dorsal horn of animals ipsilateral to 
peripheral nerve injury showed a significantly greater GluA1:actin ratio than the 
contralateral side (p<0.01, Ratio t-test, n=3). This finding showed that peripheral 
nerve injury induced an increased GluA1 subunit content in the PSD of ipsilateral 




Figure 3.8: CCI nerve injury induces increased GluA1 content in the PSD 
fraction of ipsilateral dorsal horn in adult animals.  
Immunoblots for GluA1 and actin (for normalisation of protein loading) in PSD 
fractions were prepared from ipsilateral (I) and contralateral (C) spinal dorsal horn of 
adult CCI rats and naïve (N) controls. Quantitative densitometry analysis of the 
results from 3 separate experiments was carried out using Image-J software.  
The Figure shows representative blots for GluA1 and actin from a typical example 
gel, together with quantitative analysis of GluA1:actin ratios in each case. Data are 
shown as mean ± SEM (n=3). Statistical significance of differences in 
ipsilateral:contralateral ratios for GluA1 normalised to actin was assessed using the 
Ratio t-test, Section 2.4.2  (** p<0.01). This test is recommended where comparison 
of the relative values of two measures might be predicted to provide a more 
appropriate assessment than a comparison of absolute values (Motulsky, 2003). Here 
this is indicated when comparing relative GluA1:actin ratios for the individual data 
sets, which were each run on a single gel, as such relative values will provide a more 
appropriate between-gel comparison than absolute grey scale values which will vary 
from gel to gel. Adult CCI animals showed statistically significant increases in 




























3.2.7 Measurement of changes in GluA1 association 
with its interacting protein, 4.1N in adult spinal cord 
following CCI 
Any changes in direct protein:protein interactions between GluA1 and its interacting 
protein/trafficking chaperone, 4.1N were investigated by co-immunoprecipitation 
and subsequent immunoblot for captured proteins in the spinal cord of adult CCI 
animals or naïve controls. Tissue samples were obtained from CCI animals at post-
operative day 10 when the greatest sensitisation of mechanical responses was 
detected.  
Following GluA1-directed immunoprecipitation, greater levels of its interacting 
protein, 4.1N, appeared to be captured ipsilateral to CCI (Figure 3.9a). These 
immunoprecipitations were carried out by Emer Garry as part of our joint 
experimental programme. I subsequently carried out a number of experiments to 
assess whether a reciprocal immunoprecipitation procedure, which used 4.1N as a 
pull-down target and evaluated capture of associated GluA1, was feasible. Although 
the 4.1N antibody used for Western blot detection was unsuitable for native 
immunoprecipitation, an immunoprecipitating 4.1N antiserum was sourced from 
Millipore. Despite a variety of optimisation steps including chemical crosslinking to 
protein G-Sepharose beads and extensive clean-up procedures, the reagent retained 
too much non-specific binding to allow demonstration of specific GluA1 capture 
associated with 4.1N pulldowns. The amounts of material required for co-
immunoprecipitation of such proteins expressed at low levels precluded such 
experiments being carried out on the subcellular fractions. Thus, it was not possible 
to directly evaluate the synaptic or extrasynaptic location of the GluA1:4.1N 
complexes. However, I had been able to establish in Figure 3.4c that both GluA1 and 
4.1N were expressed in a highly selective fashion in PSD rather than NSSP fractions 
of näive adult spinal cord. The detailed subcellular localisation of 4.1N within spinal 
cord neurons remains unclear as the available antibodies also proved unsuitable for 
immunohistochemistry. Current evidence suggests that 4.1N may play a part in the 




them into place within synapses in order to bring about excitation at greater levels. 
My data suggest that GluA1:4.1N interactions and hence possibly also these 
processes may occur to a greater extent following nerve injury in adults. It is possible 
that similar events to these may occur following nerve injury in neonates but this was 
not investigated in the present study. In a further series of immunoblot experiments I 
addressed the developmental time-course of GluA1 and 4.1N expression in spinal 
cord. Figure 3.9b shows that expression of GluA1 increased from P9 to P28 whereas 
4.1N showed the inverse profile of decreasing expression. However, both of these 
proteins appeared to show increased expression ipsilateral to P8 CCI when assessed 
at P28. These findings indicate that GluA1 and 4.1N appear to show reciprocal time-
courses of developmental expression in spinal cord through the early postnatal period 
but also that expression of each is increased ipsilateral to injury in animals that 





Figure 3.9: GluA1 and 4.1N show increased co-immunoprecipitation in adult 
spinal cord ipsilateral to CCI and nerve injury-induced expression in neonates 
despite distinct developmental time-courses of expression. 
Immunoblots for GluA1, 4.1N and GAPDH (for normalisation of protein loading) 
were carried out on extracts from spinal cord ipsilateral (I) or contralateral (C) to 
CCI or from naïve animals (N). In a) samples from adult CCI or N animals were 
solubilised in a non-denaturing detergent-containing medium and 
immunoprecipitated using an anti-GluA1 antibody (or non-immune IgG: NIMIgG 
control) conjugated to protein G-Sepharose beads before washing and lysis of 
captured proteins in Laemmli buffer. Protein content of solubilised preparations prior 
to immunoprecipitation is shown in „Total‟ lanes. The levels of 4.1N specifically 
associated with GluA1 immunoprecipitates appeared to be increased ipsilateral to 
CCI. b) Shows results from direct immunoblots on spinal cord lysates. Equivalence 
of protein loaded was monitored by immunoblotting for the constitutively expressed 
housekeeping enzyme, GAPDH. Expression of GluA1 appeared to increase and 4.1N 
to decrease through early post-natal development, although early life nerve injury at 
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In the presence of chronic stimulation such as inflammation or nerve injury, the CNS, 
in particular the spinal cord, has the protective capability to minimise injury by 
generating both an immediate reflex withdrawal from the harmful stimulus and an 
enhanced responsiveness to subsequent sensory inputs (i.e. hyperalgesia and 
allodynia). This hypersensitivity to further sensory inputs is maintained by changes 
in the peripheral and central nervous systems, which in the case of neuropathic pain 
states are largely dependent on central sensitisation. 
Central sensitisation has been described as “an enhancement in the function of 
neurons and circuits in nociceptive pathways caused by increases in membrane 
excitability and synaptic efficacy as well as reduced inhibition and represents a 
manifestation of the remarkable plasticity of the somatosensory nervous system in 
response to activity, inflammation and neural injury” (Latremoliere and Woolf, 2009). 
Mechanical allodynia is a typical feature of central sensitisation in neuropathic pain 
states, manifested as alterations in sensory pathways including those that do not 
normally mediate nociceptive inputs, such as large low-threshold myelinated 
mechanoreceptors, which now appear to adopt a role in mediating pain (Woolf and 
Salter, 2000a). In the present study, neonatally nerve-injured rats showed a 
significantly reduced withdrawal threshold to von Frey filaments in the hind paw 
ipsilateral to CCI compared to that in the contralateral paw. This demonstrated that 
mechanical allodynia could be elicited in very young animals by peripheral nerve 
injury. Behavioural reflex sensitisation evoked by CCI in adult rats has been reported 
widely, including by our group (Garry et al., 2003a). However, the neuropathic pain 
mechanisms in young and adult animals may vary, as about half of the nerve-injured 
young animals showed much longer-lasting behavioural sensitisation. This might be 
due to greater severity of the lesion in the neonatal animals that displayed longer 
lasting sensitisation, although it should be noted that adult CCI animals never 
displayed such long-lasting changes. The underlying basis for the different 
behaviours apparent in young animals following nerve injury needs to be further 
investigated.  
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Mechanical allodynia in neuropathic pain states is attributed to alterations in the 
properties of dorsal root ganglion (DRG) neurons and in the responsiveness of 
central neurons in the spinal dorsal horn to sensory inputs. This may be because after 
nerve injury, at least a subpopulation of DRG cells change their phenotype  and their 
activity is associated with tactile allodynia (Liu et al., 2000). Meanwhile, further 
diverse alterations of spinal somatosensory processing occur, such as hypersensitivity 
of excitatory neurons, possible disinhibition through alterations in the influence of 
GABAergic interneurons, and changes in descending facilitatory influences on spinal 
neurons (Kim et al., 1997; Suzuki et al., 2004; Miraucourt et al., 2009).  
Spinal AMPA receptors have a well-established role in transmitting fast excitatory 
information under normal conditions and can contribute to acute nociceptive inputs 
(Yoshimura and Jessell, 1990). Injection of formalin (which may activate TRPA1 
channels) is widely used as a pain model to assess the mediation and modulation of 
pain-related behaviours. Behavioural nocifensive responses to formalin in conscious 
animals contain two phases, a first acute phase for the first 10 minutes, followed by a 
transient decrease and a second tonic (centrally-mediated) phase from 30-60 minutes 
after injection (Abbott et al., 1995; McNamara et al., 2007). AMPA receptors in 
spinal cord are believed to contribute to the two phases of hypersensitivity. In the 
present studies, animals were briefly anaesthetised with isoflurane prior to formalin 
injection to avoid any additional influences of stress on response characteristics, 
which means that first and second phase responses are not so clearly delineated 
(Fleetwood-Walker, unpublished; Yaksh, T.L., personal communication). Intrathecal 
administration of the selective AMPA antagonist NBQX inhibited the acute phase of 
behavioural nociceptive response to formalin in adult rats (Hunter and Singh, 1994). 
Moreover, spinal AMPA receptors were shown to be crucial to the later phase 
behavioural response to formalin, which can be blocked by the AMPA receptor 
antagonist YM872 throughout development (King and Barr, 2007). In the present 
study, the P42 rats showed typical nocifensive behaviours including paw flinching, 
licking and lifting after formalin injection and the content of GluA1 subunits of 
AMPA receptors in the PSD of ipsilateral spinal dorsal horn was specifically 
increased ipsilateral to formalin stimulation, with significantly enhanced responses in 
animals that had received P8 nerve injury, matching behavioural hyper-
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responsiveness in these conditions. Thus our results are consistent with previous 
reports that AMPA receptors, in particular GluA1 subunits, undergo stimulus-induced 
insertion into synapses and may play a role in formalin-induced pain. However, there 
is a controversial report that intrathecal pre-treatment with a (less-selective) AMPA 
receptor antagonist, CNQX, failed to reduce the formalin nociceptive responses 
(Coderre and Melzack, 1992). The differences may be attributable to the different 
specificity profiles of the drugs or a mismatch in the adequacy of doses administered.   
Recent studies further support the idea that AMPA receptors in the spinal cord 
contribute to chronic pain. The expression of GluA2 subunits of AMPA receptors and 
of their associated interacting protein, GRIP in the spinal dorsal horn increased 
following peripheral nerve injury (Garry et al., 2003b). A role of AMPA receptors in 
sensitised nociceptive processing is further supported by a pharmacological study 
which demonstrated that administration of the selective AMPA receptor antagonist 
NBQX abolished the mechanical allodynia and neural hyperexcitability resulting 
from spinal cord injury in rats (Gwak et al., 2007). This accords with data from our 
laboratory (Figure 3.1). It has been reported that the expression of GluA1 subunits 
within the adult spinal dorsal horn is upregulated following nerve injury at post-
operative day 14, corresponding to the presence of mechanical allodynia, but not 
before post-operative day 3 or after post-operative day 35 (Harris et al., 1996; Lu et 
al., 2008). In this study, half of the young rats with early life CCI injury appeared to 
recover rapidly, with their mechanical withdrawal threshold being within the normal 
range and no discernible difference in expression of spinal GluA1 subunits being 
observed between ipsilateral and contralateral sides by post-operative day 28. The 
other half of the young nerve-injured animals maintained their hypersensitivity for 
several months, perhaps because of more severe injury. In contrast, all of the adult 
rats with CCI showed short-lasting sensitisation with paw withdrawal thresholds 
returning to normal levels beyond post-operative day 20. Therefore, my data indicate 
that the time-courses of sensitised mechanical nociceptive behaviours and of 
increased expression of spinal AMPA receptors in neonatal rats following peripheral 
nerve injury are different from those in adult rats. In addition, I find that the 
recovered young rats have greater behavioural nocifensive responses to formalin 
challenge when they grow to adulthood compared to the uninjured ones. Animals that 
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had previously received (but subsequently recovered from) early life nerve injury 
showed a significantly greater formalin-induced incorporation of GluA1 into 
synapses compared to uninjured animals, suggesting a key role of synaptic GluA1 in 
pain hypersensitivity. The role of early life injury in any alterations of nociceptive 
circuits has been poorly understood to date but it may have a great formative effect 
on subsequent nociceptive processing or even cause long-term alterations throughout 
the whole of life. I find that such a lasting hyper-responsiveness despite apparent 
recovery of acute sensory response thresholds is only elicited following nerve injury 
in neonatal but not adult rats.  
GluA1 subunit-containing AMPA receptors have been shown to play an important 
role in central neural plasticity, in particular long-term potentiation (LTP). GluA1 
subunit-containing AMPA receptors specifically translocate to synapses in 
hippocampal neurons during LTP (Hayashi et al., 2000; Boehm et al., 2006; Makino 
and Malinow, 2009). Phosphorylation of the C-terminal tail of GluA1 and interaction 
with PDZ domain proteins are required for this AMPA receptor insertion into 
synapses (Hayashi et al., 2000; Lee et al., 2003). The proportion of phosphorylated 
GluA1 correlates with the surface expression of GluA1 and synaptic efficacy. It is 
reported that every 1% phosphorylation at S845 of GluA1 causes a 0.75% increase in 
GluA1 expression on the cell surface (Oh et al., 2006). Phosphorylation of S818 of 
GluA1 by PKC is also required for AMPA receptor incorporation into synapses 
during LTP (Boehm et al., 2006). The interaction of PDZ domain proteins such as 
PSD-95 with GluA1 appears to be important for synaptic insertion but may not 
required for synaptic plasticity per se. Point mutation at T887 of the GluA1 C-
terminal tail (or deletion of the last 7 residues) both prevent PDZ-protein interactions 
of GluA1, whereas they have opposite effects on synaptic plasticity (Boehm et al., 
2006a). Therefore, the PDZ interaction at the GluA1 C-terminal tail may play more 
of a modulatory role in synaptic plasticity. 
Based on the current literature, GluA1 subunit-containing AMPA receptors are the 
prime candidate for underpinning central sensitisation in chronic pain. An increased 
synaptic distribution of GluA1 subunits correlates with the efficacy of synaptic 
transmission. Incorporation of functional GluA1 subunits into synapses elevates the 
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synaptic strength within 5-10 minutes after LTP induction in anterior cingulate cortex 
(Wei et al., 2006). In CFA-induced inflammatory pain, the expression of GluA1 
subunits in dorsal horn is not changed but their subcellular distribution is altered. The 
level of GluA1 is significantly decreased in cytosolic fractions and increased in 
membrane fractions from the ipsilateral dorsal horn at 24 hours post-CFA injection 
(Park et al., 2008). In the present study, purified subcellular fractions of dorsal spinal 
cord quadrants have been successfully prepared for the first time and further 
separated into PSD and NSSP fractions showing that both GluA1 and 4.1N in spinal 
cord are predominantly localised to the PSD rather than the NSSP fraction. It has 
been shown that under normal conditions the GluA1 subunit is predominantly 
expressed in the superficial laminae I-II of the spinal dorsal horn (Furuyama et al., 
1993; Engelman et al., 1999; Polgar et al., 2008). I report that in pathological 
conditions (i.e. CCI in adult rats), GluA1 subunits show increased expression in the 
ipsilateral dorsal horn PSD fraction at post-operative day 10. These results are 
consistent with the theory of incorporation of GluA1-containing AMPA receptors 
into synapses by lateral movement from an extrasynaptic pool (Makino and Malinow, 
2009). The increased expression of spinal GluA1 subunits in PSD fractions of 
ipsilateral dorsal horn following early life CCI injury corresponds to the marked 
increase in mechanical sensitivity as assessed by behavioural reflexes. This matches 
results following intrathecal administration of the AMPA receptor antagonist NBQX, 
which attenuated the CCI-induced ipsilateral sensitisation of mechanical allodynia in 
adult rats (Figure 3.1). I conclude that the incorporation of spinal GluA1 subunit 
containing-AMPA receptors into the PSD of dorsal horn neurons may contribute to 
the mechanical allodynia evoked by peripheral nerve injury. Therefore spinal GluA1 
subunits may well play a role in central sensitisation in neuropathic pain. 
Furthermore, I also find that formalin-induced expression of GluA1 subunits in PSD 
of spinal dorsal horn is significantly greater in animals that had received early life 
nerve injury (and since recovered) compared to naïve animals. Thus animals that had 
received nerve injury in early life have altered functional nociceptive circuits and 
some form of “memory of pain hypersensitivity” that renders them vulnerable to 
accentuated responses when faced with further noxious challenge in later life. I 
further demonstrated that while GluA1 showed decreasing expression in spinal cord 
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through early postnatal development, and 4.1N showed an inverse profile; CCI injury 
appeared to induce increased spinal cord expression of both proteins.   
The Ras/MAPK (ERK) signalling pathway is one of the best-studied nociceptive 
pathways, which may play a role in bringing about sensitised states. The 
translocation of GluR1 subunit-containing AMPA receptors into the PSD following 
noxious stimulation may be attributed at least in part, to the activation of this 
pathway. The bulk of evidence shows that ERK participates in central sensitisation 
and contributes to the pain hypersensitivity following noxious inputs (Ji et al., 1999; 
Karim et al., 2001; Kawasaki et al., 2004; Walker et al., 2007). Many of the 
mediators of central sensitisation such as NMDA receptors, group I metabotropic 
glutamate receptors, TrkB or NK1 receptors converge to activate ERK (Ji et al., 1999; 
Lever et al., 2003; Ji et al., 2009). Amongst the major activators, glutamate and 
substance P (two principal mediators of sensory inputs) activate ERK in the spinal 
dorsal horn through an elevation of intracellular Ca
2+
 concentration sufficient to 
drive a calmodulin-induced stimulation of adenylyl cyclases 1 and 8, whose cAMP 
production in turn activates PKA and subsequent cascades (Wei et al., 2006). PKA 
and PKC signalling can converge on ERK to modulate neural excitability in 
superficial dorsal horn (Hu and Gereau, 2003). One of the effects ERK produces is 
the recruitment of AMPA receptors to the membrane (Galan et al., 2004). In the 
present study, I have examined the levels of phospho-ERK in the NSSP (and PSD) 
fractions of the spinal dorsal horn, showing that this is enhanced on the ipsilateral 
side following formalin injection in animals that had received nerve injury in early 
life. This corresponds to the significantly increased content of GluA1 subunit-
containing AMPA receptors in PSD fractions. These results are consistent with 
previous reports that ERK is involved in spinal hypersensitivity and may underlie 
GluA1 subunit-containing AMPA receptor trafficking to synapses responding to 
noxious stimuli. 
Ras is considered to be a critical upstream signalling regulator of ERK and to play a 
key role in regulating synaptic trafficking of AMPA receptors in synaptic plasticity 
(Zhu et al., 2002; Qin et al., 2005). Sos-1, a Ras-GEF protein, acting as key 
controller of Ras activation, can be stimulated by receptor tyrosine kinases (RTKs) 
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when they bind growth factors or by GPCR transactivation of RTKs (Bonfini et al., 
1992; Buday and Downward, 1993; Aronheim et al., 1994). Furthermore, Sos-1 has 
been proved to play a role in transmission of hypersensitivity-associated signals from 
NMDA receptors in cortical neurons of neonatal animals (Tian et al., 2004). The 
effects of Sos-1 on nociceptive processing in neuropathic pain remain speculative. 
The current data suggest that enduring high expression of Sos-1 is found in the PSD 
fractions of the spinal dorsal horn in recovered early life CCI rats, but not in rats 
without early life nerve injury. The activation of ERK is a consequence of integrated 
modulation by multiple signalling events including Sos-1. However, Sos-1 in 
particular appears to be a marker for “pain memory” since it is still expressed at a 
high level in the early life-injured animals versus näive animals, even though the 
behavioural sensitivity of the nerve-injured animals had returned to normal. Early 
life injury may serve to influence the expression of Sos-1 in dorsal horn and thus 
alter the nociceptive processing of spinal circuits in young animals in a lasting way.   
Although the current results represent significant advances into new territory, 
establishing a likely molecular basis for the lasting hypersensitivity following early 
life pain, it is important to consider that the approaches used here have some 
limitations: These include: 1) Large amounts of tissue were required to achieve 
enough post-synaptic density fractions for assessment of protein alteration in 
synapses. Significant amounts of material were lost through the stages of PSD 
preparation. The reported protocol for PSD isolation was modified by simplifying 
Percoll/sucrose gradient layers and the times of centrifugation to reduce loss of 
material (Kennedy, 1997; Villasana et al., 2006). More extensive separation 
procedures may achieve more precise subfractionation but would have required even 
more starting material. 2) The interpretation of results from immunoblot and 
immunoprecipitation experiments is entirely dependent on the specificity of 
antibodies (despite the inclusion of appropriate control procedures). 3) The usable 
quantitative range of chemiluminescence for HRP-conjugated secondary antibodies 
in immunoblots is relatively limited. Furthermore the image density does not give a 
directly linear measure of the amount of target protein because the secondary 
antibody may not bind to the primary in a 1:1 ratio and its HRP conjugate is catalytic 
rather than being a directly measurable chemical tag. An improved linearity and 
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dynamic range may be obtained with antibodies directly tagged with labels such as 
near-infrared dye if they were available. As the X-ray films exposed to the 
chemiluminescence signal could be saturated in grey scale by a strong signal, a 
control lane was loaded for each blot to estimate whether the exposure time was 
appropriate or not and I always carried out a range of development times to ensure 
that data were obtained from submaximal exposures. While comparison to levels of a 
„housekeeping protein‟, (whose levels generally do not alter) improves confidence in 
the specificity of changes, it is always possible that the conditions here could elicit 
previously unreported changes in the „housekeeping protein‟. In addition, there is 
always an open question of whether the running of each gel lane, electrotransfer to 
PVDF and access of antibodies, chemiluminescent reagents and film development 
chemicals is identical between lanes. Although these factors may contribute to 
variability, it is likely that they will not impact in a biased manner on the results.  
Despite these caveats, the results indicate that nerve injury induces synaptic 
incorporation of GluA1 following adult CCI together with its increased association 
with partner protein 4.1N that may underlie pain hypersensitivity. In addition, early 
life nerve injury can produce temporary or very long-lasting hypersensitivity. In 
animals with short-lasting (recovered) hypersensitivity after early life nerve injury, 
an acute noxious challenge with formalin elicited accentuated pain behaviours and 
increased incorporation of GluA1 into synapses; a potential basis for the functional 
hypersensitivity. Increases in levels of phospho-ERK (a potential driver of GluA1 
incorporation into synapses) in the non-synaptic synaptoneurosomal fraction were 
also induced by formalin challenge following early life CCI, together with a long-
lasting increase in spinal cord expression of the ERK pathway regulator, Sos-1. 
These findings suggest that not only adult, but in particular early life nerve injury 
induces increased synaptic incorporation of GluA1 that may be in part dependent on 
lasting changes in the ERK MAP kinase pathway and that the effects of early life 
nerve injury may cause long-lasting hyper-responsiveness at both behavioural and 
biochemical levels. 
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Chapter 4: Fluorometric measurement 
of dynamic responses to receptor 
stimulation in freshly isolated neural 
tissue samples 
The processes underlying neuronal hyperexcitability are poorly understood and many 
different signalling events may contribute to this. The previous chapter described a 
multidisciplinary approach, bringing together in vivo behavioural assessments and in 
vitro analysis of synaptic proteins, to address the events underlying hypersensitivity 
in somatosensory processing. However to date, only a limited range of techniques 
has been available to explore dynamic aspects of such cellular mechanisms, 
especially at the interface between biochemical and physiological assessments. In 
order to directly address this deficit I sought to develop new approaches that would 
enable quantitative assessment of dynamic receptor-mediated responses in ex vivo 
neural tissue samples. Such approaches can potentially provide a key way forward 
for elucidation of the mechanisms underlying neuronal hyperexcitability, as for 
example in chronic pain states.  
The general strategy taken aimed for a consensus view of dynamic changes that 
could be associated with hyperexcitability rather than assessing individual neurons 
by electrophysiological or microscopy techniques. To obtain finely divided 
preparations of ex vivo neural tissue, two approaches were taken. In the first, tissue 
was homogenised in protective medium (ice-cold, highly oxygenated medium 
containing high Mg
2+
 and glutamate receptor antagonist to minimise unwanted Ca
2+
 
entry during preparation, protease inhibitors and metabolic supplements). These 
preparations were then passed through a succession of defined pore microfilters to 
obtain tissue segments in the 30-100 m range and a sub - 5 m fraction enriched in 
synaptoneurosomes (closely apposed resealed pre- and postsynaptic elements) 
(Hollingsworth et al., 1985). Each of these types of preparation was subsequently 
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assessed. In the second approach, 150 m × 150 m microslices of tissue were 
rapidly made using a McIlwain tissue slicer and resuspended in the protective 
medium.  
In order to provide a dynamic measure of excitability in ex vivo tissue samples once 
they were returned to normal extracellular medium, I investigated fluorometric dyes 
that indicate cytosolic Ca
2+
 concentration or membrane potential, focusing on the 
former because of their greater signal-to-noise ratio. The use of proprietary “no 
wash” dyes from Molecular Devices, with which external fluorescence is suppressed 
by an impermeant quenching agent, gave the advantage that extensive washing of the 
tissue samples was unnecessary. In order to facilitate parallel comparisons with a 
number of pharmacological agents it was decided to adopt a plate-reader format 
where aliquots of tissue preparations were dispensed into wells rather than a cuvette-
based assay where measurements would need to be made one at a time. It was 
initially unclear whether the tissue preparations would be in sufficiently good 
structural and metabolic condition to produce dynamic responses to stimuli, whether 
there would be sufficient signal-to-noise ratio to enable useful measurements and 
whether the tissue preparations would need to be maintained in suspension or 
allowed to settle to the bottom of the well in order to give better results. The 
experiments described here show how I developed an optimised procedure that 
achieved successful outcomes in each of these aspects and then used it in pilot 
studies to show dynamic responses to ionotropic and metabotropic receptor stimuli 
and their possible interaction.  
A number of the experiments carried out to develop and optimise these techniques 
utilised cerebral cortex tissue, where as proof-of-concept studies I have addressed 
responses of example metabotropic and ionotropic receptors.  Having successfully 
developed and validated these approaches, pilot experiments were carried out to 
establish feasibility in spinal cord, prior to their future application in addressing 




4.1.1 The organisation and functional interaction of 
cerebral cortex and brainstem 
The cerebral cortex is classically described as consisting topographically of frontal, 
parietal, temporal and occipital cortex or consisting functionally of many specific 
areas such as somatosensory, auditory, visual, and motor areas (Barker and Barasi, 
2008a). Cortical areas are richly interconnected with each other and with subcortical 
structures. In microanatomy, the cortex is vertically divided into six layers I-VI with 
diverse cellular subpopulations and the layering of the cortex reflects the radial 
organisation of all the input-output relationships. For example, the primary target of 
the ascending input, layer IV, is defined cytoarchitecturally by the dense packing of 
small cells which contains pyramidal and stellate cells and is also known as the inner 
„granular layer‟. Layer IV includes a majority of excitatory synapses, of which 95% 
represent intrinsic connections between layer IV pyramidal cells and 5% are 
contributed by the ascending input. Ascending inhibitory synapses are far less 
numerous, forming only about 10–20% of all contacts made by the ascending axon 
terminals (Shipp, 2007).  
Structurally, brainstem comprises the medulla, pons, midbrain and diencephalon and 
forms the connection of the motor and sensory systems from the main part of brain to 
the rest of the body, in addition to multiple other functions. As described in Chapter 1, 
the brainstem plays a crucial role in relaying the inputs and outputs along the 
ascending and descending pathways. For example, the thalamic afferent fibres, 
relaying sensory inputs, largely project to cortical layers I and IV, often with a 
smaller input to layer VI, and terminate in discrete patches thus ensuring that sensory 
information from a specific location and/or receptor type is relayed to a specific area 
of cortex (Kharazia and Weinberg, 1994; Rubio-Garrido et al., 2009). Interneurons in 
layer VI relay the thalamic input vertically to layers II, III, and V, which in turn 
project to other cortical and subcortical sites.  
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4.1.2 Central noradrenaline pathways in the brain 
Noradrenergic fibres innervate structures throughout the brain and are thought to 
have important modulatory effects on a variety of brain functions (Moore and Bloom, 
1979). The noradrenaline pathways in the brain have been mapped by fluorescence 
histochemistry in conjunction with selective surgical and pharmacological lesions 
(Dahlstrom and Fuxe, 1964; Ungerstedt, 1971). Noradrenergic fibres with cell bodies 
in the pons and medulla give rise to large ascending and descending tracts, 
terminating at discrete sites in brain and spinal cord respectively. 
The noradrenergic fibres innervating the cerebral cortex originate from the locus 
coeruleus (LC, noradrenergic cell group A6) in the pons and run vertically into the 
layers of cortex with extensive collateralisation, then turn horizontally to run parallel 
to the surface as the vertical fibres reach layer I where the innervation is much 
greater than that of other layers of cortex (Levitt and Moore, 1978). Other 
noradrenergic fibres taht originate in the cell groups A1, A2, A5, A6 and A7 in the 
pons and medulla give rise to the ascending noradrenaline pathways innervating the 
hippocampus, cerebellum, hypothalamus, limbic system and the lower brainstem 
(Livett, 1973; Longstaff, 2000) (Figure 4.1a and 4.1b). Descending pathways 
comprise two systems: one arises from LC and terminates in the lower brainstem 
nuclei, whereas the other arises from the cell group A1 and innervates the ventral 
horn and other sites in the lateral column and dorsal horn of the spinal cord (Levitt 
and Moore, 1978; Martin et al., 1978; Fleetwood-Walker and Coote, 1981). 
Noradrenergic transmission is believed to be important in numerous centrally 
regulated processes, including alerting responses, long-term memory and blood 
pressure regulation (Cahill et al., 1994; Morgan et al., 1997). There are two 
subgroups of noradrenaline receptors, -adrenergic receptors and -adrenergic 
receptors. It has been shown that noradrenaline acts through -adrenergic receptors 
to inhibit protein phosphatases which oppose the induction of long-term potentiation 
(LTP) and thereby facilitates the induction of LTP in CA1 hippocampal neurons 
(Thomas et al., 1996). Intracellular signalling enzymes such as adenylyl cyclase, 
PKA and in some cases CaMKII, can be activated by noradrenaline via -adrenergic 
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receptors (Longstaff, 2000; Hall, 2004; Wang et al., 2004). Moreover, there is 
evidence for the involvement of AMPA receptors in noradrenaline-regulated LTP in 
that the synaptic delivery of GluA1 subunits is facilitated by noradrenaline through 
GluA1 phosphorylation at S831 and S845 sites (Hu et al., 2007). In some situations, 
noradrenaline has an excitatory effect mediated by -adrenergic receptors. Activation 
of -adrenergic receptors contributes to the disinhibitory influence of noradrenaline 
over synaptic transmission in rat hippocampal neurons (Madison and Nicoll, 1988). 
Furthermore, it has been reported that noradrenaline increases cytosolic Ca
2+
 
concentrations and mobilisation through binding to 1-adrenergic receptors in 
cultured local interneurons of mouse olfactory bulb (Tani et al., 1992). Taking 
together, noradrenaline has been suggested to play a number of key roles in 
biochemical and physiological events associated with long-term modification of 
neuronal excitability and synaptic transmission.  
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Figure 4.1: Central noradrenaline pathways in rat brain 
a) Source: taken from Longstaff A. (2000), Neuroscience 
Saggital representation of the rat brain shows the major noradrenergic pathways. A6 
is the Locus Coeruleus. 
Abbreviations: 
        MFB- Medial Forebrain Bundle 
        ST- Stria Terminalis. 
 
b) Source: taken and modified from Livett (1973), Histochemical visualisation of 
peripheral and central adrenergic neurons 
Horizontal representation of ascending and descending noradrenaline pathways in rat 
brain. 
Key: 
                      : Noradrenergic fibres originating from the A6 cell group in the 
brainstem 
                      : Noradrenergic fibres originating from A1/A2 cell groups 











4.1.3 Central acetylcholine pathways in the brain 
Acetylcholine is very widely distributed in the brain, occurring in all parts of the 
forebrain, midbrain and brainstem, though there is little in the cerebellum. The key 
acetylcholine pathways in the brain are shown in Figure 4.2. There are two major 
pathways: the one with cell bodies located in the magnocellular forebrain nuclei in 
the basal forebrain gives rise to the main acetylcholine pathways which innervate 
many parts of the cortex, while the other one with cell bodies located in the 
septohippocampal nucleus sends projections to the hippocampus (Rang et al., 2003). 
Apart from these there are other projection pathways, originating in lower brainstem 
and many local cholinergic interneurons particularly in the cortex, corpus striatum 
and spinal cord (Sherriff et al., 1991; Woolf, 1991). 
The functional roles of acetylcholine are related to cognitive processes such as 
arousal, attention, fear, learning and memory, and motor control via cholinergic 
pathways mediated by various subtypes of receptors which are classified into two 
major types, muscarinic (G protein-coupled) and nicotinic (ionotropic) (Phillis and 
Chong, 1965; Phillis, 2005; Raybuck and Gould, 2010). Five subtypes of muscarinic 
receptors (M1-5) and their transduction pathways, localisation and functional 
responses have been characterised (Caulfield and Birdsall, 1998; Jones et al., 1999). 
M1, M3 and M5 receptors couple through Gq/11 to phospholipase C activation and 
function predominantly as postsynaptic receptors, while M2 and M4 receptors, which 





often function as presynaptic receptors, to regulate excitatory and inhibitory 
neurotransmitter release in the central nervous system (Caulfield and Birdsall, 1998; 
Rouse et al., 1998; Whalley and Constanti, 2006). In addition, it has been shown that 
muscarinic receptors auto-inhibit acetylcholine release from cholinergic neurons in 
the cortex of rats (Raiteri et al., 1984). Recent experiments suggest that M1 and M2 
subtypes in the cortex are involved in neuropathic pain (Ortega-Legaspi et al., 2010). 
Neuronal nicotinic receptors are pentameric, being assembled from - and - 
subunits as a heteromeric receptor, or five -subunits as a homomeric receptor (Dani, 
2001; Leonard and Bertrand, 2001). The main varieties occurring in the cortex and 
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the hippocampus are thought to be the heteropentameric  subtype and 
homopentameric 7 subtype respectively (Rollema et al., 2009; Loughead et al., 
2010). For the most part (but not exclusively), nicotinic acetylcholine receptors 
locate presynaptically and act to facilitate the release of other transmitters, such as 
glutamate, dopamine and GABA (Metherate and Hsieh, 2003; Anderson et al., 2009; 
McClure-Begley et al., 2009). Activation of nicotinic receptors causes changes in 
synaptic transmission and in turn modulates the cognitive responses of the brain to 
external stimulation. For instance, 7 subtype nicotinic receptors can bring about 
postsynaptic excitation by enhancing NMDA currents and functionally co-operate 
with AMPA receptors in rat auditory cortex (Levy and Aoki, 2002). Activation of -
subunit-containing nicotinic receptors induces the release of GABA from 
synaptosomes isolated from the mouse brain (Lu et al., 1998). However, some 
nicotinic receptors function in a postsynaptic role by mediating fast synaptic 
transmission in the hippocampus and in the sensory cortex (Zhang et al., 1993). The 
changes mediated by presynaptic and postsynaptic nicotinic acetylcholine receptors 
in the efficacy of synaptic transmission could underlie the proposed functions of 
acetylcholine in cognitive responses of the cerebral cortex and the hippocampus. 
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Figure 4.2: Central acetylcholine pathways in rat brain  
Source: taken from Longstaff A. (2000), Neuroscience 





















4.1.4 Central 5-hydroxytryptamine pathways in the 
brain 
5-Hydroxytryptamine (5-HT) neurons are concentrated in the mid-line Raphe nuclei 
in the pons and medulla, projecting diffusely to the cortex, hypothalamus, limbic 
system and spinal cord, in a similar way to the noradrenergic projections (Barnes and 
Sharp, 1999) (Figure 4.3). 5-HT pathways play a variety of roles in behavioural 
responses and control of mood, emotion, sleep, and sensory (nociceptive) pathways, 
which have been mentioned in the descending pathways section of Chapter 1. 
Fourteen subtypes of 5-HT receptors have been identified (5-HT1-7 are the main 
variants and some of these exist as further distinct isoforms) and all are expressed in 
the central nervous system (Mengod et al., 1996). 5-HT2 receptors, in particular 5-
HT2A receptors, are abundant in the cerebral cortex and exert an excitatory 
postsynaptic effect through coupling via Gq/11 to phospholipase C (Marek and 
Aghajanian, 1999).  
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Figure 4.3: Central 5-HT pathways in rat brain  
Source: taken from Longstaff A. (2000), Neuroscience 
The diagram shows major serotonin pathways in a sagittal section of the rat brain. 
The cell groups B1-B8 corresponding to the 5-HT-containing Raphe nuclei (except 
B4 and B6). The major B7 and B8 groups correspond to the Dorsal and Median 
Raphe Nuclei, respectively (Hillarp et al. 1966). 
Abbreviations: 
MFB: Medial Forebrain Bundle; 


















The morphological characteristics of the different preparations were examined 
microscopically and found to be consistent with previous reports. In order to try and 
directly measure the ability of noradrenergic, cholinergic and serotonergic 
metabotropic receptors, as well as ionotropic glutamate receptors, to cause activation 
in cortical tissue, I used freshly isolated rat frontal cortex segments (and in some 
cases synaptoneurosomes) to examine changes in the neuronal excitability using 
fluorescent indicators of intracellular Ca
2+
 concentration and voltage. The dyes 
enabling such successful measurements were no-wash formulations with external 
quenching agents to suppress non-specific extracellular fluorescence (supplied by 
Molecular Devices). In addition, I used the Ca
2+
 indicator to investigate the 
excitability of freshly isolated spinal cord samples in several different formats (30-
100 m tissue segments, synaptoneurosomes or microslices) following stimulation 
with AMPA or nociceptor-associated agonists. 
4.2.1 Morphological characteristics of acute ex vivo 
tissue preparations 
Frontal cortex or spinal cord tissue samples were prepared as described in Chapter 2 
and their morphology assessed at light microscopy or electron microscopy levels as 
appropriate. Figure 4.4 shows fluorescence microscopy images of basal Calcium 4 
fluorescence taken with × 10 (a), and × 40 objective lenses (b) and (c), using a Zeiss 
LSM510 Axiovert microscope. Samples were aliquoted into collagen-coated cover-
slip-based chambers and loaded with Ca
2+
 indicator as normal before assessment 
without washing. Typical profiles are illustrated of 30-100 m tissue segments, 
occasionally observed single cell bodies and synaptoneurosomal elements with dual 
apposed vesicular structures. The morphology of the synaptoneurosome elements 
corresponds closely to those described and illustrated in previous studies 
(Hollingsworth et al., 1985; Johnson et al., 1997). A number of attempts were made 
to add activating agents to the medium to assess responses in real time but in each 
case turbulence disturbed the optical field of view. Further experiments with 
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coverslips coated with cell-adhesion agents to promote anchorage of the samples 
may enable imaging of single tissue elements before and after drug addition, but this 
was not further investigated here. 
Figure 4.5 shows a high-resolution electron microscopy image of a typical 
synaptoneurosome profile (with presynaptic and postsynaptic sealed vesicular 
structures, as well as the electron-dense postsynaptic density). While the light 
microscopy image of a presumed synaptoneurosome profile in Figure 4.4(c) shows 
little detail as the size of the structure is approaching the limits of resolution for 
visible light, it does appear in terms of both size and the overall dual vesicular 
appearance to match closely with the electron microscopy image in Figure 4.5. 
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Figure 4.4: Microscopic assessment of 30-100 m tissue segments, neuronal cell 
bodies and synaptoneurosomes from rat lumbar spinal cord 
Light microscopy in Calcium 4-loaded samples was used to show basal intracellular 
Ca
2+
 fluorescence in a) 30-100 m tissue segments, b) occasionally observed 
neuronal cell bodies within the synaptoneurosome fraction and c) apparent 
synaptoneurosomal elements with a dual vesicular structure, corresponding closely to 
those described originally by Hollingsworth et al (1985). Samples in collagen-coated 
coverslip-based chambers were loaded with dye for 45 minutes at 37
o
C under 
standard conditions (Chapter 2) and then transferred (without washing) to a Zeiss 
Axiovert LSM510 microscope for imaging using × 10 (a) or × 40 objective lenses (b) 
and (c). These images show basal Calcium 4 fluorescence under unstimulated 
conditions. Similar observations were made with samples from frontal cortex. 
Attempts to carry out real-time imaging of the same tissue elements before and after 
drug addition were unsuccessful due to turbulence affecting the field of view. 
Possible approaches to overcome this were not further investigated in the present 





















Figure 4.5: Electron microscopic assessment of the morphology of 
synaptoneurosomes from rat lumbar spinal cord 
Electron microscopy of the synaptoneurosome fraction from rat spinal cord revealed 
the presence of composite structures with sealed presynaptic and postsynaptic 
membrane elements and electron-dense postsynaptic densities, which were 
morphologically identified as synaptoneurosomes matching closely to the structures 
described by Hollingsworth et al. 1985. Samples were fixed in 
glutaraldehyde/osmium tetroxide and stained with uranyl acetate and lead citrate. 
Ultrathin (10 nm) sections were imaged using a Phillips Biotwin electron microscope. 
Similar observations were made with samples from frontal cortex.  




















 fluorescence responses of ex vivo tissue 
segments and synaptoneurosomes from frontal 
cortex 
Frontal cortex segments of 30-100 m diameter and synaptoneurosomes were rapidly 
prepared in oxygenated media, aliquoted to 24-well plates, and loaded with no-wash 
fluorometric Ca
2+ 
indicator, Calcium 4 (Molecular Devices). Plates were then 
transferred to a fluorometric plate reader with the plate-carrier stage maintained at 
28
o
C. The samples were allowed to settle for 3 minutes following the turbulence 
associated with manual transfer of the 24-well plate from the incubator. CLOSE 
TWO GAPS LITINGDrugs or appropriate vehicle were then added as 40 l per well 
(total well volume of 400 l) from stock solutions at 10 fold higher concentrations. 
Immediately following drug addition and initiation of the plate-reader programme, 
sequential fluorescence readings were made from every well every 30 seconds with 
excitation set at 488 nm and emission at 519 nm for periods of up to 15 minutes. 
Data for the purpose of quantifying drug effects was generally obtained by averaging 
6 sequential readings after responses had reached stable plateau values. For 30-100 
m tissue segments data collection was routinely begun after 6 minutes, whereas for 
synaptoneurosomes (and microslices, see below) data collection was started after 3 
minutes. This difference in protocol was due to the impression that the tissue 
segments were more mobile and susceptible to disturbance in the wells than 
synaptoneurosomes or microslices which tended to settle more quickly. However 
extended time-course observations from each type of preparation showed that 
responses had reached relatively stable plateau values in each case throughout either 
of these time periods. In general terms the strategy of assessing multiple samples in 
parallel by plate-reader is not ideally suited to measuring early phase responses with 
sequential observations only being possible in the tens of seconds time-scale (here 
using a 30 seconds reading cycle). Real time (but individual sample) observations 
made by cuvette fluorometer or fluorescence microscopy may be more suitable for 
this but each would involve its own technical limitations. Some distinctions between 
the early phase responses to different stimuli were observed when investigated but 
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these were not as marked or consistent as distinctions in plateau-phase responses, so 
were not routinely assessed.   
4.2.2.1 Ionomycin and Noradrenaline  
Initial experiments were carried out to evaluate whether the protocol developed could 
deliver consistent results with sufficient signal to noise ratio to enable quantitative 
analysis. 30-100 m tissue segments or synaptoneurosomes from frontal cortex were 
aliquoted into wells and loaded with the fluorescent Ca
2+
 indicator, before the 
following additions were made: ionomycin (5 M final concentration), l-
noradrenaline (100 M) or vehicle. The Ca
2+
 ionophore ionomycin was used as a 
positive control in each experiment as it generates Ca
2+
-permeable pores in 
membranes and would provide a maximal signal, allowing equilibration of 
extracellular Ca
2+
 with the intracellular cytosol which would be maintaining a lower 
Ca
2+
 concentration if the preparations were metabolically viable. l-noradrenaline was 
used as an agonist for adrenergic receptors, an example class of G protein-coupled 
receptors that are expressed in cerebral cortex. The vehicle was 0-0.5% 
dimethylformamide in assay medium, as appropriate because some drugs (such as 
ionomycin) needed to be dissolved in solvent before dilution to the aqueous solutions 
used for addition to the wells.  The addition of vehicle had no discernible effects on 
fluorescence readings and vehicle control wells were taken to represent baseline 
signals. Using 30-100 m tissue segments, 5 M ionomycin rapidly caused a marked 
increase in Ca
2+
 fluorescence, reaching fluorescence values 2.5-3 fold those of basal 
(vehicle control) wells within about 3 minutes that were then maintained for up to 15 
minutes with little apparent change. A typical example set of data is shown in Figure 
4.6a together with an indication of the standard data collection period in the 
established response phase of 30-100 m tissue segments that was normally used for 
quantitative comparisons. 100 M l-noradrenaline also increased Ca
2+
 to about 30-
40% of the increment above basal shown by ionomycin. Fluorescence of the basal 
(vehicle control) wells and wells to which no addition was made showed an increase 
at the start of the recording period, which was considered likely to be an 
instrumentation artifact due to the movement of the sample within the wells as the 
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plate was moved into its recording position. Experiments were not carried out to 
determine absolute molar concentrations of Ca
2+
, using ratiometric dyes (which 
would require washing after loading) or detergent and defined Ca
2+
:EGTA buffers. 
Instead the comparison of responses to basal and ionomycin responses provided 
relative quantitation that was fully adequate for the purposes of the present study. 
Figure 4.6b shows mean fluorescence values (in relative fluorescence units) taken 
from readings between 6.0 and 8.5 minutes for basal, 100 M l-noradrenaline and 5 
M ionomycin in 3 separate experiments. Statistical analysis by One-way ANOVA 
with Tukey‟s post-test indicated significant differences between the mean values for 
basal, l-noradrenaline and ionomycin groups. The results indicate that the freshly 
isolated neuronal tissue segments were metabolically functional in terms of being 
able to maintain lowered cytosolic Ca
2+
 concentrations and that consistent elevation 
of intracellular Ca
2+
 concentrations was elicited by l-noradrenaline but to a lesser 
extent than the positive control ionomycin. Further validation of specificity was 
provided by the demonstration that the Ca
2+
 response to l-noradrenaline was 
concentration-dependent (Figure 4.6c). These data were plotted as the ratio of the l- 
noradrenaline-induced response above basal relative to the ionomycin-induced 
response above basal, an approach, which was widely utilised in further experiments. 
This indicated that a large part of the response to l-noradrenaline occurred with a 
high potency of less than 1 M and that an additional component (that was perhaps 
not mediated by adrenoreceptors) may have been evoked at high concentrations (30 
M and above). Further experiments characterising the Ca
2+
 fluorescence response to 
l-noradrenaline were carried out using frontal cortex synaptoneurosomes. The time-
course responses of a typical example data set are shown in Figure 4.6d together with 
an indication of the standard data collection period in the established response phase 
of synaptoneurosomes that was normally used for quantitative comparisons. 3 M l-
noradrenaline induced an increase in Ca
2+
 fluorescence to around 50% of the extent 
shown by 5 M ionomycin. Figure 4.6e further validates the receptor specificity of 
the l-noradrenaline response, showing that it was significantly attenuated (almost 
entirely prevented) in the presence of a combination of selective antagonists at 1- 
and -subtype adrenoreceptors, prazosin and l-propranolol, 6 M in each case 
(p<0.001, One-way ANOVA, with Tukey‟s post-test, n=4). Noradrenaline could 
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cause elevation of cytosolic Ca
2+
 concentrations by mobilisation of intracellular Ca
2+
 
stores and receptor-operated Ca
2+
 entry through activating 1-receptors. Alternatively 
adrenoreceptor activation of adenylyl cyclase and PKA could lead to 
phosphorylation facilitating the operation of voltage-sensitive Ca
2+
 channels.   
4.2.2.2 Comparative responses to noradrenaline and different 
ionotropic glutamate receptor agonists  
The actions of metabotropic adrenoceptors and ionotropic glutamate receptors in 
frontal cortex segments were examined through the simultaneous application of 
noradrenaline and different glutamate receptor agonists. Figure 4.7a shows time-
courses of responses to 100 M l-noradrenaline, 100 M AMPA, 100 M NMDA 
plus 100 M ACPC (an agonist at the glycine co-agonist recognition site of NMDA 
receptors (Watson and Lanthorn, 1990)) or 5 M ionomycin. Responses are plotted 
as mean ± SEM at each time point from 4 separate experiments and illustrate the 
reproducibility of the technique. The adrenoreceptor and glutamate receptor agonists 
each induced Ca
2+
 fluorescence responses of approximately 50% of the extent shown 
by ionomycin. Figure 4.7b shows these responses after subtraction of corresponding 
basal data in each case, (i.e. revealing purely the evoked responses) and indicates the 
standard data collection period in the established response phase that was normally 
used for quantitative comparisons. The responses shown were maintained at similar 
levels for up to 15 minutes.  
When the earliest part of the responses was examined in detail it was possible to 
distinguish some difference in their properties. Figure 4.7c shows that when the 
responses were each normalised to their own first data point the rate of rise for 
ionomycin and AMPA was greater than that for NMDA/ACPC or l-noradrenaline. 
Over the first two minutes of response Repeated-Measures ANOVA with Tukey‟s 
post-test indicated a significant difference between the relative curves for ionomycin 
or AMPA and that for l-noradrenaline. This could be consistent with rapid Ca
2+
 entry 
through ionomycin pores or a Ca
2+
-permeable (GluA2 subunit-lacking) population of 
AMPA receptors compared to slower, second messenger-mediated effects through 
adrenoreceptors mobilising intracellular Ca
2+
 stores or acting indirectly on voltage-
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sensitive ion channels. NMDA/ACPC responses may be slowed because of the need 
for concurrent depolarisation to remove the basal block of the NMDA receptor 
channel by Mg
2+
.  Although of interest, these apparent differences were much less 
clear-cut and reproducible than the differences in plateau phase responses so were 
not further studied.  
Figure 4.7d illustrates the low level of variability of established-plateau phase 
responses to 100 M l-noradrenaline, 100 M AMPA, 100 M NMDA plus 100 M 
ACPC and 5 M ionomycin, shown as mean ± SEM values at each time point 
through the 6.0 to 8.5 minutes recording period (n=4).  Figure 4.7e compares the 
mean values for these evoked responses throughout this period and shows that 
approximately similar sized responses were elicited by each of the agonists which 
were around half the magnitude of the ionomycin response. One-way ANOVA with 
Tukey‟s post-test indicated that each of the agonist responses was significantly 





 fluorescence responses of ex vivo tissue segments and 
synaptoneurosomes from frontal cortex: noradrenaline and ionomycin 
Tissue segments of 30-100 m diameter or synaptoneurosomes in 24-well plates 
were loaded with the fluorometric Ca
2+ 
indicator, Calcium 4. After transfer to a 
fluorometric plate reader, three minutes were allowed for settlement and then drugs 
were added before sequential fluorescence readings were made every 30 seconds 
from each well. a) Shows representative records from individual wells in a typical 
example experiment with 30-100 M tissue segments stimulated with l-
noradrenaline 100 M (red, NA10), ionomycin 5 M (black, IONO5) or control 
(purple). The standard data collection period in the established phase of responses 
that was generally used for quantitative analysis is outlined. b) Shows mean 
fluorescence values averaged over the 6.0-8.5 minutes time range, from traces as in 
part a) with data taken from 3 separate experiments and shown as mean ± SEM.  
Statistical analysis by One-way ANOVA with Tukey‟s post-test indicated significant 
differences between the mean values for basal, l-noradrenaline (NA100) and 
ionomycin (IONO5) groups (*, p<0.05). Consistent elevation of intracellular Ca
2+
 
concentrations was elicited by l-noradrenaline but to a lesser extent than the positive 
control ionomycin. c) Shows concentration-dependence of responses to l-
noradrenaline (0.01-300 M) in tissue segments with values representing mean ± 
SEM from 3-4 separate determinations expressed as evoked responses normalised to 
ionomycin-evoked responses (ionomycin responses being designated a value of 1.0) 
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d) Shows representative records from individual wells in a typical example 
experiment with synaptoneurosomes, stimulated with l-noradenaline 3 M (red, 
NA3), l-noradrenaline 3 M plus prazosin 6 M and l-propranolol 6 M (green; 
NA3 + PRAZ6 + PROP6), ionomycin 5 M (black, IONO5) or basal control (purple). 
The standard data collection period in the established phase of responses that was 
generally used for quantitative analysis is outlined. e) Shows mean evoked responses 
over the 3.0-5.5 minutes recording period from traces as in part d) (after subtraction 
of basal values) with data taken from 4 separate experiments. The evoked responses 
are normalised to ionomycin-evoked responses and shown as mean ± SEM. Mean 
evoked responses are shown to l-noradrenaline 3 M (NA), l-noradrenaline plus 
prazosin 6 M (NA3 + PRAZ6), l-noradrenaline plus l-propranolol 6 M (NA3 + 
PROP6) and l-noradrenaline plus both prazosin and propranolol (NA3 + PRAZ6 + 
PROP6).  Statistical analysis by One-way ANOVA with Tukey‟s post-test indicated 
that the NA3 + PRAZ6 + PROP6 response was significantly reduced compared to 
the NA response (***, p<0.001) and compared to the NA3 + PRAZ6 or NA3 + 
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 fluorescence responses of ex vivo tissue segments from frontal 
cortex: noradrenaline in comparison with different ionotropic glutamate 
receptor agonists 
Tissue segments of 30-100 m diameter or synaptoneurosomes in 24-well plates 
were loaded with the fluorometric Ca
2+ 
indicator, Calcium 4. After transfer to a 
fluorometric plate reader, three minutes were allowed for settlement and then drugs 
were added before sequential fluorescence readings were made every 30 seconds 
from each well. a) Shows time-course data expressed as mean ± SEM values from 4 
separate experiments in which tissue segments were stimulated with ionomycin 5 
M (black, IONO5), l-noradrenaline 100 M (pale blue, NA100), AMPA 100 M 
(red, AMPA100), NMDA 100 M plus ACPC 100 M (green, NMDA100 + 
ACPC100) or basal control (purple). b) Shows the stimulus-evoked components of 
the responses in part a), obtained by subtraction of relevant basal values in each case 
and indicates the time period through the established plateau phase of responses from 
which data were normally taken for subsequent quantitative analyses. Symbols show 
ionomycin (black, IONO5), l-noradrenaline (pale blue, NA100), AMPA (red, 
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c) Shows evoked responses through the initial 2 minutes period, which have been 
normalised to their own initial data point in each case. Responses to ionomycin 
(black) and AMPA (red) appeared to increase with a steeper initial gradient than 
those to NMDA plus ACPC (green) or l-noradrenaline (pale blue). Statistical analysis 
of curves through the first 2 minutes (readings 2-4) by Repeated-Measures ANOVA 
with Tukey‟s post-test indicated a significant difference between the curve for l-
noradrenaline and those for either AMPA or ionomycin (*, p<0.05, n=4 in each case).  
d) Shows the mean ± SEM values for evoked increases in Ca
2+
 fluorescence through 
the 6.0-8.5 minutes time period of the established plateau phase of responses (shown 
in part b) from which data were normally collected for subsequent quantitative 
analysis. Symbols show ionomycin (black, IONO5), l-noradrenaline (pale blue, 
NA100), AMPA (red, AMPA100) and NMDA plus ACPC (green, NMDA100 + 
ACPC100). e) Shows the overall mean values for the evoked responses shown in part 
d) averaged over the 6.0-8.5 minutes time points in each case and then displayed as 
the mean ± SEM values from 4 separate experiments. Statistical analysis by One-way 
ANOVA with Tukey‟s post-test showed that responses to AMPA (AMPA100), 
NMDA plus ACPC (NMDA100 + ACPC100) and l-noradrenaline (NA100) were all 
significantly less than responses to ionomycin (IONO), ***, p<0.001, n=4 in each 








































































































































































































































































































4.2.2.3 Noradrenaline in combination with ionotropic 
glutamate receptor agonists at different concentrations 
In order to further explore the types of analysis that could be achieved with these 
newly developed protocols and assess whether there was any evidence for 
interactions between l-noradrenaline- and AMPA- or NMDA/ACPC-evoked Ca
2+
 
fluorescence responses, experiments were carried out with combinations of agonists 
on 30-100 m tissue segments from frontal cortex. To achieve this the glutamate 
receptor agonists were initially added in combination (AMPA plus NMDA plus 
ACPC; ANA) at a range of concentrations (10, 30 and 100 M for each component 
in each case), establishing concentration-dependence of the mixed ionotropic 
glutamate receptor response with small evoked increases at 10 M and 30 M ANA 
and a much larger response at 100 M (Figure 4.8). 100 M l-noradrenaline 
(NA100), was then tested alone and in combination with ANA (10-100 M). Data 
were collected from the 6.0-8.5 minutes recording period in each case, averaged, and 
then mean values from 4 separate experiments calculated, with results being 
expressed as mean ± SEM of the evoked response normalised to the evoked response 
from 5 M ionomycin (which was designated a value of 1.0). l-noradrenaline alone 
induced a clear increase in Ca
2+
 fluorescence (as seen in Figures 4.6 and 4.7) and 
increased the size of responses to ANA at submaximal concentrations of 10 M and 
30 M but not at 100 M, where the response may be approaching its maximum 
extent. Statistical analysis comparing the responses to each concentration of ANA, 
with or without l-noradrenaline LITING CLOSE GAP100 M indicated that 
responses were significantly greater in the presence of l-noradrenaline at ANA 
concentrations of 10 M and 30 M but not 100 M (p<0.05, Student‟s paired t-test, 
n=4 in each case; Figure 4.8). However, l-noradrenaline alone produced Ca
2+
 
fluorescence responses greater than the magnitude of increment it caused in ANA 
responses, so while these data certainly add to the characterisation of both 
metabotropic and ionotropic receptor responses assessed by the new assay they do 
not provide any evidence for synergistic interactions (although it may be possible 
that this could be seen at different combinations of agonist concentrations). 
Nevertheless, the precise interrelations between the effects of adrenergic, AMPA and 
 196 
NMDA receptor activation were not further investigated here as the aim was simply 
to establish that dynamic Ca
2+
 responses to each could be successfully monitored 
with these protocols.   
4.2.2.4 The effect of acetylcholine on frontal cortex Ca2+ 
fluorescence levels, its effect on responses to glutamate 
receptor agonists and the modulatory influence of 
noradrenaline on these responses 
The role of acetylcholine in the regulation of the intracellular Ca
2+
 concentration of 
ex vivo 30-100 m frontal cortex segments was assessed alone and then in 
combination with mixed glutamate receptor agonists and subsequently with the 
addition of noradrenaline applied either acutely or following pre-incubation. Figure 
4.9 shows mean overall stimulus-evoked responses from these data normalised to 
ionomycin-evoked responses. Acetylcholine 20 M evoked a small increase in Ca
2+
 
fluorescence of 30-100 m tissue segments from frontal cortex and when 
administered in conjunction with a combined stimulus from AMPA 20 M, NMDA 
20 M and ACPC 20 M (ANA 20 M) appeared to amplify the response, although 
there was no evidence that this was to a greater than additive extent. When l-
noradrenaline was added acutely to the ANA plus Ach stimulus, responses to 
acetycholine plus glutamate receptor agonists appeared to be increased but this did 
not reach statistical significance by One-way ANOVA with Tukey‟s post-test. If l-
noradrenaline was pre-incubated with the samples for 45 minutes, rather than acutely 
applied, the response to ANA 20 M plus acetylcholine 20 M was significantly 
amplified (p<0.01 by One-way ANOVA with Tukey‟s post-test, n=4 in each case). 
This may imply that optimal facilitation of ionotropic glutamate receptor 
responsiveness in the presence of acetylcholine is engendered by some relatively 
slowly developing signalling influence elicited by noradrenaline (perhaps involving 
indirect processes such as phosphorylation of voltage-sensitive ion channels 




 fluorescence responses of ex vivo tissue segments from frontal 
cortex: noradrenaline in combination with ionotropic glutamate receptor 
agonists at different concentrations 
Tissue segments of 30-100 m diameter or synaptoneurosomes in 24-well plates 
were loaded with the fluorometric Ca
2+ 
indicator, Calcium 4. After transfer to a 
fluorometric plate reader, three minutes were allowed for settlement and then drugs 
were added before sequential fluorescence readings were made every 30 seconds. 
Data were collected and averaged from the 6.0-8.5 minutes period of plateau phase 
responses following drug addition, basal values were subtracted and the mean 
evoked responses were normalised to responses evoked by 5 M ionomycin (which 
were designated a value of 1.0). These values were expressed as mean ± SEM from 4 
separate experiments. The evoked responses are shown to AMPA plus NMDA plus 
ACPC (ANA, with each component at either 10 M, 30 M or 100 M; ANA10, 
ANA 30, ANA100), to l-noradrenaline 100 M (NA100) and to combinations of 
these stimuli. Statistical analysis of responses to different concentrations of ANA, 
with or without l-noradrenaline indicated significantly greater responses to ANA 10 
M and 30 M but not 100 M in the presence of l-noradrenaline (*, p<0.05, 
















































































































































 fluorescence responses of ex vivo tissue segments from frontal 
cortex: effect of noradrenaline pre-incubation on responses to acetylcholine and 
glutamate receptor agonists 
Tissue segments of 30-100 m diameter or synaptoneurosomes in 24-well plates 
were loaded with the fluorometric Ca
2+ 
indicator, Calcium 4. After transfer to a 
fluorometric plate reader, three minutes were allowed for settlement and then drugs 
were added before sequential fluorescence readings were made every 30 seconds. 
Data were collected from 6.0-8.5 minutes time points in the established plateau 
phases of responses, basal values were subtracted, then the average evoked response 
in each case was normalised to the averaged ionomycin-evoked response from the 
same plate (which was designated a value of 1.0). Results were plotted as mean ± 
SEM values from 4 separate experiments. Tissue segments were stimulated with a 
combination of glutamate receptor agonists, AMPA 20 M, NMDA 20 M, ACPC 
20 M (ANA20), acetylcholine 20 M (ACh20) or these added together (ANA20 + 
ACh20). In addition, some of these samples were stimulated with 100 M l-
noradrenaline either acutely (ANA20 + ACh20 + NA100 acute) or following pre-
incubation throughout the 45 minutes dye-loading period (ANA20 + ACh20 + 
NA100 pre-incubation). ANA20 and ACh20 produced small increases in Ca
2+
 
fluorescence. The combination ANA20 + ACh20 appeared to produce a larger 
response but not to the extent of being greater than additive. The further addition of 
100 l l-noradrenaline (which would produce clear rises in Ca
2+
 fluorescence alone, 
Figures 4.6, 4.7, 4.8) resulted in a larger response when added acutely (ANA20 + 
ACh20 + NA100 acute) but this was clearly enhanced if the noradrenaline was 
applied with pre-incubation (ANA20 + ACh20 + NA100 pre-incubation). Statistical 
analysis by One-way ANOVA with Tukey‟s post-test indicated that responses to the 
ANA20 + ACh20 + NA100 pre-incubation stimulus were significantly greater than 
those to ANA20 + ACh20, whereas responses to ANA20 + ACh20 + NA100 acute, 
were not (**, p<0.01, n=4 in each case). Pre-incubation with noradrenaline amplified 
responses to acetycholine and glutamate receptor agonists to a greater extent than 



















































































































































4.2.3 Membrane potential fluorescence responses of 
ex vivo tissue segments from frontal cortex 
Apart from the intracellular Ca
2+
 fluorescence responses, membrane potential 
fluorescence responses of the tissue segments were examined to confirm that they 
were able to maintain a membrane potential difference and that the effects of 
ionotropic glutamate receptor stimulation involved a depolarisation of this membrane 
potential.   
Frontal cortex segments of 30-100 m diameter were rapidly prepared in oxygenated 
media, aliquoted to 24-well plates, and loaded with no-wash fluorometric voltage-
sensitive dye (R8042, MP Blue; Molecular Devices). After transfer to a fluorometric 
plate reader, 3 minutes were allowed for settlement and then drugs or appropriate 
vehicle were added in one tenth of the well volume from stocks at ten-fold higher 
concentrations. Sequential fluorescence readings were made every 30 seconds from 
each well with excitation set at 530 nm and emission at 565 nm. 
As a trial, I investigated co-activation of 5-HT and glutamate receptors in these 
experiments (Figure 4.10). The selective 5-HT2A receptor agonist DOI was added 
together with AMPA and cyclothiazide (CTZ), which acts to minimize AMPA 
receptor desensitisation (Kovacs et al., 2004).  Medium containing an additional 50 
mM concentration of K
+
 was used as a strongly depolarising positive control. Figure 
4.10a shows the time-course of responses to 50 mM K
+
 and both metabotropic and 
ionotropic receptor stimuli. Clear and reproducible increases above basal 
fluorescence were seen in each case, with a similar temporal profile to the Ca
2+
 
fluorescence responses studied with this assay system. Stable plateau responses were 
reached within the first few minutes and then maintained for up to 15 minutes. 
Although adequate for quantification of drug-induced responses, the relative degree 
of increase over the basal fluorescence (only in the order of 20-25%) was not as great 
as with the Ca
2+
 fluorophore. As this was a pilot proof-of-concept study and the 
ability to quantify and compare relative responses was sufficient for current purposes, 
I did not attempt to calibrate the dynamic range of the assay with a range of K
+
 
concentrations and ionophore. Data were collected from the 6.0-8.5 minutes time 
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points, background was subtracted and average values were expressed as evoked 
responses normalised to 50 mM K
+
-evoked responses. These results are shown in 
Figure 4.10b as mean ± SEM values from 4 separate experiments. DOI 3 M alone 
evoked a clear membrane potential fluorescence response and a greater response was 
elicited by AMPA 100 M in the presence of CTZ 30 M. The combination of DOI 3 
M with AMPA 100 M plus CTZ 30 M however, evoked a response that was no 
greater than that due to AMPA plus CTZ alone. Statistical analysis by One-way 
ANOVA with Tukey‟s post-test indicated that both AMPA plus CTZ and DOI plus 
AMPA plus CTZ responses were significantly greater than those due to DOI alone 
(p<0.01, n=4). These results showed that DOI, AMPA plus CTZ (in the absence or 
presence of DOI) and high K
+
 medium each elicited clear changes in fluorescence of 
the membrane potential-sensitive dye, establishing the idea that this kind of 
preparation could be used to assess stimulus-induced changes in membrane potential 




Figure 4.10: Membrane potential fluorescence responses of ex vivo tissue 
segments from frontal cortex: effects of a selective 5-HT2A receptor agonist, DOI 




Tissue segments of 30-100 m diameter or synaptoneurosomes in 24-well plates 
were loaded with the fluorometric Ca
2+ 
indicator, Calcium 4. After transfer to a 
fluorometric plate reader, three minutes were allowed for settlement and then drugs 
were added before sequential fluorescence readings were made every 30 seconds. 




50), DOI 3 M (green, 
DOI3), AMPA 100 M plus an inhibitor of AMPA receptor desensitisation, 
cyclothiazide, CTZ 30 M (red, AMPA100 + CTZ30), the combination of DOI plus 
AMPA and CTZ (blue, DOI3 + AMPA100 + CTZ30) or basal. Values were plotted as 
mean ± SEM from 4 separate experiments.   
a) Shows the time-course of membrane potential fluorescence responses through the 
6.0-8.5 minutes recording period expressed as evoked responses (i.e. following 
subtraction of basal fluorescence values) from the 4 separate experiments, revealing 
the good reproducibility of responses.  
b) Shows data collected from the 6.0-8.5 minutes time points in each case expressed 
as evoked responses normalised to the 50 mM K
+
-evoked responses in each 
experiment, (which were designated a value of 1.0) then calculated as mean ± SEM, 
from the 4 separate experiments. Statistical analysis by One-way ANOVA with 
Tukey‟s post-test indicated that the membrane potential fluorescence responses to 
AMPA100 + CTZ30 and DOI3 + AMPA100 + CTZ30 were both significantly greater 
than responses to DOI3 alone (**, p<0.01, n=4). DOI alone, AMPA plus CTZ (in the 
absence or presence of DOI) or high K
+
 medium each elicited clear changes in 








































































































































































































































 fluorescence responses of ex vivo tissue 
segments from lumbar spinal cord 
Lumbar spinal cord tissue was dissected following laminectomy under isoflurane 
anaesthesia as there would otherwise have been an excessive delay after death before 
the tissue was prepared in oxygenated medium compared to the cerebral cortex tissue. 
Surgery was carried out by S. Fleetwood-Walker and myself as described in detail in 
Section 2.2.1. Subsequent procedures with spinal cord tissue segments were the same 
as those for cerebral cortex segments. 
Time-courses of Ca
2+ 
fluorescence responses evoked by AMPA 100 M, AMPA plus 
CTZ 30 M, ionomycin 5 M and basal were recorded. In Figure 4.11a results are 
shown as the mean ± SEM evoked responses (i.e. after subtraction of corresponding 
basal values) at each time through the 6.0-8.5 minutes period of established 
responses, with data from 4 separate experiments. The temporal profile of Ca
2+ 
fluorescence responses from spinal cord tissue segments was very similar to that seen 
with cerebral cortex tissue. Stimulation with AMPA produced a small increase in 
Ca
2+ 
fluorescence which appeared to be greater in the presence of CTZ, although as 
expected ionomycin produced a greater response than either.  
Figure 4.11b shows the mean evoked responses (averaged through the 6.0-8.5 
minutes time points), normalised to the ionomycin-evoked responses from each 
experiment (which were designated a value of 1.0), then calculated as mean ± SEM 
from 4 separate experiments. Stimulus-induced responses are shown to AMPA 100 
M and AMPA 100 M plus CTZ 30 M. Statistical analysis by Student‟s paired t-
test indicated that AMPA-induced Ca
2+ 
fluorescence responses in the presence of 
CTZ were significantly greater than in its absence (p<0.05, n=4).  These results 
indicated that Ca
2+ 
fluorescence responses to AMPA, AMPA plus CTZ and 
ionomycin could be elicited from spinal cord tissue segments with the newly 
developed methodology and paved the way forward for future studies on altered 
responsiveness of ex vivo spinal cord tissues in states of chronic pain or 




 fluorescence responses of ex vivo 
synaptoneurosomes from lumbar spinal cord 
Lumbar spinal cord tissue was dissected under isoflurane anaesthesia and 
synaptoneurosomes prepared as described in 2.3.1. Synaptoneurosomes were 
aliquoted into 24-well plates and loaded with no-wash fluorometric Ca
2+ 
indicator, 
Calcium 4. After transfer to a fluorometric plate reader, 3 minutes were allowed for 
settlement before starting the recording of fluorescence values. Samples were 
stimulated with the broad spectrum agonist of glutamate receptors, DL-homocysteic 
acid (DLH) 400 M (Curtis et al., 1961; Mayer and Westbrook, 1984), and agonists 
of receptors selectively localised to nociceptive primary afferents, TRPA1, TRPV1, 
and bradykinin (allyl isothiocyanate (AITC) 20 M (Bandell et al., 2004a), capsaicin 
10 M (Caterina et al., 1997a) and bradykinin 10 M respectively), ionomycin 5 M 
or vehicle as basal control. The recorded Ca
2+
 fluorescence readings from the 3.0-5.5 
minutes time points were plotted against time as the mean ± SEM values from 5 
separate experiments (Figure 4.12a). The results indicated that the isolated spinal 
cord synaptoneurosomes were functional and consistent Ca
2+ 
fluorescence responses 
could be elicited by ionomycin, DLH or the mixture of agents acting on nociceptive 
afferents (ACB). Figure 4.12b shows the mean Ca
2+ 
fluorescence values averaged 
throughout this time period as mean ± SEM from the 5 separate experiments. 
Statistical analysis by Student‟s paired t-test indicated that DLH and ACB each 
elicited significant increases in Ca
2+ 
fluorescence above basal levels. While 
mediators of some of these responses are likely to be present on postsynaptic 
elements (such as those responding to DLH), the AITC/capsaicin/bradykinin (ACB) 





 fluorescence responses of ex vivo tissue segments from lumbar 
spinal cord: effects of AMPA, AMPA plus CTZ and ionomycin 
Tissue segments of 30-100 m diameter or synaptoneurosomes in 24-well plates 
were loaded with the fluorometric Ca
2+ 
indicator, Calcium 4. After transfer to a 
fluorometric plate reader, three minutes were allowed for settlement and then drugs 
were added before sequential fluorescence readings were made every 30 seconds. 
Tissue segments were stimulated with AMPA 100 M (green, AMPA100), AMPA 
100 M plus CTZ 30 M (red, AMPA100 + CTZ30), ionomycin 5 M (black, 
IONO5) or basal. 
a) Shows evoked Ca
2+ 
fluorescence responses (i.e. after subtraction of corresponding 
basal values) expressed as the mean ± SEM at each time point through the 
established response phase at 6.0-8.5 minutes, from 4 separate experiments. Each of 
the stimuli produced reproducible responses with a similar temporal profile to 
responses in cerebral cortex tissue.  
b) Shows mean evoked Ca
2+ 
fluorescence responses from data averaged through the 
6.0-8.5 minutes recording period, normalised to ionomycin-evoked responses from 
the same experiment (which were designated a value of 1.0) and then calculated as 
mean ± SEM from the 4 separate experiments. Statistical analysis by Student‟s paired 
t-test indicated that responses to AMPA in the presence of CTZ were significantly 
greater than those in its absence (*, p<0.05, n=4).  Thus, consistent Ca
2+
 fluorescence 
responses to AMPA, AMPA plus CTZ (and also to ionomycin) could be achieved 
from spinal cord tissue segments and the presence of CTZ appeared to amplify 















































































































































































































 fluorescence responses of ex vivo synaptoneurosomes from 
lumbar spinal cord: effects of DLH, the combination of AITC, capsaicin and 
bradykinin (ACB), and ionomycin 
Synaptoneurosomes in 24-well plates were loaded with the fluorometric Ca
2+ 
indicator, Calcium 4. After transfer to a fluorometric plate reader, three minutes were 
allowed for settlement and then drugs were added before sequential fluorescence 
readings were made every 30 seconds. Synaptoneurosomes were stimulated with 
DLH 400 M (green, DLH400), AITC 20 M plus capsaicin 10 M plus bradykinin 
10M (red ACB10), ionomycin 5 M (black, IONO5) or basal vehicle control 
(purple, Basal).  
a) Shows evoked Ca
2+ 
fluorescence records through the 3.0-5.5 minutes period of 
established plateau phase responses that was generally used to obtain data from 
quantitative analysis. Values at each time point represent the mean ± SEM from 5 
separate experiments. DLH and ACB elicited small but consistent Ca
2+ 
fluorescence 
responses from spinal cord synaptoneurosomes. 
b) Shows mean Ca
2+ 
fluorescence responses from data as in a) averaged through the 
3.0-5.5 minutes data collection period and then expressed as mean ± SEM  values 
from 5 separate experiments. Statistical analysis by Student‟s paired t-test indicated 
that DLH or ACB elicited significant increases in Ca
2+ 
fluorescence above basal 
































































































































































 fluorescence responses of ex vivo 
microslices from lumbar spinal cord 
In order to develop a protocol with samples that retained a degree of neuronal 
interconnectivity, lumbar spinal cord tissue was dissected under brief isoflurane 
anaesthesia and 150 × 150 m microslices rapidly prepared as described in 2.3.1. 
The subsequent procedures with microslices from lumbar spinal cord were the same 
as those for spinal cord synaptoneurosomes. Microslices were suspended and washed 
in ice-cold oxygenated media, aliquoted to 24-well plates and loaded with no-wash 
fluorometric Ca
2+
 indicator, Calcium 4. After transfer to the plate reader, 3 minutes 
were allowed for settlement before drug additions and commencement of 
fluorescence readings. Microslices were stimulated with AMPA 100 M plus CTZ 30 
M, AITC 20 M, capsaicin 10 M, ionomycin 5 M or basal vehicle control. 
Figure 4.13a shows the time-course of Ca
2+
 fluorescence responses to AMPA plus 
CTZ, ionomycin and basal, expressed as mean ± SEM values at each time point, 
from 4 separate experiments. Both AMPA plus CTZ and ionomycin elicited clear and 
consistent increases in Ca
2+
 fluorescence. Figure 4.13b shows mean Ca
2+
 
fluorescence values averaged over the 3.0-5.5 minutes data collection period (at 
which stable plateau phase responses were achieved) and then calculated as mean ± 
SEM values for the 4 separate experiments. Statistical analysis by Student‟s matched 
pair t-test indicated that AMPA plus CTZ caused significant increases in Ca
2+
 
fluorescence above basal levels (p<0.05, n=4).  Further experiments were carried out 
to investigate the effects of DLH 400 M and the combined stimulus of nociceptive 
afferents ACB (AITC 20 M plus capsaicin 10 M plus bradykinin 10 M) on Ca
2+
 
fluorescence of spinal cord microslices. Figure 4.14a shows the time-course of 
responses to DLH, ACB, ionomycin and basal vehicle control through the 3.0-5.5 
minutes period of stable plateau phase responses used to collect data for further 
analysis. Values are shown as mean ± SEM at each time point from 3 separate 
experiments and demonstrate that the responses were clear and reproducible. Figure 
4.14b shows the mean Ca
2+
 fluorescence responses averaged through the 3.0-5.5 
minutes period in each experiment and then expressed as the overall mean ± SEM 
from the 3 separate experiments. Statistical analysis by Student‟s paired t-test, or by 
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One-way ANOVA with Tukey‟s post-test, indicated that DLH or ACB each elicited 
significant increases in Ca
2+
 fluorescence above basal control levels (p<0.05, n=3). 
These results suggest that microslices could also represent a viable test platform to 
assess alterations in neuronal excitability in response to agonists that might 




 fluorescence responses of ex vivo microslices from lumbar 
spinal cord: effects of the combination of AMPA and CTZ, AITC, capsaicin or 
ionomycin 
Spinal cord microslices in 24-well plates were loaded with the fluorometric Ca
2+ 
indicator, Calcium 4. After transfer to a fluorometric plate reader, three minutes were 
allowed for settlement and then drugs were added before sequential fluorescence 
readings were made every 30 seconds. Spinal cord microslices were stimulated with 
AMPA 100 M plus CTZ 30 M (redAMPA100 + CTZ30 AITC 20 M AITC20, 
capsaicin 10 M (capsaicin10) and ionomycin 5M (black, IONO5) or basal 
vehicle control (purple, Basal). 
a) Shows time-courses of evoked Ca
2+ 
fluorescence readings from spinal cord 
microslices stimulated with AMPA plus CTZ, ionomycin or basal expressed as mean 
± SEM values at each time point from 4 separate experiments. Clear and 
reproducible responses to AMPA plus CTZ (and also to ionomycin) could be 
achieved from spinal cord microslices, although AITC or capsaicin alone only 
produced small increments in Ca
2+
 fluorescence.   
b) Shows mean Ca
2+
 fluorescence readings averaged through the 3.0-5.5 minutes 
time period of plateau phase responses that was used to collect data for subsequent 
analysis, then calculated as overall mean  SEM values from the 4 separate 
experiments. Statistical analysis by Student‟s paired t-test indicated that AMPA plus 
CTZ elicited a significant increase in Ca
2+
 fluorescence above that in basal controls 
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 fluorescence responses of ex vivo microslices from lumbar 
spinal cord: effects of DLH, the combination of AITC, capsaicin and bradykinin 
(ACB) or ionomycin. 
Spinal cord microslices in 24-well plates were loaded with the fluorometric Ca
2+ 
indicator, Calcium 4. After transfer to a fluorometric plate reader, three minutes were 
allowed for settlement and then drugs were added before sequential fluorescence 
readings were made every 30 seconds. Spinal cord microslices were stimulated with 
DLH 400 M (greenDLH400 AITC 20 M plus capsaicin 10 M plus bradykinin 




fluorescence readings through the 3.0-5.5 minutes period of stable 
plateau phase responses used to collect data for subsequent analysis. Values at each 
time point are expressed as the mean ± SEM from 3 separate experiments. DLH, 
ACB and ionomycin each elicited clear and reproducible increases in Ca
2+ 
fluorescence. 
b) Shows mean Ca
2+ 
fluorescence values averaged through the 3.0-5.5 minutes data 
collection period in each case and then expressed as the overall mean from the 3 
separate experiments. Statistical analysis by Student‟s paired t-test (or One-way 
ANOVA with Tukey‟s post-test) indicated that DLH and ACB each caused a 
significant increase in Ca
2+ 
fluorescence above basal control levels (*, p<0.05, n=3). 
These results show that clear Ca
2+ 
fluorescence responses could be obtained from 
DLH and from the combined nociceptive afferent stimulus of AITC, capsaicin and 








































































































































































Traditional approaches to the study of cell signalling events that may be applied to 
studying states of altered somatosensory processing often focus on single receptor or 
channel activation. The functions of such molecules are commonly examined using 
pharmacological, electrophysiological, genetic and behavioural techniques. While 
there is little doubt that these investigations have been of substantial utility in 
understanding cell signalling, it is widely realised that the signalling involves 
systems of interacting component molecules rather than individual molecules 
functioning independently. In the present study, a new methodological strategy was 
developed to enable dynamic assessment of the co-ordinated effects of stimulating 
multiple receptors and different signalling pathways in acutely isolated ex vivo neural 
tissue preparations. The demonstration of consistent Ca
2+
 fluorescence responses 
induced by noradrenaline or ionomycin in the 30-100 m cortical tissue segments 
and synaptoneurosomes provided the first evidence that the newly developed method 
had been successfully set up. The responses to noradrenaline were reproducible, 
concentration-dependent and reversible (in synaptoneurosomes) by highly NO 
HYPHEN LITINGselective -adrenoreceptor and -adrenoreceptor antagonists, 
thus likely to represent receptor-mediated actions. Further experiments indicated that 
both AMPA- and NMDA-type ionotropic receptors for glutamate could increase Ca
2+
 
fluorescence of cortical tissue segments, similarly to the effect of metabotropic 
adrenergic receptors. 
Any functional interactions between influences of adrenergic and glutamate receptors 
could possibly reflect some aspect of the alerting response which is brought about by 
noradrenaline in higher levels of the CNS in animals. It has been reported that 
noradrenaline enhances NMDA receptor-mediated depolarisation in the cortex 
without affecting the AMPA receptor-mediated responses (Radisavljevic et al., 1994). 
My results showed that cortical tissue segments showed a concentration-dependent 
elevation of Ca
2+
 in response to a combination of AMPA and NMDA receptor 





stimulus. However there was no evidence in these initial studies for greater than 
additive effects. There is also evidence that glutamate causes a concentration-
dependent stimulation of noradrenaline release from rat prefrontal cortex slices 
(Russell and Wiggins, 2000). These findings could all be consistent with the idea that 
noradrenaline plays a facilitatory role in glutamatergic depolarisation in rat frontal 
cortex that may be subject to positive feedback enhancement. Noradrenergic cells 
that give rise to ascending sensory pathways innervate the cortex, where they may 
participate in cognitive responses such as alertness and pain perception. The current 
findings are consistent with the idea of co-operation of noradrenergic and 
glutamatergic inputs to cortex that could contribute to accentuated cognitive 
responses in rats. 
Acetylcholine exerts its actions via nicotinic and muscarinic receptors in the brain. It 
has been proposed that nicotinic acetylcholine receptors expressed in the 
postsynaptic density of the somatosensory cortex work together with AMPA 
receptors to facilitate the activation of glutamatergic synapses in rats (Levy and Aoki, 
2002). However, direct and specific evidence for modulatory effects of central 
acetylcholine on glutamatergic synapses is very limited. I applied acetylcholine 
together with combined ionotropic glutamate agonists to activate Ca
2+
 fluorescence 
responses of cortical tissue segments and then investigated the effect on that of acute 
or prior addition of noradrenaline. Pre-incubation with noradrenaline markedly 
increased the Ca
2+
 responses to acetylcholine and glutamate agonists to a 
significantly greater extent than acute application. This is consistent with the idea 
that excitability of cortical neurons may be increased by the influence of activity in 
noradrenaline-releasing fibres so that these cortical neurons may be ready to give 
enhanced responses to subsequent incoming stimuli, by way of relatively slow 
intracellular signalling changes taking place over a tens of minutes time-scale.  
It is possible that measurements of raised intracellular Ca
2+
 levels may not directly 
represent the membrane excitability in that they could be due in part to release from 
intracellular endoplasmic reticulum stores by diverse calcium-mobilising receptors 
and Ca
2+





membrane potential-sensitive dye was also evaluated as a more direct measure of 
excitability in trial experiments. I examined the effects of a 5-HT2A receptor agonist 
and an ionotropic glutamate receptor agonist on the membrane potential-sensitive 
fluorescence of rat cortex segments. Clear membrane potential responses were 
detected following application of DOI or AMPA plus CTZ. This indicated that 
substantial depolarisation of the membrane was occurring either due to the 
metabotropic 5-HT2A receptor agonist alone, or to a greater extent, in the presence of 
AMPA plus CTZ or the joint presence of the 5-HT2A receptor agonist and 
AMPA/CTZ. Although I found no definitive evidence to prove the idea in these 
initial experiments, it is possible that the metabotropic receptor may work together 
with ionotropic glutamate receptors to facilitate transmission in the cortex and that 
this may be more readily revealed under different experimental conditions.  
Additionally the approach of fluorometric assessment of ex vivo tissue responses was 
evaluated on lumbar spinal cord tissue. Small Ca
2+
 fluorescence responses to the 
glutamate receptor agonist, AMPA were detected in spinal cord tissue segments 
especially in the presence of the inhibitor of AMPA receptor desensitisation, CTZ. 
Moreover, synaptoneurosomes from lumbar spinal cord gave small but significant 
Ca
2+
 fluorescence responses to the broad spectrum glutamate receptor agonist DLH 
and to activation of nociceptive afferents by a combination of TRPA1, TRPV1 and 
bradykinin receptor agonists. This suggests that Ca
2+
 gradients can be maintained 
also in ex vivo spinal cord synaptoneurosomes. In addition, microslices from spinal 
cord tissue were prepared with the idea that these could maintain some level of 
neuron:neuron connectivity. Combined TRPA1, TRPV1 and bradykinin receptor 
agonists, as well as AMPA in the presence of CTZ, or DLH elicited significant 
increments in Ca
2+
 fluorescence from spinal cord microslices. These results further 
confirm that synaptoneurosomes and microslices could be successfully prepared 
from spinal cord in viable form and that they are functionally responsive to external 
receptor-mediated stimulation. 
Together, these studies establish that the newly developed technological platform 





and interpretable results in both cortical and spinal cord ex vivo tissue with an array 
of different tissue preparations, 30-100 m segments, synaptoneurosomes and 150 × 
150 m microslices. Furthermore, our pilot experiments illustrated that the 
excitability of isolated central neurons in response to stimulation could potentially be 
increased by the co-activation of several different monoaminergic neuronal systems, 
which may occur in animals under physiological and pathological circumstances, 
such as in chronic pain states. Such changes might be quantifiable following the 
further fine tuning of experimental conditions. 
The experiments described here show that ex vivo CNS tissue samples prepared 
under the conditions used show consistent and quantifiable dynamic responses to 
receptor stimuli as assessed by Ca
2+
- or voltage-sensitive fluorophores. 30-100 m 
tissue segments, synaptoneurosomes and 150 × 150 m microslices were all shown 
to be viable preparations for Ca
2+
 fluorometry.  Synaptoneurosomes are of particular 
interest as they may reflect more closely any functional changes at synapses and 
microslices are of interest because they may retain some neuron:neuron 
interconnections. Further studies would be required to assess these aspects. In 
general terms, the present results suggest that the tissue preparations maintain 
competent plasma membranes and metabolic activity to a degree sufficient to show 
receptor-mediated increases in Ca
2+
 fluorescence and membrane potential 
fluorescence.  In each case the development of ion gradients in basal conditions prior 
to stimulation would require sealed membranes and metabolic activity to drive Ca
2+
 











Further studies would be required with precisely controlled ionic composition buffers 
and membrane permeabilisation or alternative ratiometric fluorophores in order to 
give absolute numerical estimates of intracellular Ca
2+
 concentrations or membrane 
potential.  It may well be that these are not entirely normal as in vivo but the 
approach gives a model system in which dynamic receptor responses are quantifiable 
and readily analysed in relative terms to evaluate changes in responsiveness.  
Comparisons between experiments are made possible by the inclusion of a maximal 









 fluorescence and a substantially depolarising K
+
 concentration 
for membrane potential fluorescence).  Receptor-mediated responses above basal 
readings are then normalised to the positive control-mediated responses above basal, 
yielding values that are comparable between different experiments.  
The affinity of the Ca
2+
 fluorophore for Ca
2+
 is not formally disclosed by the 
manufacturer as it is one of their proprietary no-wash reagents protected by patent.  
However they indicate that the fluorophore is similar to Fluo-4 from Invitrogen, 
which has an affinity (Kd, dissociation constant) for Ca
2+ 
of 350 nM and is 
extensively used in the literature to assess receptor-mediated Ca
2+ 
fluorescence 
responses in a range of cell types. Such an affinity is well suited for detection of 
receptor-mediated increases from normal cytosolic concentrations in the 100 nM 
range. As for Fluo-4, Calcium 4 is loaded as an inert but membrane-permeable 
acetoxymethoxy ester, which is then cleaved by intracellular esterases to yield the 
active form of the fluorophore to chelate Ca
2+ 
and shift its fluorescence spectrum 
accordingly. The molecular identity of the MP Blue fluorophore used to assess 
membrane potential fluorescence is similarly not disclosed by the manufacturer but is 
indicated to be similar to bis-oxonol dyes of the DiBAC series, which selectively 
enter depolarised cells. The fluorescent signal increases in intensity during 
membrane depolarisation as dye follows positively charged ions moving inside the 
cell. During membrane hyperpolarisation, the fluorescent signal decreases in 
intensity as dye follows the positively charged ions out of the cell. The manufacturer 
describes a useful dynamic range of the dye through the range 5-60 mM external K
+
, 
corresponding to membrane potentials of approximately -65 to -10 mV but this was 
not investigated in the present study. DiBAC series dyes redistribute relatively 
slowly over several tens of seconds and although MP Blue responds several fold 
faster than other DiBAC dyes, it would still not be fast enough to monitor action 
potentials. However such dyes can measure longer lasting changes due to receptor 
activation and may be able to follow slow rhythmic changes such as slow oscillations 





The assay was designed in plate-reader format to enable the parallel assessment of 
responses to aliquots of the same preparation. Stimuli were added separately to each 
well and responses followed for up to 15 minutes. Responses to receptor agonists and 
positive controls increased above basal through the first 2-3 minutes and then 
maintained an elevated plateau level until the end of the experiment where measured 
for Ca
2+
 or membrane potential fluorescence in each type of tissue preparation. None 
of the data suggested the presence of rapid but transient responses that had peaked 
before our measurements commenced. A limitation is that this format does not allow 
very short time scale measurement of responses, which would be ideal in modeling 
physiological responses. Real-time rapid measurements with programmed injection 
of drugs into wells are possible with plate readers but when this was investigated the 
turbulence caused by fluid addition caused unacceptable variability in readings. It 
may be possible to measure responses of samples in suspension in a cuvette 
fluorometer but this would have the disadvantage of processing samples only one at a 
time and it seems possible that continuous stirring may cause deterioration of the 
tissue. This approach was not investigated in the present study. The relative 
contribution of fluorescence from pre- or postsynaptic compartments is a question of 
considerable interest, especially with the synaptoneurosome preparation. Further 
study will be required to assess this and it is possible that new developments in 
super-resolution confocal imaging will enable progress to be made. The use of 
selective stimuli for nociceptive afferent fibres in spinal cord synaptoneurosomes 
represented a first step towards understanding pre- and postsynaptic contributions to 
the fluorescence signals recorded. One possible approach to assessing whether 
functional transmission could occur across the synaptic gap in stimulated 
synaptoneurosomes might involve the use of presynaptic release-modifying toxins 
such as botulinum or tetanus toxin. 
There are clearly many further avenues of research to be followed to more fully 
characterise these models of dynamic functional responses in ex vivo CNS tissue 
preparations. The validation of the general approach provided in the current study 





Chapter 5: General discussion 
Many studies indicate that neurochemical and neurophysiological changes contribute 
to pain arising from injury to the nervous system. Tissue injury results in the release 
of pro-nociceptive mediators that sensitise peripheral nerve terminals (peripheral 
sensitisation), leading to neurochemical and phenotypic alterations of sensory 
neurons and increased excitability of spinal cord dorsal horn neurons (central 
sensitisation). In addition, the response of the nervous system to pain is not static, but 
is modulated by descending systems originating in the brain that can modulate pain 
thresholds.  
Central sensitisation may involve functional changes in the influence exerted by 
central neurons, including inhibitory interneurons, anatomical changes in the 
connectivity of non-nociceptive terminals (although this is still a controversial area) 
and variations in the sensitivity or cellular influence of postsynaptic receptors. The 
excitatory ionotropic NMDA and AMPA receptors that respond to glutamate are 
important mediators of synaptic transmission in the central nervous system (CNS). 
AMPA receptors are widely distributed across the spinal dorsal horn and they not 
only mediate the fast excitatory information transmission in response to acute 
peripheral stimulation, but also play a pivotal role in transmission during chronic 
neuropathic pain (Furuyama et al., 1993; Garry et al., 2003b; Platt, 2007).  The 
translocation of GluA1 subunit-containing AMPA receptors into synapses is believed 
to enhance synaptic transmission and contribute to synaptic plasticity in long-term 
potentiation (LTP) in hippocampal neurons (Shi, 2001). Activation of NMDA and 
AMPA receptors may directly or indirectly increase intracellular Ca
2+
 concentrations, 
thereby activating cascades serving to alter membrane excitability and protein 
expression as well as protein trafficking. Ca
2+
-dependent proteins such as CaM 
kinase II and perhaps Ca
2+
-dependent activators of the Ras/MAPK pathway (ERK) 
may play a crucial role in bringing about GluA1 translocation underlying LTP. 
Following nerve injury, phosphorylation of extracellular signal-regulated protein 





increase is long-lasting in dorsal horn neurons (Ji et al., 1999). It is further possible 
that the expression of Ras-GEFs such as Sos-1, key upstream regulators of ERK, 
may be altered in spinal neurons in response to peripheral noxious stimulation. 
Here, attention is given to the synaptic alterations in expression of GluA1 subunit-
containing AMPA receptors and phosphorylated ERK within spinal dorsal horn in the 
chronic constriction injury (CCI) model (Bennett and Xie, 1988), using biochemical 
methods to help elucidate neuropathic pain mechanisms. These studies in both adult 
and neonatal neuropathic pain re-challenge models necessitated considerable 
refinement and optimisation of procedures to allow their application to very small 
tissue samples. In addition, I developed entirely new protocols enabling the 
assessment of neurophysiological responses of the CNS including cortex and spinal 
cord to stimulation by multiple receptor systems in ex vivo neural tissue. This novel 
approach may lead to the discovery and development of novel pharmacological 
interventions that may have clinical utility, not necessarily limited to treating 
neuropathic pain. 
5.1 Increased synaptic translocation of GluA1 
subunits in spinal dorsal horn after noxious 
challenge 
In the present study, synaptic translocation of GluA1 in spinal cord was increased by 
peripheral nerve injury (i.e. CCI) in adult rats or by formalin stimulation in young 
adult rats. Formalin caused greater synaptic insertion of GluA1 in animals that had 
received neonatal CCI and since recovered, compared to uninured controls. The 
findings were consistent with the hypothesis I had proposed, that increased 
translocation of spinal GluA1 subunit-containing AMPA receptors into postsynaptic 






In young animals with nerve injury at P8, Western blots showed an increased 
expression of GluA1 subunits in ipsilateral spinal dorsal horn compared to the 
contralateral side, which is not generally reported in adults. In adult animals, 
although it has been reported that the expression of the GluA1 subunits was not 
changed in the superficial dorsal horn of the spinal cord after intradermal injection of 
capsaicin in adult rats, the subcellular location of the GluA1 subunits may be altered, 
since phosphorylation of GluA1 at S831 and S845, which modifies trafficking, is 
dramatically increased (Fang et al., 2003b). Some studies support such an idea 
because GluA1 subunit-containing AMPA receptors in crude membrane fractions are 
elevated by CFA injection (Park et al., 2008) or intra-colonic instillation of capsaicin 
(Galan et al., 2004). In addition, translocation of GluA1 subunits to synapses is 
found following acute noxious stimulation and suggests that GluA1 trafficking may 
play a role in nociceptive transmission (Larsson and Broman, 2008). Taken together, 
I conclude that incorporation of GluA1 subunit-containing AMPA receptors to 
synapses is caused by nerve injury and may play a key part in underpinning the 
chronic hyper-responsive pain state. 
GluA1 may additionally be present in other cell types such as glial cells. It has been 
reported that the expression of GluA1 in astrocytes is upregulated after spinal cord 
injury (Gomez-Soriano et al., 2010). With the subcellular fractionation technique 
here, I reported for the first time that GluA1 levels are increased in neuronal 
postsynaptic densities of the spinal dorsal horn following peripheral nerve injury. 
Although I cannot be entirely certain that the increased GluA1 content in synapses 
represents fully functional receptors and contributes to the synaptic transmission in 
neuropathic pain state, this seems most likely to be the case.  
If animals subjected to CCI at P8 (that had then recovered from the mechanical 
hypersensitivity caused by that injury) were subsequently challenged with 
intraplantar formalin, this acute stimulus became able to elicit a significantly greater 
synaptic incorporation of GluA1. This corresponded with a greater degree of 
formalin-induced nocifensive behaviours in these animals. No such enhancement of 





recovered before a formalin challenge. Taken together, these findings indicate that 
increased levels of GluA1 in the PSD fraction correspond to the states of sensory 
hyper-responsiveness, either in a chronic situation, established adult CCI pain state, 
or an acute situation (formalin re-challenge) in neonatally injured and recovered rats. 
Neonates therefore display a lasting potential for hyper-responsiveness to later life 
noxious stimuli or „pain memory‟ that is not observed after adult injury. Therefore, 
the expression and the distribution of GluA1 subunit in spinal dorsal horn appear to 
be key factors in nociceptive processing that are tightly regulated through the whole 
of life. Many additional factors may of course play a part in bringing about the 
lasting hyper-responsiveness following early life nerve injury, for example potential 
changes in neuronal circuitry, but little is yet known of such processes.  
I then sought to explore the signalling events contributing to GluA1 trafficking and 
potentially also the lasting susceptibility to hyper-responsiveness observed in 
neonatally injured animals.  
The origin of the increased level of GluA1 subunits in the postsynaptic density is not 
clear. Two potential mechanisms could account for such an upregulation of synaptic 
receptors: redistribution of existing membrane receptors to synaptic sites or 
translocation of intracellular receptors into synaptic membranes. Correspondingly, 
two major trafficking theories for GluA1 recruitment to synapses have been proposed. 
One theory supports the first mechanism, which the additional synaptic GluA1 
subunits originate from extrasynaptic membrane of dendrites or spines. It has been 
reported that lateral movement of GluA1 subunit-containing AMPA receptors from 
non-synaptic spine plasma membranes enhances the number of these receptors at the 
synapse in hippocampal neurons (Makino and Malinow, 2009). The non-synaptic 
expression of GluA1 may serve as an extra-synaptic pool, which is replenished by 
exocytosis during subsequent plasticity. 4.1N may act as a regulator for GluA1 
translocation to synapses since 4.1N can associate with the membrane proximal 
region of the C-terminal tail of GluA1 in vivo and disruption of the interaction of 
GluA1 with 4.1N decreased the surface expression of GluA1 and attenuated LTP in 





the subcellular location in 4.1N of näive adult spinal dorsal horn, which was found to 
be predominantly in the PSD fraction, where it may co-localise with GluA1 subunits. 
The GluA1 co-immunoprecipitation results which showed increased association of 
GluA1 with 4.1N after nerve injury in adult spinal dorsal horn, may well support the 
idea of a facilitatory role for 4.1N in the synaptic insertion of GluA1.  It has been 
suggested that the exocytosis of GluA1 does not directly increase the number of 
synaptic GluA1 subunits and may not occur at the same time as lateral movement 
(Makino and Malinow, 2009). An alternative, earlier theory suggests that GluA1 
subunit-containing AMPA receptors are transported to synapses directly by 
exocytosis through secretory pathways originating from endoplasmic reticulum 
(Broutman and Baudry, 2001). The increased level of GluA1 subunits at synaptic 
sites is accompanied by decreased levels of this subunit at intracellular sites and can 
be inhibited by brefeldin A (BFA), which inhibits anterograde protein secretion from 
the Golgi apparatus (Broutman and Baudry, 2001). Therefore, the precise basis for 
GluA1 trafficking mechanisms remains incompletely understood and further 
investigation is needed. 
5.2 Contribution of the Ras/MAP kinase 
pathway to the neuropathic pain 
Multiple inflammatory mediators released from damaged tissue not only acutely 
excite primary sensory neurons in the peripheral nervous system, producing 
accentuated or ectopic discharge, but also lead to a sustained increase in their 
excitability. Hyperexcitability also develops in the central nervous system (for 
instance, in dorsal horn neurons), and both peripheral and spinal elements contribute 
to neuropathic pain, so that spontaneous pain may occur or normally innocuous 
stimuli may produce pain. Inflammatory mediators and aberrant neuronal activity 
activate several signalling pathways including Ras/MAP kinases in dorsal horn 
neurons that mediate the induction and maintenance of neuropathic pain through both 





In animals that had received early life nerve injury and had since recovered from the 
mechanical allodynia that this induced, intraplantar formalin evoked a greater 
(statistically significant) activation of ERK in the NSSP fraction. Similar but less 
marked observations were made in the PSD fraction. These observations are 
consistent with a role of ERK in contributing to the signals driving synaptic insertion 
of GluA1-containing AMPA receptors. One possible mechanism for enabling greater 
responsiveness to further noxious challenges (despite all overt signs of sensory 
hyper-responsiveness having recovered) might be a long-lasting increase in the 
expression of key regulators of such signalling pathways (such as GTP-exchange 
factors for the small G protein Ras) even though they are not active under quiescent 
recovered conditions. In the ERK pathway, such a rate-limiting regulator could be 
the Ras-GEF, Sos-1. Indeed the current experiments provide preliminary data to 
suggest exactly this; enduring elevated expression of Sos-1 maintained long after 
early life (now recovered) nerve injury and its possible further increase ipsilateral to 
a subsequent formalin challenge. My working hypothesis so far is therefore that this 
maintained elevation of Ras-GEF expression following neonatal injury may be 
responsible (at least in part) for the „pain memory‟ ie lasting susceptibility to noxious 
hyper-responsiveness in later life.    
5.3 Dynamic receptor responses in isolated ex 
vivo neural tissue  
In Chapter 4 I set about trying to develop and validate a new methodological 
approach that would enable fluorometric measurements to be made on live acutely 
isolated neural tissue preparations. Given that I could isolate and sustain such 
samples under conditions that would preserve or allow the restoration of ion 
gradients through metabolic activity, I then hoped to be able to use no-wash 
fluorometric dyes to monitor changes in intracellular Ca
2+
 and membrane potential. 
Careful consideration was given to the tissue preparation procedure. In preparing the 
tissue samples, neural shock may follow because of the traumatic disruption of the 





minimise this, I used special additions to buffers based around a classical Krebs-
Henseleit buffer (Krebs and Henseleit, 1932). The special precautions involved rapid 
removal of tissues, rigorously maintaining oxygenation, initial cooling (to try to 
avoid toxic metabolite accumulation) and blockade of NMDA-type glutamate 
receptors and voltage-sensitive Ca
2+
 channels in high Mg
2+
 concentrations (hence 
reduced synaptic transmission and neurotoxic Ca
2+
 entry), together with metabolic 
supplementation with a glycolytic intermediate and energy source. The technique 
was tested by two different kinds of fluorescent dyes and consistent, concentration-
dependent responses were detected to various receptor stimuli.  These findings 
demonstrate that this technique had been successfully set up and validated for use in 
further studies. 
The responses of noradrenergic, cholinergic, and serotonergic receptors in frontal 
cortex of rats were examined separately or in combination with ionotropic glutamate 
receptor responses using the new developed technique.  
Noradrenaline is a catecholamine with multiple roles including as a stress-related 
neurotransmitter in the autonomic nervous system and the CNS. Noradrenaline 
increases excitability in parts of the brain where alertness and responses to danger are 
controlled, most likely through its receptor-mediated signalling pathways up-
regulating excitatory processes or down-regulating inhibitory processes. Along with 
adrenaline secreted from the adrenal glands, noradrenaline also underlies the fight-
or-flight response (Bracha et al., 2004), increasing heart rate, triggering the release of 
glucose from energy stores, and increasing blood flow to skeletal muscle. As a 
neurotransmitter, noradrenaline can also suppress neural inflammation when released 
diffusely in the brain from the Locus Coeruleus (Heneka et al., 2010). Furthermore, 
cortical noradrenergic pathways promoted by interleukin-1 (IL-1) release are 
involved in changes in sensory processing that involve NMDA receptors (Kamikawa 
et al., 1998). The present work indicates that intracellular concentrations of Ca
2+
 are 
increased by activation of adrenergic receptors or ionotropic glutamate receptors 
frontal cortex segments. Although it was not possible to unequivocally demonstrate a 





the present conditions. I suspect that these receptors and their signalling pathways 
may be activated and work together in animals when they face noxious challenges in 
real life. 
Acetylcholine is involved in synaptic plasticity by enhancing the amplitude of 
synaptic potentials following LTP in many regions in brain including dentate gyrus, 
hippocampus and cerebral cortex (Matsuyama et al., 2000; Wu et al., 2001; Lopes 
Aguiar et al., 2008). It has been reported that Ca
2+
 entry through 7 subunit-
containing nicotinic acetylcholine receptors is critical for the induction of NMDA 
receptor-independent LTP in hippocampus (Wu et al., 2001; Jia et al., 2010). 
Muscarinic cholinergic neurotransmission enhances the late phase of LTP in rat 
hippocampus in vivo (Lopes et al., 2008), so both nicotinic and muscarinic 
acetylcholine receptors could contribute to enhanced transmission. Intracellular 
signals from muscarinic acetycholine receptors also modify the levels of productions 
of noradrenaline and serotonin in the CNS (Lopes et al., 2008). A recent study 
showed that noradrenaline depletions facilitates the release of acetylcholine and 
serotonin in the hippocampus, illustrating a further level of functional interaction 
(Heneka, 2009). These findings suggest a monoaminergic network exists in the brain 
to regulate synaptic transmission, as exemplified by LTP. Here, I illustrated that 
intracellular Ca
2+
 concentrations increased following activation of cholinergic 
receptors in frontal cortex, especially in combination with activation of combined 
ionotropic glutamate receptors, and that this joint response was further amplified by 
prior noradrenaline stimulation.   
Serotonin (5-hydroxytryptamine)-containing neurons originating from the brainstem 
Raphe nuclei also innervate diverse regions of the CNS, where they exert a variety of 
roles, for example, in affective and associative processing, sleep and at 
brainstem/spinal levels, in regulation of sensory processing. In frontal cortex, 
pyramidal cells, thalamic afferents and interneurons receive serotonergic inputs and 
respond (especially via 5-HT2A receptors) with generally increased excitability to 
other inputs (Aghajanian and Marek, 1997; Jakab and Goldman-Rakic, 1998; Puig et 





between AMPA and 5-HT2A receptor responses in increasing excitability levels 
within frontal cortex.  
5.4 Management of neuropathic pain 
Pain relief can be approached using a number of different therapies, which work by 
reducing the sensitivity of nociceptive receptors, interrupting nociceptive 
transmission, and activating inhibitory receptors in spinal cord or descending 
inhibitory pathways originating from the brainstem. For example, stimulation of non-
nociceptive receptors can inhibit the transmission of nociceptive information in the 
dorsal horn of spinal cord, which means that painful stimuli can be „gated‟ out using 
non-painful stimuli, as a basis of „Gate Control‟ theory (see details in section 1.2). 
The proposed „Gate Control‟ system is not directly targeted by current analgesic 
agents, which interact with a variety of distinct peripheral and central targets instead. 
One example study showed that ralfinamide, a sodium channel blocker, suppressed 
Na
+
 currents in dorsal root ganglion and reduced pain responses in an animal model 
of neuropathic pain (Yamane et al., 2007) pointing to Na
+
 channel blockade as a 
potential therapeutic strategy. Similarly, gabapentin, a blocker of 21 Ca
2+
 channel 
subunits in nociceptive afferents is an effective analgesic for neuropathic pain (Rose 
and Kam, 2002). However, the most common analgesic strategy is to manipulate the 
function of interneurons through opioid receptors by administration of exogenous 
morphine or its analogues to attenuate pain. Opioid analgesics are drugs that exert 
their influence through activation of opioid receptors to reduce pain transmission at 
synapses in the dorsal horn of spinal cord. Opioids also stimulate noradrenergic, 
serotoninergic and enkephalinergic neurons in the brainstem that descend to the 
spinal cord and further inhibit the relay neurons of the Spinothalamic tract. The side 
effects of opioid analgesics are that repeated doses may cause dependence so that a 
withdrawal syndrome may be seen after sudden termination. Therefore, they are not 
recommended as first line treatments. Favoured treatments are antidepressants, 
anticonvulsants (such as gabapentin and Na
+
 channel blockers), and topical agents 





desensitise nociceptive TRP channels). The mode of action of antidepressants such as 
selective serotonin-noradrenaline re-uptake inhibitors (SNRIs) is probably to re-
inforce the activation of receptors that respond to descending noradrenergic and 
serotoninergic pathways and thereby limit pain signals in spinal cord and minimise 
their ascent to the brain.  
With current therapeutic strategies for chronic neuropathic pain, only 40-60% of 
patients achieve relief, which in itself is only partial and is undermined by 
problematic side effects (Dworkin et al., 2007). Novel specific drugs that relieve 
neuropathic pain but do not disturb normal somatosensory processing would 
represent the gold-standard target for the development of next-generation analgesics. 
It is anticipated that the developments made in the current work; ie the optimisation 
of quantitative biochemical techniques to a smaller scale than before, together with 
the newly developed techniques for assessing dynamic receptor responsiveness of 
living ex vivo neural tissue samples will play a future part in identifying new 
molecular targets for analgesia. Their contribution to this process would be by 
helping to elucidate the mechanisms that bring about hyper-responsiveness, which 
would highlight potential targets for intervention. Ultimately, such improved 
treatments may serve to fill the unmet need of efficacious analgesia for chronic pain 
states. The application of these approaches may benefit not only sufferers from 
neuropathic and other types of chronic pain states, but potentially also help in 
elucidating the events underlying other neurological and psychiatric dysfunctional 
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